|
|
·|û¡Ghung120110149413 µoªí®É¶¡:2020/6/24 ¤U¤È 02:11:23
|
¥«³õº¨£·sÃÄ(¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸) Àø®Ä¤ÀªR p=0.009 6634 ªYÄ£ ªÑ¥»: 3.832»õ ¥Dn·~°È: ¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo ¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤) ¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤) Ä~Äò©¹¤U¬Ý...! ============================================================================= ²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ) ¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ« 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.µL¦w¥þ©Ê°ÝÃD ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x ¬ãµo¶¥¬q: 1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á 2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ Àø®Ä¤ÀªR¡G 1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n 2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009) ============================================================================= ²£«~02¡GSNP-630 ¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE) 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~ ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡ 4.µL¦w¥þ©Ê°ÝÃD ¬ãµo¶¥¬q: 1.Á{§É«e 2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C 3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C Àø®Ä¤ÀªR¡G 1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05 ============================================================================= ²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯) ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯) ²£«~Àu¶Õ: 1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê 2.¸Ñ¨M¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs) 3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ« 2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^ 3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O ¬ãµo¶¥¬q: 1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç 2.¤w¥Ó½ÐUSFDA¼Ï纽Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D 3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç ============================================================================= ²£«~04¡GSNP-830/ SNP-840 ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B««×¯kµh) ²£«~Àu¶Õ: 1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è 2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è 2.½Æ¤è¤w¥Ñ¬ü°êFDAn¨D°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä 3.¦³¨Ï¥Î±M§Q¡A¥iקï©Î§R°£FDA¨x¬rĵ»y 4.¥i¼W¥[¤AñQÓi×ô¾¯¶q ¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A°§C¦¨Å}°Æ§@¥Î 5.¤GªÌ¾Ü¤@±ÂÅv 6.¥i¼W¥[¥«¦û²v ¬ãµo¶¥¬q: 1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ýn¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ ============================================================================= ***************************************************************************** SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G 1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 ============================================================================= ***************************************************************************** ¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G 1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv 2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv 3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv ============================================================================= ***************************************************************************** ¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@p¹º §Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó ¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ùȱo´Á«Ý¡A¦³¾÷·|¬O ¤U¤@Ó ¦X¤@ ÄÆªÑ ----------------------------------------------------------------------------- ¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×) |
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/12 ¤W¤È 10:03:20²Ä 2709 ½g¦^À³
|
³Ìªñµoªíªº´X½g½×¤å¡A§ó¤ã¹ê¹v¦VCYP2E1ªºNASHªvÀø®ÄªG¡C 1. 2012.12.14-aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.26200 ¬ã¨sªí©ú¡ACYP2E1 ¹ï RIPK3 ªºªí¹F°µ¥X¤F«¤j°^Äm! CYP2E1 ªº¯Ê¥¢°fÂà¤F¤A¾J¤¶¾Éªº RIPK3 ªí¹F¡A¦Ó RIPK3 ªº¯ÓºÜ¨Ã¥¼§ïÅܤA¾J³B²z»¤¾Éªº CYP2E1 ªí¹F¤É°ª¡Aªí©ú CYP2E1 §@¬° RIPK3 ªº¤W´å°^ÄmªÌ¡C 2. 2022.6.23 -www.nature.com/articles/s41419-022-05009-y ¤HÃþ RIPK3 C¸ÁC»Ä¤Æ¹ï©óÃa¦º«H¸¹¶Ç¾É¦ÜÃö«n 3. 2021.12.17 www.nature.com/articles/s41419-021-04442-9 ³o¨Ç¼Æ¾Ú[º¦¸ÃÒ©ú]¤F RIPK1 ¤¶¾Éªº²ÓM¦º¤`¦b¤HÃþ©Mø¥¾¦°Êª« ACLF ¤¤ªº«n©Ê¡C §Ṳ́§«e´¿³ø¾É¹L ACLF ±wªÌµo¥Í«Dä¤`©Ê²ÓM¦º¤`ªº«n©Ê [ 9 ]¡CACLF ±wªÌ RIPK3 ´`Àô¤ô¥ªºÅãµÛ¼W¥[¤ä«ù RIPK1 ¤¶¾Éªº²ÓM¦º¤`¥i¯à¬O¨ä§@¥Î¾÷¨îªºÆ[ÂI¡CRIPK3 »P RIPK1 ©M pMLKL ¤@°_¬OÃa¦º©Êä¤`³~®|ªºÃöÁä²Õ¦¨³¡¤À¡C «nªº¬O¡ARIPK3 ¤ô¥»P¥þ¨ª¢¯g¼Ð»xª«±K¤Á¬ÛÃö¡A³o¤w³QÃÒ©ú¬O ACLF µo®iªº®Ö¤ß¾÷¨î ¦]¬°¦b¤@¨Ç¬ã¨s¤¤¹v¦V RIPK3 ¤¶¾ÉªºÃa¦º©Êä¤`¥i¦³®Ä¹w¨¾ APAP »¤¾Éªº«æ©Ê¨x°IºÜ¡A¦ý¦b¨ä¥L¥O¤H¾á¼~ªº¬O¡A¦b¤M¨§ ²y³J¥Õ A (ConA) »¤¾Éªº¦Û¨§K¬Ì©Ê¨xª¢¤¤¡ARIPK3 ¯Ê¥¢¨ã¦³«OÅ@§@¥Î¡A¦Ó RIPK1 §í¨î·|¥[¼@¯e¯f¡B¥[³t°Êª«¦º¤`¡A¨Ã ¥B»P¨x²ÓM¦º¤`¼W¥[¦³Ãö¡C ³o¤@Æ[¹îµ²ªG±o¨ì¤F¨âÓ±wªÌ¶¤¦C¼Æ¾Úªº¤ä«ù¡A¨ä¤¤ RIPK3 ´`Àô¤ô¥¤É°ª»P±wªÌ±q AD ¶i®i¬° ACLF¡BACLF ªºÄY«µ{«× ©Mµu´Á¦º¤`²v¬ÛÃö¡Cºî¤W©Òz¡A¸Ó¬ã¨sªí©ú¡A´`Àô RIPK3 ¥i¯à§@¬°¤@ºØ¼ç¦bªº¥Íª«¼Ð»xª«¡A¥Î©ó¿ï¾Ü±wªÌ±µ¨ü°w¹ï RIPK1 ¤¶¾Éªº²ÓM¦º¤`ªºÃĪ«ªvÀø¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/9 ¤W¤È 10:13:18²Ä 2708 ½g¦^À³
|
³o¦¸¬O¤£¬O¯uªº¡m¯T¨Ó¤F¡n?§Æ±æJP¦b10.17¥X®u¬ü°êÃľǮa¦~·|«á¡A¦A¦¸±Æ³X«e10¤jÃļt! 1.2022.9.22-ªYÄ£¤îµhÃÄÅçÃÒ µL¨x¬r©Ê(±Nµ²ªG´£¨Ñµ¹¦³»P¤½¥qñq¦³Àv¦X¬ù¤§°ê»Ú¤îµhÃļt°Ó) 2.2022.10.17JP¦b¬ü°êÃľǮa¦~·|µoªí-«D°sºë©Ê¯×ªÕ¨x©w¶q¨x¥\¯àÀË´ú eventscribe.net/2022/PharmSci360/fsPopup.asp?Mode=posterinfo&PosterID=528564 3.2022.10.19-ªYÄ£¯×ªÕ¨xª¢·sÃĤG´ÁÁ{§Éµ²ªG ¦b¬ü°êÃľǮa¦~·|µoªí 4.2022.10.30-ªYÄ£¤îµh·sÃĸÑÂê40¦~¨x¬r©Ê°ÝÃD °ê»Ú¤j¼t±ÂÅv¦b±æ(¦¶¸³±µ¨ü¤¤¥¡ªÀ±M³X)¡u¿ïÃD¡B¤H¤~¡B´¼¼z°]²£«OÅ@¦n¤£¦n¡B°]°È±Ã©w«×¡A³£¬O·sÃĤ½¥q¦¨¥\ªº¥ý¨M±ø¥ó¡v ·sÃĶ}µo_¿ïÃD www.facebook.com/100064104724409/videos/1202540343488971/?__so__=watchlist&__rv__=video_home_www_playlist_video_list -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 08:52:57²Ä 1956 ½g¦^À³ 05_·sÃĶ}µo_¿ïÃD J¤j¯«¦b14:15¬í°_:...½Í¨ì³Ì«á ¥L»¡±z̯ण¯à ³o®a.§Ú´N¶R±z̪ºªÑ²¼°Ú.§ë¸ê±z̪ºªÑ²¼°Ú...§Ú»¡ ¥xÆWªºªÑ²¼¤Ó«K©y..¹ï¤£°_ ¤£¦æ ±zn´N¶Rcompound ±z·Q¶R[¤½¥q] §Ṳ́£½æ±z....½Í¨ì³o¼Ë£²... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/8 ¤U¤È 07:03:40²Ä 2707 ½g¦^À³
|
³o2¦~¤º±µ³s¸ÕÅ祢±Ñªº3¤ä¤îµhÃÄ¡A±ÂÅvª÷«Ü¥iÆ[(辉·ç18»õ¬ü¤¸ /ACP-044¦~±ÂÅv»ùÈ8.87»õ¬ü¤¸/ ¥x·LÅé6.7»õ¬ü¤¸¤îµhÃÄ)! www.pharmavoice.com/news/pain-med-non-opioid-addiction-free-South-Rampart-Pharma/637665/ ¤å¤¤´£¤Îªº¤îµhÃĪ«ACP-044¡A¤µ¦~4¤ë«Å¥¬¸ÕÅ祢±Ñ! ACP-044¦b2020¦~±ÂÅv»ùÈ(8.87 »õ¬ü¤¸): ®Ú¾Ú¥æ©ö¡AACADIA ¥H 5250 ¸U¬ü¤¸ªº»ù®æÁʶR¤F CerSci ªº©Ò¦³¬y³qªÑ¡C¦¹¥~¡A¦pªGÀò±o§åã¡ACerSci ªÑªF¥i¯à·|Àò ±o°ª¹F 8.87 »õ¬ü¤¸ªº¶}µo¡B°Ó·~©M¾P°â¨½µ{¸O¡A¥H¤Î²b¾P°âÃBªº¤¤µ¥Ó¦ì¼Æ¯S³\Åv¨Ï¥Î¶O¡C ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/9/23 ¤U¤È 01:10:22²Ä 1420 ½g¦^À³ 23»õ¬ü¤¸±ÂÅvª÷ªº·s«¬¤îµhÃÄ¡A3¤ë¦b¬ü°êFDA½²î¡A¤W¶g¤S¦b¼Ú¬wEMA½¨®! ªvÀø°©Ãö¸`ª¢(osteoarthritis)¤SºÙ¬°°h¤Æ©ÊÃö¸`ª¢ªº²Ä1½uÃĪ«:¤AñQÓi×ô»P«DÃþ©T¾J®øª¢¤îµhÃÄ(NSAID). 2006¦~¡A辉·çªá¤F约5亿¬ü¤¸¦¬购Rinat Neuroscience¡A进¦Ó获±o¤FTanezumab¡Cþ÷来¦b2013¦~ÉO辉·ç签订¤F¤@¥÷°ª达18亿¬ü¤¸ªº协议... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/8 ¤U¤È 06:40:27²Ä 2706 ½g¦^À³
|
2022.12.1- µL¬rµLÅ}¡G·s«¬¤îµhÃĪº«e´º ¬°¤°»ò South Rampart Pharma ªº·s«¬¤À¤l¥i¯à¦¨¬°¸Ñ¨M¥þ²y¯kµh¬y¦æ¯fªºÃöÁä¡C www.pharmavoice.com/news/pain-med-non-opioid-addiction-free-South-Rampart-Pharma/637665/ ¦pªG±z¦¨¥\±N¨ä±À¦V¥«³õ¡A±z¬Æ¦Ü¥i¥H¹w´ú¸ÓÃĪ«ªº»ùȬO¦h¤Ö¡H ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/21 ¤U¤È 12:33:43²Ä 2636 ½g¦^À³ ²Ä2®a¬ü°ê¶¤South Rampart Pharmaªº SRP-001¨S¦³¨x¬r©Ê¨S¦³µÇ¬r©Ê--Á{§É¸ÕÅç¦h¾¯¶q»¼¼W(MAD)¨ì4000mg(4g)??? ¹wpP1µ²ªG±N¦b 2023 ¦~²Ä¤G©u«×¤½§G¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/4 ¤U¤È 05:01:34²Ä 2705 ½g¦^À³
|
NASHªºµo¯f¾÷¨î¤Ó½ÆÂø¡A·sªº¬ã¨sµ²ªG¤£Â_´é²{¡AGSKªá10»õ¬ü¤¸±ÂÅvªºÃĪ«¡A¤p¹«¼Ò«¬²£¥Í¤F¤£¤@Pªºµ²ªG¡AÁÙ¦Ûµoµo®i¬°¿ðµo©Ê¯×ªÕ¨x¡C 1. 2021.3.16 Hsd17b13 ¯Ê³´¤£¯à«OÅ@¤p¹«§K¨üPªÎD©Ê¶¼¹·l¶Ë www.ncbi.nlm.nih.gov/pmc/articles/PMC8627256/ 2. 2022.7.16(2011¦~¿Õ¨©º¸¥Í²zÂå¾Ç¼ú±o¥DBruce Beutlerªº½×¤å) www.nature.com/articles/s41467-022-31812-4 ...³Ìªñªº¤@½g½×¤å³ø¾É¤F¤@Ó¤£¦PªºÆ[¹îµ²ªG¡A§YHsd17b13°ò¦]ºV°£¤p¹«¦b´XºØ¯×ªÕ¨x»¤¾Éªº¶¼¹±ø¥ó¤U¡A¦b¨x¯×ªÕÅÜ ©Ê¡B¨x·l¶Ë¡BÅÖºû¤Æ©Mª¢¯g¤è±»P WT ¤p¹«¨S¦³®t²§! 3. 2022.1.7 («nì³ÐªÌ:Ĭ¤å) www.ncbi.nlm.nih.gov/pmc/articles/PMC8776652/ ¥O¤HÅå³Yªº¬O¡A³Ìªñ¹ï HSD17B13 °ò¦]ºV°£¤p¹«ªº¬ã¨sªí©ú¡AHSD17B13 ¯Ê¥F¯g¥¼¯à«OÅ@¨xŦ§K¨ü°ª¯×ªÕ¶¼¹¡B¦è¤è¶¼ ¹©M°sºë¼ÉÅS¤Þ°_ªº¯×ªÕÅÜ©Ê·l¶Ë¡A³oªí©ú HSD17B13 ¯Ê¥F¯g¥i¯à¹ï¤p¹« NAFLD ¨S¦³«OÅ@§@¥Î¼Ò«¬¡C¦P¼Ë¡A¥t¤@²Õ³ø §i»¡¡A¯Ê¥F HSD17B13 °ò¦]ªº¤p¹«¦b 9 Ó¤ë¤j®É¦b¥¿±`¶¼¹¤U¦Ûµoµo®i¬°¿ðµo©Ê¯×ªÕ¨x.³o¨Ç·N·Q¤£¨ìªºµ²ªG¥Ø«e¯Ê¥F ¾÷¨î¸ÑÄÀ¡A»Ýn¶i¤@¨B¬ã¨s¡C ---------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/3 ¤U¤È 01:47:05²Ä 2700 ½g¦^À³ GSKªº10»õ¬ü¤¸±ÂÅvª÷¡A«nì³ÐªÌ¦b2014¦~µoªíªº½×¤å©~µM¦³[±m³J]Åå³ß! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/12/4 ¤U¤È 02:29:05²Ä 2704 ½g¦^À³
|
¦n¹³ÁÙ¬O¦³¥X9±iªº¼Ë¤l?!¦ý¬O½Ö§Ú²q¤£¨ì¤F ¥»¶g¸ÉÓ¦ì¼Æ¦^·í©`¦Ì¤á ======================== ºÃ? 2¦ì¶^¯}¤d«á¡A´X¶g¨Ó«ç»ò¤£½æ¤F??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/4 ¤W¤È 09:15:27²Ä 2703 ½g¦^À³
|
¶Ç¥XGSK©Î¦¨¬°¿ÕµØ¼ç¦b¦¬ÁʥؼÐ? 2022.11.30--GSK is a potential buyout candidate for Novartis - Intron Health |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/12/3 ¤U¤È 04:04:35²Ä 2702 ½g¦^À³
|
¦A¦^¹L¥h°Q½×¯d¨¥¬Ý¡A¦]gsk2®a¦b2018¦~´N¤wñ¦X§@¨óij¡A¨º®ÉªYÄ£ÁÙ¯u¨S¦³¬Ü¥Ø¡A¤º¤ß¥i¥HÄÀÃh¤F¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/12/3 ¤U¤È 03:28:03²Ä 2701 ½g¦^À³
|
gskËß10»õ¬ü¤¸¦b°¯×ªÕ¨x¦X§@±ÂÅv¨ºÁûÃÄ¡A¶i«×©MÀø®Ä¤ñªYÄ£ºC©M®t¡I¡H¨S§äªYÄ£ÆZ¥i±¤¡IYµ¹15»õ¬ü¤¸¨âÁûÃĦh¦n¡AªÑªF¤]ÅwªY¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/3 ¤U¤È 01:47:05²Ä 2700 ½g¦^À³
|
GSKªº10»õ¬ü¤¸±ÂÅvª÷¡A«nì³ÐªÌ¦b2014¦~µoªíªº½×¤å©~µM¦³[±m³J]Åå³ß! ±m³JP values <0.01: retinol metabolism:ARO-HSD¬O°w¹ï³o¤@¹vÂI³]pªºRNAiÀøªk¡A¥i¥H§í¨î³o¤@°ò¦]ªí¹FªºHSD17£]13³J¥Õ(¨xŦµø¶À¾J²æ²B酶)ªº²£¥Í--->GSKªº10»õ¬ü¤¸±ÂÅvª÷! metabolism of xenobiotics by cytochrome P450, drug metabolism--->SNP-610»PSNP-630 1. 2022.11.19 奋¤æªÌ¨¬迹 | °ò础¬ì¬ã´N¬O¦bÆÓ数¦¸¥¢败¤¤«e¦æ m.mp.oeeee.com/a/BAAFRD000020221119741302.html 2. 2014½×¤å: www.pnas.org/doi/10.1073/pnas.1410741111 ... Interestingly, a group of cytochrome P450 family proteins, such as cyp2E1, cyp4A11, and cyp2C9, was also found to be associated with the LDs and up-regulated in fatty liver, perhaps suggesting that these cytochrome P450 enzymes are involved in the development of NAFLD ...there was an enrichment in 4 KEGG pathways with P values <0.01 (i.e., retinol metabolism, metabolism of xenobiotics by cytochrome P450, drug metabolism, and linoleic acid metabolism) (SI Appendix, Table S8). In the retinol metabolism pathway, 11 enzymes involved were up-regulated in the LDs of fatty livers ------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/11/26 ¤U¤È 11:03:33²Ä 1487 ½g¦^À³ ¤p¤À¤lÃĪ«»PRNAÀøªk¦a¼Æ¾Ú: SNP-610 ALT¡BAST显µÛ¤U° mops.twse.com.tw/nas/STR/663420190724M001.pdf VS 2021.11.23---GSK¯{10»õ¬ü¤¸Äâ¤âArrowhead ¶}µo«D°sºë©Ê¯×ªÕ¨xRNAiÀø(¹w¥I1.2»õ¬ü¤¸) www.drugtimes.cn/2021/11/26/10yimeiyuangskyinjinarowheaddenashrnailiaofa/ 100mg¥H¤W剂¶q组¡AALT¡BAST显µÛ¤U° |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/3 ¤W¤È 09:48:30²Ä 2699 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/19 ¤W¤È 09:55:09²Ä 2674 ½g¦^À³ ¤j·§¬O¦~ªì¨´¤µ¡A«ùªÑ¤d±i¥H¤W¡A¨C¶g©T©w½æ¥X´X¤Q±i¡A§Ú¤£t³d¥ôªº±À´ú¥X¨º2¤H! ---------------------------------------------------------------------------------------------------- ºÃ? 2¦ì¶^¯}¤d«á¡A´X¶g¨Ó«ç»ò¤£½æ¤F??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/2 ¤U¤È 03:35:32²Ä 2698 ½g¦^À³
|
¤@¼Ë½M¤lºN¶H(¦Û¥H¬°¬O)¡A¦p¦³¤j¤j¥h¹qªYÄ£¨DÃÒ¡A½Ð¤£§[«ü¥¿! Cordyceplen²q´ú¬O Cordycepin + Ceplene ªº¤Æ¦Xª«??? 1.J¥®®E §Ü¯f¬r药ªü©õ¬¥韦经¥Ö§l¦¬¨î剂.pdf - 专§Q -¥d敌ûÒ(Cordycepin) www.zhuanlichaxun.net/p-319243.html 2. 2019.6.14 Âίó¯À(Cordycepin)ªºªvÀø¼ç¤O©M¥Íª«¾ÇÀ³¥Î¥H¤Î²£Âίó¯À¯uµßªº¥NÁ¾÷¨î www.mdpi.com/1420-3049/24/12/2231/htm 3.2021.2.12 Âίó¯À(Cordycepin)³q¹L¿E¬¡ AMP ¿E¬¡³J¥Õ¿E酶«H¸¹³q¸ô§ïµ½«D°sºë©Ê¯×ªÕ©Ê¨xª¢ aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.31749 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/2 ¤W¤È 09:20:07²Ä 2697 ½g¦^À³
|
¥u¯à½M¤lºN¶H¤F!¥ÌÅS¾J¥i¼W±jCepleneªºÂíµh§@¥Î??? Ceplenitol 1. Ceplen: Histamine dihydrochloride¡]°Ó«~¦WCeplene¡^¬O¤@ºØ²ÕÓiÆQ¡A¤]¬O FDA §å㪺§½³¡Âíµh¬¡©Ê ¦¨¤À¡A¥Î©ó¼È®É½w¸Ñ»PÃö¸`ª¢¡B³æ¯Â©ÊIµh¡B·ï¶Ë¡B§á¶Ë©M©Ô¶Ë¬ÛÃöªº¦Ù¦×©MÃö¸`ªº»´·L¯kµh©M¯kµh¡A nitol:mannitol(¥ÌÅS¾J) SNP-810½á§Î¾¯ 2.2020.11.26 ¥ÌÅS¾J¼W±jf®ü©Ô©ú(Diphenhydramine)§@¬°´À¥N§½³¡³Â¾K¾¯ªºÂíµh§@¥Î www.ncbi.nlm.nih.gov/pmc/articles/PMC7714595/ ³Ìªñ³ø¾É¥ÌÅS¾J¥i¦³®Ä¼W±j§Q¦h¥d¦]ªºÂíµh§@¥Î¡C ...¥»¬ã¨sº¦¸ÃÒ©ú¥ÌÅS¾J¥i¼W±jf®ü©Ô©úªºÂíµh§@¥Î¡C |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/12/1 ¤U¤È 09:24:00²Ä 2696 ½g¦^À³
|
½Ð°Ý¦U¦ì¤j¤j¬O§_ª¾¹D³o¤TÓµù¥U°Ó¼Ð µù¥U¤é´Á2018-3-1 FATTIDOTE ¦r¸q¤WÀ³¸Ó¬O´î«ÃÄ µù¥U¤é´Á2021-10-1 Cordyceplen µù¥U¤é´Á2021-12-1 Ceplenitol |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/1 ¤U¤È 03:30:17²Ä 2695 ½g¦^À³
|
这Ïú¨u见ªº¯×ªÕ组织亚¸s¡A©Î许¯àûñ§Ú们§ó¦nªºú£ªÎ! 2021.1.7 ¼¶¤å | 陈¤åüL¡]«¢¦ò¤j学³Õ¤h¦Z¡^(2020.10.28 nature¤å³¹¾ÉŪ) www.linkresearcher.com/theses/2c809fcd-0744-4f49-a040-53d3a1705a13 CYP2E1ªí达阳©Êªº¯×ªÕ细M¥i¯à参ÉO调±±产热®Ä应¡C ´£¥ÜALDH1A1+CYP2E1+细M¥i¯àªí达¬Y个®Ç¤Àªc¦]¤l来§í¨î´Ä¦â¯×ªÕ细Mªº产热®Ä应¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤W¤È 11:15:56²Ä 2021 ½g¦^À³ ...2.2020.10.28 Nature³o½g:www.nature.com/articles/s41586-020-2856-x ...µo²{¤@Ó»P²£¼ö¦³Ãöªº°ò¦] Aldh1a1¡A¸Ó°ò¦]»P Cyp2e1 Ãö«Yºò±K¡CAldh1a1 »P Cyp2e1 ¬V¦âµ²ªG¦b¦UºØ¯×ªÕ²Õ´ ¤¤§e²{¥X§¹¬üªº«¦X¡A¶i¤@¨B¦LÃÒ¤F¥¦ÌªºÃö«Y¨Ã¤£¤@¯ë¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/1 ¤U¤È 01:32:18²Ä 2694 ½g¦^À³
|
Âù²¸±[(CYP2E1§í¨î?)¨Ï¤p¹«Ê^«4©Pú£轻40%¡I www.eurekalert.org/news-releases/744765 ...¡§·í§Ú̬ݨì¼Æ¾ÚÅã¥Ü¤p¹«ÌÅé«ÆJ´î¡A¶V¨Ó¶V½G¡A§Ú̱±¬Ûòó¡A²ª½¤£´±¬Û«H¦Û¤vªº²´·ú¡C¡¨³o¶µ¬ã¨sªº²Ä¤@§@ªÌMichel Bernier³Õ¤h»¡¹D¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/12/1 ¤U¤È 12:36:02²Ä 2693 ½g¦^À³
|
©¹©õªYÄ£6¡B8¨tÀu²§¬ãµoªí²{¡F¦b¨xŦ¸Ñ¬r¡B»Ã¯À¥¥x¹ï§Ö³t´îªÎ¨Åé¥NÁª«¸Ñ¨Mµ¥¡AªYÄ£¬O±j¶µ¤]¤ñ§O®a·sÃĬãµo¤½¥q¦ûÀu¶Õ¡CY¤½¥q¦³³W¹º´îªÎÃĬãµo¡A¬O¥þªÑªF¡B¥þ¤HÃþ¤§ºÖ¡A«D±`¤ä«ù¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/1 ¤W¤È 10:24:56²Ä 2692 ½g¦^À³
|
±q®É¶¡¥ý«á¨Ó¬Ý¡A杨¨q伟团队·|±´¯ÁCYP2E1§ÜªÎD§@¥Î(¬ã¨s½×¤å±NCYP2E1¡VPPAR £\¶b©w¸q¬°ªÎDªvÀøªº·sªvÀø¹vÂI)¡A¥i¯à¬O¬Ý¨ì2020¦~ªºÂù²¸±[±j¤jªº§ÜªÎD§@¥Î©Ò±Òµo¡C ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/30 ¤U¤È 10:15:00²Ä 2690 ½g¦^À³ Ê^«4©Pú£轻40%¡I(CYP2E1 §í¨î?) 2020.05.19 www.163.com/dy/article/FCVT73P105349C3F.html ..ªA¥Î双²¸仑ªº¤p¹«们¡A¥X现ªº变¤Æ让¬ì学®a们·P¨ì·N¥~¡C尽ºÞ¤´¦b¦Y°ª¯×ªÕ¹ª«¡A¹¶q¤]没¦³变¤p¡A¥¦们ªºÊ^««D¦ý没¦³¼W¥[¡A还«æ剧¤U°¡C¤×¨ä¬O¤j剂¶q双²¸仑组ªº¤p¹«¡Aµuµu¥|©P内¡AÊ^«³Ì¦hú£轻达40%.. ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/29 ¤W¤È 10:20:26²Ä 2035 ½g¦^À³ ¥N谢酶(CYP2E1)ÉO®Ö¨üÊ^(PPAR£\)¤§间¦p¦ó协§@调±±¯×ªÕ´Ä¦â¤Æ¤ÎªÎD发¯f鲜见报¹D¡C 杨¨q伟团队ªº½×¤å´N¬O2022.5¤ë³o½gwww.sciencedirect.com/science/article/pii/S2211383522000545 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/30 ¤U¤È 10:26:19²Ä 2691 ½g¦^À³
|
Âù²¸±[[¨ã¦³±j¤jªº§ÜªÎD§@¥Î]¡A¤]¦³«Ü±j¤jªº°Æ§@¥ÎºÙ¬°[Âù²¸¨Ú¼Ë¤ÏÀ³]¡A¨¬¥HÅýÃļt¿³½ì¯Ê¯Ê. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/30 ¤U¤È 10:15:00²Ä 2690 ½g¦^À³
|
Ê^«4©Pú£轻40%¡I(CYP2E1 §í¨î?) 2020.05.19 www.163.com/dy/article/FCVT73P105349C3F.html ..ªA¥Î双²¸仑ªº¤p¹«们¡A¥X现ªº变¤Æ让¬ì学®a们·P¨ì·N¥~¡C尽ºÞ¤´¦b¦Y°ª¯×ªÕ¹ª«¡A¹¶q¤]没¦³变¤p¡A¥¦们ªºÊ^««D¦ý没¦³¼W¥[¡A还«æ剧¤U°¡C¤×¨ä¬O¤j剂¶q双²¸仑组ªº¤p¹«¡Aµuµu¥|©P内¡AÊ^«³Ì¦hú£轻达40%.. ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤U¤È 12:12:56²Ä 2024 ½g¦^À³ ..FDA §å㪺¥Î©óªvÀø°sºë¤¤¬rªºÃĪ«Âù²¸±[ [¨ã¦³±j¤jªº§ÜªÎD§@¥Î]¡A¦Ó³o¨Ã«D³q¹L¨ä¹ïîDzæ²B酶2(ALDH2)ªº§í»s§@¥Î¨Ó¹ê²{ªº¡C¦bµ²ºc¤W¡AÂù²¸±[¥i¥H¥NÁ¦¨ DDC¡ACYP2E1 §í»s¾¯¡A¦]¦¹¥i¥H¦X²z¦a±ÀÂ_Âù²¸±[ªº§@¥Î¥i¯à¬O³q¹L¨ä¥NÁª« DDC ¤¶¾Éªº CYP2E1 §í¨î¡C ---------------------------------------------------------------------------------------------- SNP¤]¸Ó±´¨s¤@¤U´îªÎ®ÄªG! |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/11/29 ¤U¤È 02:35:22²Ä 2689 ½g¦^À³
|
¦bªYÄ£°Ýµª§ä¨ìµª®×¡A2016¦~¬ü°ê¤AñQ¦w×ô³B¤è¡B«D³B¤èÀ禬40»õ¬ü¤¸¡A¦Ê¤À¤§¥|±À¤É¤µ¦~¬O50»õ¬ü¤¸¡F8¨t2ÁûÃĵL¨x¬rµÇ¬r§l¤Þ¤O¡A¥þ²y¶W¹L150»õ¬ü¤¸¡A¤À¼íª÷5¦Ê¤À¤ñºâ¡A¨CªÑÁÈ300¤¸¡F6¨tµ¥630¤G´Áµ²ªG¥X¨Ó¡A´N¬O±ÂÅv¦¨¼ô¤F¡A±N¤ñ8¨t§ó¾_¾Ù¡I¤j®aºÖ®ð°Õ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/27 ¤U¤È 02:51:54²Ä 2688 ½g¦^À³
|
2022¦~4¤ë¦P¦æµoªíªº¬ã¨s½×¤å[¤@Ó¥H«e¥¼³Q»{ÃѪºMBL¾÷¨î]¡A«Ü¦n¦a¸ÑÄÀ¤FSNP-610/SNP-630¯àÅãµÛ°§C¨xŦÅÖºû¤Æªº¾÷¨î!!! SNP-610´Á¤¤¤ÀªR:F4ªº²Õ¡AªvÀø«e«á¦³[ÅãµÛ®t²§] 1. 2022.4.¤ëwww.sciencedirect.com/science/article/pii/S2352345X22000637 §Ú̪º¬ã¨sµ²ªG´¦¥Ü¤F¤@Ó¥H«e¥¼³Q»{ÃѪº¾÷¨î¡A¨ä¤¤ MBL-HSC ¬Û¤¬§@¥Î«P¶i HSC °I¦Ñ©MÀH«áªºÅÖºû¤Æ½w¸Ñ¡A¬°»P¨xÅÖºû¤Æ¬ÛÃöªº CLD ªºªvÀøµ¦²¤´£¨Ñ¤F¨£¸Ñ¡C ³o¨Ç¼Æ¾Úªí©ú¡A¨xŦ MBL ªí¹Fªº«ì´_½w¸Ñ¤F¥Ñ©ó MBL ¯Ê¥F¤Þ°_ªº¨xÅÖºû¤Æ¶i®i¡A³o·N¨ýµÛ MBL ¦³§U©ó§ïµ½¨xÅÖºû¤Æ¶i®i¡C«ì´_¨x MBL ªí¹F´X¥G§¹¥þ®ø°£¤F¥Ñ©ó MBL ¯Ê¥¢¾ÉPªº¨xÅÖºû¤Æ¥[«¡A´£¨Ñ¤F MBL ¦³§U©ó§ïµ½¨xÅÖºû¤ÆªºÃÒ¾Ú¡C Á`¤§¡A§Ú̪º¼Æ¾Ú´£¨Ñ¤F¥O¤H«HªAªºÃÒ¾Ú¡AÃÒ©ú MBL ¹ï©ó±±¨î¨xÅÖºû¤Æ¶iµ{¦ÜÃö«n 2. 2008¦~ pubmed.ncbi.nlm.nih.gov/18336595/ »P¤¤«×ÅÖºû¤Æ±wªÌ¡]F2 ´Á¡^¬Û¤ñ¡A««×ÅÖºû¤Æ±wªÌ¡]F4 ´Á¡^»P§C¤ô¥MBL¡]XA/XA¡BXA/YO ©M YO/YO¡^¬ÛÃöªº°ò¦]«¬Åã µÛ°§C¡]P = 0.04) ©M¹ï·Ó²Õ (P = 0.011)¡C ---------------------------------------------------------------------------------------------------- ·|û¡GRock00910149258 µoªí®É¶¡:2022/10/19 ¤U¤È 05:04:37²Ä 2619 ½g¦^À³ 1.¨Æ¹êµo¥Í¤é:111/10/19...¤@¡BSNP-630ªvÀøªº¤p¹«ªº¨xµoª¢¡B¨x¯×ªÕÅÜ©Ê©MÅÖºû¤Æ±o¨ìÅãµÛ§ïµ½¡A¨äALT¤ô¥¡B ÅÖºû¤Æ¬ÛÃö¥Íª«¼Ð°O¡]§Yalpha-SMA¡BCol1a1¡BCol3a1©MTimp-1¡^§¡ÅãµÛ°§C¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/7/3 ¤W¤È 08:30:15²Ä 2172 ½g¦^À³ F4°ò¥»ºâ¬O¥Ø«eÃĪ«¬ãµoªº¸T°Ï¡A¯e¯f¶i®i¨ì¨xµw¤Æ¤§«á¦A°fÂà¬O«D±`§xÃøªº¡A¦pªG¯à°µ¥XÀø®Ä¡A¯uªº´N¤jº¡³e¤F¡C ©Ò¥HSNP-610´Á¤¤¤ÀªR:F4ªº²Õ¡AªvÀø«e«á¦³[ÅãµÛ®t²§]---¹Ú´K¥H¨D¦Ó¥B¬Ý¨ì$$$ª÷¥ú°{°{$$$ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/27 ¤U¤È 12:18:59²Ä 2687 ½g¦^À³
|
¬°¦óSNP-810½á§Î¾¯:¥ÌÅS¾J»P¤T´â½©¿}¯à¸Ñ¨M¨x¬r©Ê°ÝÃD? ©³¤Uªº¬ã¨s½×¤å»P¼v¤ù¦³µª®×!(¥ÌÅS¾J»P¤T´â½©¿}-->MBL-->§í¨îCYP2E1-->´î¤ÖAPAP¨x¬r©Ê) 1. 2019.2.1 ¥ÌÅS»EÁÞµ²¦X¾®¶°¯À(MBL)³q¹L ROS ¨Ì¿à©Ê JNK/SP1 ³q¸ô½Õ¸` CYP2E1 ªí¹F¡A±q¦Ó´î»´¹ï¤A酰®ò°ò×ô»¤¾Éªº¨x¬r©Ê onlinelibrary.wiley.com/doi/full/10.1002/eji.201847830 MBL ¬O¤@ºØ·½¦Û¨xŦªº´`Àô¦å¼ß³J¥Õ....³o¨Ç¼Æ¾Úªí©ú MBL ¦b APAP »¤¾Éªº«æ©Ê¨x·l¶Ëªºµo¯f¾÷¨î¤¤§í¨î CYP2E1 ªí¹F¡C 2.Lectin Pathway of Complement System www.youtube.com/watch?v=9Y0q_z2o-_c ¾®¶°¯À³~®|©l©ó¥ÌÅS¿}µ²¦X¾®¶°¯À (MBL) ©Î»P¬Y¨Ç¿}µ²¦XªºÅÖºû½¦³J¥Õ¡C¦b¸Ó³~®|¤¤¡Aµ²¦X¥ÌÅS¿}ªº¾®¶°¯Àµ²¦X¥ÌÅS¿}¡B¸²µå¿}©Î¨ä¥L¨ã¦³ 3- ©M 4-OH °ò¹Îªº¿} |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/27 ¤W¤È 11:12:21²Ä 2686 ½g¦^À³
|
J&J¨S¸Ñ¶}ªº¨x¬r©Ê! 2022.8¤ë-J&J¶}µoªºµL¨x¬rTylenol(JNJ-10450232)¬ã¨s³ø§i www.sciencedirect.com/science/article/abs/pii/S0273230022001234 JNJ-10450232 (NTM-006) ¬O¤@ºØ·sªº¤À¤l¹êÅé¡A¨äµ²ºc»P¹ï¤A酰®ò°ò×ô¬Û¦ü¡A¥i¦b°Êª«©M¤HÃþ¤¤´£¨ÑÃþ¦üªºÂíµh§@¥Î¡A¦Ó¤£·|¦bÁ{§É«e¼Ò«¬¤¤¤Þ°_»P¹ï¤A酰®ò°ò×ô¹L¶q¬ÛÃöªº¨x¬r©Ê¡C ¦h¾¯¶qµ¹ÃÄ«á¡A¶À´³¥Ö¯l©M¥þ¨©Ê¬õ´³¬O³Ì±`¨£ªºÃĪ«¬ÛÃö¤£¨}¨Æ¥ó¡C ------------------------------------------------------------------------------------------------ ¹ïSNP-810¤£ºc¦¨«Â¯Ù¡A¤è¤è±±¨Ó¬ÝSNP-810¬Ò³Ó¥X! 1.J&J¦b2019.10.10±NJNJ-10450232½æµ¹Neumentum¤½¥q(NTM-006) www.thepharmaletter.com/article/neumentum-nabs-j-j-pain-molecules 2.P2¸ÕÅç°±¯d¦b2017¦~clinicaltrials.gov/ct2/show/NCT02209181?term=JNJ-10450232&draw=2&rank=1 3.³o¤äNTM-006»P¤§«e´£¹Lªº3®a¬ü°ê¶¤¦P¼Ë¬OAPAPµ²ºcÃþ¦üª«¡A±q쪫®Æ»P»sµ{³]³ÆÅܰʪº»s³y¦¨¥»¡A»PAPAPµ²ºcÃþ¦üª«¦s ¦³ªº¦w¥þ©ÊµS¥¼ª¾?(SNP-810½á§Î¾¯:¥ÌÅS¾J»P¤T´â½©¿}¦bÂåÃÄ·~»P¹«~·~¤w¨Ï¥Î¼Æ¤Q¦~) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/27 ¤W¤È 09:17:51²Ä 2685 ½g¦^À³
|
¯}»õ¤F!!! 2022.11.24¥@¤W³Ì¶QÃľ¯Àòã¤W¥« ¤A«¬¦å¤Í¯f°ò¦]Àøªk¨C¾¯©w»ù¶W¹L1»õ¤¸¥x¹ô FDA§åã¿D¬wÃļtCSL Behringªº¤A«¬¦å¤Í¯fªº°ò¦]ÀøªkHemgenix¡A³o¬O¤@ºØ¤@¦¸©Ê¿é²G¡A¦³§U±wªÌ§K©ó±`³WªvÀø¡A¦ý¬OCSL±N¨C¤@¾¯©w»ù¬°350¸U¬ü¤¸¡]¬ù1.09»õ¤¸¥x¹ô¡^¡A¦¨¬°¥@¬É¤W³Ì©ù¶QªºÃĪ«¡C ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/8/18 ¤U¤È 12:44:04²Ä 2324 ½g¦^À³ ¥k¤âÂå«O°ê½Íªk®×¤j¤M¬åÃÄ»ù¡A¥ª¤â¤Sµ¹¤F¥v¤W³Ì©ù¶QªºÃĪ«»ù280¸U¬ü¤¸! 2022.8.18 ¥v¤W³Ì©ù¶QªºÃĪ«©w»ù°ª¹F280¸U¬ü¤¸ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/25 ¤W¤È 08:23:48²Ä 2684 ½g¦^À³
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/8/16 ¤U¤È 01:47:04²Ä 2317 ½g¦^À³ ...¸zªc¯ÀÃĪ«¬O±q°§C¹¼¤¤Î©µ¿ð±ÆªÅG³¡ªº®ÄªG¨Ó¹F¦¨´îªÎªº®ÄªG¡A¦Ó SNP-610/630 ¬O´î¤Ö¯×ªÕ§Î¦¨¤ÎÂà´«¨x¯×ªÕªº¯S©ÊÅܦ¨¤£¶Ë¨x¡A¤£¬O±q¼ö¶qÄá¨ú·½ÀYµÛ¤â¡A§Ú²q®ÄªG¥i¯à¨S¦³¸zªc¯ÀÃĪ«¨ÓªºÅãµÛ´î¤ÖÅé«¡A¦ýªÖ©w¬O¦³¨ó¦Pªº®ÄªG¡C ------------------------------------------------------------------------------------------------ GLP-1°§C¹¼¤´î¤Ö¼ö¶qÄá¨ú + SNP(§í¨îCyp2e1¼W¥[¼ö¶q®ø¯Ó)-->2ªÌÁpÃĪº¨ó¦P´îªÎ®ÄªG¤j·§·|«ÜÅå¤H! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/25 ¤W¤È 08:09:47²Ä 2683 ½g¦^À³
|
¯S§O¬O¡ACyp2e1¯Ê¥F¼W¥[¯à¶q®ø¯Ó!!! --------------------------------------------------------------------------- 2022.8¤ë¬ã¨s论¤å¡G细M¦â¯ÀP450 2E1°ò¦]ºV°£©Î§í¨î³q过调节¯à¶q®ø¯Ó预¨¾°ª¯×饮¹诱导ªºªÎDwww.sciencedirect.com/science/article/abs/pii/S0006295222002544 ¾÷¨î¬ã¨sªí©ú¡ACyp2e1¯Ê¥F¤£¶È¼W¥[´Ä¦â¯×ªÕ²Õ´¡]BAT¡^©M¥Ö¤U¯×ªÕ²Õ´¡]SAT¡^¤¤²£¼ö°ò¦]ªºªí¹F¡A¦Ó¥B«P¶i¨xŦ©MBAT¤¤ªº¯×ªÕ»Ä¥NÁ¡C¯S§O¬O¡ACyp2e1¯Ê¥F³q¹L¼W¥[¨xŦ¥Í¦¨ªº酰°ò¦×ÆP¦Ó¼W¥[¯à¶q®ø¯Ó¡A酰°ò¦×ÆP¥i¥H«P¶i´Ä¦â¯×ªÕ²£¼ö¨Ã¼W¥[£]-®ñ¤Æ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/25 ¤W¤È 06:08:31²Ä 2682 ½g¦^À³
|
1.¦b¥»¬ã¨s¤¤ªº¤@ÓÅå¤Hµo²{¬O CYP2E1 ¯Ê¥F·|¿E¬¡¥Õ¦â¯×ªÕ[½ÅÅÜ]....³o¨Çµo²{±N CYP2E1-PPAR £\¶b©w¸q¬° [ªÎDªv Àø] ªº·sªvÀø¹vÂI¡C 2.´îªÎ·s¤èªk¡I±N¯×ªÕ¡u½ÅÅÜ¡v¥i¼W¿U¯×®Ä²v ¦¶³Í¥Áªí¥Ü...¦P®É±N¥[³t¯×ªÕ¨x·sÃÄSNP-610¶}µo¡Aº¥ý±NÂX¼W1¿ªº¬ãµo¤Hû<--->ªÎDªvÀø¥«³õ¥i¯à¦b 250 »õ¦Ü 270 »õ¬ü¤¸¤§¶¡¡A¤£±´¨sªÎDªvÀø¤Ó¥i±¤¤F!!! -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤W¤È 11:15:56²Ä 2021 ½g¦^À³ 1.2022.5¤ë www.sciencedirect.com/science/article/pii/S2211383522000545 ³Ìªñªº¬ã¨s¶°¤¤¦b½Õ¸`«DŸ§Ý²£¼ö¥HªvÀøªÎD¯g...½Õ¸`²£¼ö[¯×ªÕ½ÅÅÜ]¡C³o¶µ¬ã¨sªº¤@ÓÅå¤Hµo²{¬O CYP2E1 ¯Ê¥F·|¿E ¬¡¥Õ¦â¯×ªÕ[½ÅÅÜ]¡A¦ñÀHµÛ®Ö¤ß·Å«×©M¯à¶q®ø¯Óªº¼W¥[ 2.2020.10.28 Nature³o½g:www.nature.com/articles/s41586-020-2856-x ...µo²{¤@Ó»P²£¼ö¦³Ãöªº°ò¦] Aldh1a1¡A¸Ó°ò¦]»P Cyp2e1 Ãö«Yºò±K¡CAldh1a1 »P Cyp2e1 ¬V¦âµ²ªG¦b¦UºØ¯×ªÕ²Õ´ ¤¤§e²{¥X§¹¬üªº«¦X¡A¶i¤@¨B¦LÃÒ¤F¥¦ÌªºÃö«Y¨Ã¤£¤@¯ë¡C ¼Æ¾Úªí©úAldh1a1 / Cyp2e1 +²ÓMªí¹F¤@ºØ®Ç¤Àªc¦]¤l¡A¥¦§í¨î´Ä¦â¯×ªÕ²ÓMªº²£¼ö¥\¯à¡C 3.´îªÎ·s¤èªk¡I±N¯×ªÕ¡u½ÅÅÜ¡v¥i¼W¿U¯×®Ä²v ¥Õ¦â¯×ªÕ²Õ´¡A¦¨¤HÅ餺´X¥G³£¬O³oÃþ«¬ªº¯×ªÕ¡A¥Dn¬O°µ¬°Àx¦s¥H¨Ñ«áÄò¨Ï¥Î¡C -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/25 ¤U¤È 11:04:16²Ä 2018 ½g¦^À³ CYP2E1 ¯Ê¥F·|¿E¬¡¨xŦ¹L®ñ¤Æª«酶Åé¼W´Þª«¿E¬¡¨üÅé£\ (PPAR£\ )¹v°ò¦]ªºªí¹F¡A¥]¬A¦¨ÅÖºû²ÓM¥Íªø¦]¤l (FGF) 21¡A³o¨Ç°ò¦]¦b±q¨xŦÄÀ©ñ«á¡A·|¼W±j¯×ªÕ½ÅÅÜ©M¯à¶q®ø¯Ó¡A±q¦Ó´î¤ÖªÎD¡C -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/11 ¤W¤È 09:54:26²Ä 2061 ½g¦^À³ 2022.6.10 §ÚÌ¥¿¦b¥H¤@ºØ·sªº¤è¦¡¬Ý«ÝªÎD¡X¡X4 ºØÂåÃĪѥi¯à·|¨ü¯q ..¾Ú´X¦ì¥«³õ¬ã¨s¤HûºÙ¡A2027-28 ¦~ªÎDªvÀø¥«³õ¥i¯à¦b 250 »õ¦Ü 270 »õ¬ü¤¸¤§¶¡ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/24 ¤U¤È 07:16:35²Ä 2681 ½g¦^À³
|
Ãz¬õªºSaxendaµ½ÅÖ¹F(½G½Gµ§)¡A¨Ó¦Û¤¦³ÁNovoNordisk¿Õ©M¿Õ¼wÃÄ«~¤½¥q¬ãµo! SNP610/630´îªÎ®ÄªG¯à¹F¨ì10%´N¦³¥«³õ¡A¤£¥Î·B¬ü¨ìGLP-1ªº20%! ------------------------------------------------------------------------------------------------- ·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/8/16 ¤U¤È 01:47:04²Ä 2317 ½g¦^À³ ´î«Ãijq±`¤j¥b®³¤£¨ì«OÀIµ¹¥I¡A¨S·Q¨ì³ºµM¯à½æ³o»ò¦n¡A»á¤H¥O¤H·N¥~¡C ¬d¤F¤@¤U¡Aì¨Ó¥xÆW¤w¸g¦³«Ü¦hÂå¥ÍÀ°·Q´îªÎªº¤H¨Ï¥Î¸zªc¯ÀÃĪ«(off lable use)¡A¥L̳qºÙ½G½G°w¡A¤@¦~ªºÃĪ«¶O¥Î 8~10 ¸U¡C Ò\«e¸pªø´¿°Ý¹LJ±Ð±Â¡ASNP-610/630 ¯à¤£¯à·í´îªÎÃĨϥΡAJ¯ºµÛ¦^»¡¤£¦æ¡C±µµÛ¤S»¡ªA¥Î SNP-610/630 ´Nºâ¦³¯×ªÕ¨x¤]¤£¦AÅܦ¨¯×ªÕ¨xª¢¡A¤£¥²´îªÎ¡C ¸zªc¯ÀÃĪ«¬O±q°§C¹¼¤¤Î©µ¿ð±ÆªÅG³¡ªº®ÄªG¨Ó¹F¦¨´îªÎªº®ÄªG¡A¦Ó SNP-610/630 ¬O´î¤Ö¯×ªÕ§Î¦¨¤ÎÂà´«¨x¯×ªÕªº¯S©ÊÅܦ¨¤£¶Ë¨x¡A¤£¬O±q¼ö¶qÄá¨ú·½ÀYµÛ¤â¡A§Ú²q®ÄªG¥i¯à¨S¦³¸zªc¯ÀÃĪ«¨ÓªºÅãµÛ´î¤ÖÅé«¡A¦ýªÖ©w¬O¦³¨ó¦Pªº®ÄªG¡C ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/8/6 ¤U¤È 07:24:51²Ä 2305 ½g¦^À³ 2021¦~¿Õ©M¿Õ¼wGLP-1ÃþÃĪ«ºâ¤W´îªÎ»â°ì¦Xp°^ÄmÀ禬¹F95»õ¬ü¤¸! Y¦bNASH¤]®³¨ìÃÄÃÒ¡A¿Õ©M³o¤äGLP-1ÃÄ(¿}§¿¯f+´îªÎ+NASH)°ª®pÀ禬µ´¹ï¯}200»õ¬ü¤¸¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/8/6 ¤U¤È 06:53:40²Ä 2304 ½g¦^À³ «¥ªº20»õ±o©¹¤W+17=37»õ¬ü¤¸¤F! 2022.3.8§â¿}§¿¯f药卖¦¨ú£ªÎ药¡I诺©M诺¼w2025¦~¡§发»}¡¨n卖¨ì37亿¬ü¤¸ www.sohu.com/a/527948439_359980 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/24 ¤W¤È 10:22:06²Ä 2680 ½g¦^À³
|
2022.11.24 -¡u½G½Gµ§¡v¤j¯Ê³f ¤@¤ä1000¤¸öt¨ì1¸U¤¸ «UºÙ¡u½G½Gµ§¡vªº©ö¶g¿}µ¥ÃÄ«~¤j¯Ê³f¡A¥x°Ó¤Î¶Q°ü©ê«è¶R¤£¨ìÃÄ¡A¦³ªº¶E©Ò¤§«e¦³§yÃÄ¡A²{¦b©_³f¥i©~¡A¡u쥻1¤ä1000¤¸´N¶R±o¨ì¡A²{¦böt¨ì1¸U¡v¡A»ù®æ½º¦9¦Ü10¿¡A®`¯u¥¿ªº¿}§¿¯f±wªÌªÌ®³¤£¨ìÃÄ¡A¹ê¦b¤ÓÂ÷ÃСC -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/8/16 ¤U¤È 04:27:24²Ä 2318 ½g¦^À³ §Ú·|¬°¡§¦n¬Ý¡¨¶R³æ´îªÎ! ¡§ÃCȸgÀÙ¡¨: ³o¬O¤@Ó¬ÝÁyªº®É¥N¡A©ÎªÌ»¡¬ÝÃCȪº®É¥N¡C m.21jingji.com/article/20210530/herald/fd370e54f45dfecbff7049c4877f2ec7_zaker.html |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/22 ¤W¤È 07:26:11²Ä 2679 ½g¦^À³
|
[·s«¬°t¤è¡uSNP-810¡v¡A¸g°Êª«¹êÅçµo²{¡A¥i²M°£¤j¹«¡B¤p¹«±µ¨ü°ª¾¯¶qAPAP¤Þ°_ªº¨x·l¶Ë©M²§±`¯f²zµ²ªG¡A¬Æ¦Ü¦bÄá¤JÁ`¾¯¶q°ª¹F8000 mg/kg¡B¬Û·í©ó70¤½¤çªº¤HÃþªA¥Î90§J¤U¡A¤´¹F¨ì¦s¬¡¡C] ¤W±ªº¤å¦r±Ôz¤£©ö©ú¥ÕSNP-810»P´¶®³¯kªº¨x¬r©Ê®t²§¦³¦h¤j¡AFBªº¤ñ¸û¹Ïªí¥iÅý±z²M·¡©úÁA®t²§¦³¦h¤j! ´¶®³¯k(2g/kg)6°¦¤j¹«¦b1~6¤p®É¤º¦º¥ú VS SNP-810(8g/kg)6°¦¨ì14¤Ñ¥þ¬¡µÛ ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/19 ¤W¤È 09:36:59²Ä 1994 ½g¦^À³ ..www.facebook.com/watch/?v=3194947797458964 ³o±i¤j¹«P¦º¾¯¶q¹ÏªíÀ³¸Ó´N¬O¥ÑGLP¹êÅç«Ç§¹¦¨ªº¸ÕÅç? P2000(mg/kg)´¶®³¯k:6°¦¤j¹«¦b1~6¤p®É¤º¦º¥ú / (S2000(SNP-810)6°¦¤j¹«¦Ü14¤Ñ¥þ¬¡µÛ. ... P8000(mg/kg)´¶®³¯k:6°¦¤j¹«¦b1¤p®É¤º¥þ¦º /(S8000(SNP-810)1°¦¤j¹«¦b4¤p®É¦º¥h¡A5°¦¤j¹«¨ì14¤Ñ¬¡µÛ. J³Õ»¡¦A°µ¤@¦¸¹êÅç(S8000(SNP-810)6°¦¨ì14¤Ñ¥þ¬¡µÛ. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/21 ¤W¤È 11:29:12²Ä 2678 ½g¦^À³
|
file:///C:/Users/USER/Downloads/105%E5%B9%B4%E5%BA%A6%E5%B9%B4%E5%A0%B1.pdf ±q105¦~³ø:ÄǸtªâ. 1,450±i / ÄÇ·çªl.1,450±i-->·N§Y2¤H¨S¦³°Ñ»P«á¨Óªº´X¦¸¼W¸ê! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/11/21 ¤W¤È 08:28:18²Ä 2677 ½g¦^À³
|
R¤j¸Ñ´b¤F ¤§«e¤@ª½²q¤£¨ì¬O½Ö¨C¶g³£¦b°½¥X¡A¤S¬Ý¤£¨ì¥Ó³ø(·Q»¡¬O¤£¬O¤jªÑªF??) ³o¼Ë¥i¥H§ä®É¶¡¦^¸É¤F ========================================================== ¤j·§¬O¦~ªì¨´¤µ¡A«ùªÑ¤d±i¥H¤W¡A¨C¶g©T©w½æ¥X´X¤Q±i¡A§Ú¤£t³d¥ôªº±À´ú¥X¨º2¤H! 110.4.12: ÄǸtªâ. 1,450±i / ÄÇ·çªl.1,450±i |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/11/20 ¤U¤È 12:11:22²Ä 2676 ½g¦^À³
|
±qª©«e¬Ý¬ü°ê¤AñQ¦w×ô40»õ¬ü¤¸À³¥]¬A³B¤è¡B«D³B¤è¡A¤~²Å¦X¥þ²y100»õ¬ü¤¸¡F¤§«e±À¦ô¿ù»~¡A©êºp¡IªYÄ£µL¨x¬r¡BµÇ¬r¡A¬O§¹¬ü¯«ÃÄ¡I8¨t100»õ¬ü¤¸¥«¦û¡A5¦Ê¤À²v¤À¼íª÷¡A¨CªÑÁÈ200¤¸¡A¤£·Q·íªÑ¤ý³£Ãø¡Iªø®É¶¡µ¥«Ý¡A6¨t§ó¬Oæfæf¬õ¬P¡I¤j®a®¥³ß¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/20 ¤W¤È 11:19:26²Ä 2675 ½g¦^À³
|
2022.11.18--¥_ºa¡u2022¦~°ê»Ú¤¤¬r¨¾ªv¬ã¨sµo®i¬ã°Q·|¡v health.ltn.com.tw/article/breakingnews/4127629 °ê¨¾Âå¾Ç°|±Ð±ÂJ¥®®E«ü¥X¡A°ê¤º¶}µo1ºØ·s«¬°t¤è¡uSNP-810¡v¡A¸g°Êª«¹êÅçµo²{¡A¥i²M°£¤j¹«¡B¤p¹«±µ¨ü°ª¾¯¶qAPAP¤Þ°_ªº¨x·l¶Ë©M²§±`¯f²zµ²ªG¡A¬Æ¦Ü¦bÄá¤JÁ`¾¯¶q°ª¹F8000 mg/kg¡B¬Û·í©ó70¤½¤çªº¤HÃþªA¥Î90§J¤U¡A¤´¹F¨ì¦s¬¡¡C .... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/19 ¤W¤È 09:55:09²Ä 2674 ½g¦^À³
|
¤j·§¬O¦~ªì¨´¤µ¡A«ùªÑ¤d±i¥H¤W¡A¨C¶g©T©w½æ¥X´X¤Q±i¡A§Ú¤£t³d¥ôªº±À´ú¥X¨º2¤H! 110.4.12: ÄǸtªâ. 1,450±i / ÄÇ·çªl.1,450±i --------------------------------------------------------------------------- ²z¥Ñ:1.³o¶g800±i¥H¤W13¤H¡A¶È¶È´î¤Ö6±i¡A¦ý¬O¤d±i¤j¤á«o¥Ñ12¤H´î¬°10¤H! 2.¤d±i¥H¤W´î¤Öªº±i¼Æ¡A2¦ìÄÇ®a¤H¦P¶i°hªº¥[Á`¼Æ³Ì§k¦X¡C(¦¶¸³»¡¥L¥u¼W¥[¤£´î¤Ö) |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/11/11 ¤U¤È 12:05:37²Ä 2673 ½g¦^À³
|
¦]¬°°ê¥~«ß®v®³¨ìªº¿ú¬OµLªk·Q¹³~~¤£n°Ý¬°¤°»ò~~¿Ë¨¸Õ¹L ¦ýÀ°§A®³¦^¨Óªº¤]¬O¬Û¹ï¦h«Ü¦h °ê¤º «¢«¢ ¥u·|«»@10W??50W?? °ê³»©Ô·sÃÄ·Q¸É¸É¤£¦^¨Ó¨ì300ªºÞ»î ¤@±i´NÁȦh¤Ö¤F ¦Eºâ§r |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/11/11 ¤W¤È 10:02:55²Ä 2672 ½g¦^À³
|
«Ü¥i±¤¡A¥xÆW¨S¦³³oºØ¨DÀv¨î«×¡I ¤£µM´N¤£·|¦³¡uÂûÀn¡v¡B¡u¸¹³»¡v¡B¡uªG³»¡v¡B¡u¿|ºÝ¡v µ¥µ¥¨Æ±¡µo¥Í ¸ê°T¬Û¹ï¤£¹ïºÙ¡A´²¤á§ë¸ê¤H¥ô¤H®_³Î¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/11 ¤W¤È 09:44:12²Ä 2671 ½g¦^À³
|
¤@¼ËªºÄF§½¡A°ê¥~°¨¤W´£§i¯Á½ß! --------------------------------------------------------------------------------------------- 2022.11.10 Schall «ß®v¨Æ°È©Ò«Å¥¬¥¿¦b½Õ¬d°w¹ï Veru Inc. ªº¯Á½ß¡A¨Ã¹ªÀy¾D¨ü·l¥¢ªº§ë¸êªÌÁpô¸Ó¤½¥q ¥þ°êªÑªFÅv§Q¶D³^¤½¥qSchall Law Firm«Å¥¬¡A¥¦¥¿¦b¥Nªí Veru Inc.¡]¡§Veru¡¨©Î¡§¥»¤½¥q¡¨¡^¡]¯Ç´µ¹F§JªÑ²¼¥N½X¡GVERU ¡^ªº§ë¸êªÌ½Õ¬d¯Á½ß) ¹H¤ÏÃÒ¨éªk¡C ½Õ¬dªº«ÂI¬O¤½¥q¬O§_µo¥¬¤Fµê°²©M/©Î»~¾É©Ê³¯z©M/©Î¥¼©ÜÅS»P§ë¸êªÌ¬ÛÃöªº«H®§¡C¦b FDA ¿Ô¸ß©eû·|§ë²¼¤Ï¹ï¬°¨ä COVID-19ÃĤY VERU-111±ÀÂË EUA «á¡AVeru ªºªÑ»ù¦b 2022 ¦~ 11 ¤ë 10 ¤éªº½L¤¤¥æ©ö¤¤¤U¶^¤F 51%¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/11/10 ¤U¤È 07:08:29²Ä 2670 ½g¦^À³
|
ªYÄ£8¨t±ÂÅv®ø®§¥²µM·|¨Ó¡AªÑ»ù¤]·|º¦Â½¤Ñ¡I¤@¸ô¤W¤WÂd¡B8¨t±ÂÅv¡BY¦³§Ö³t¬ð¯}§ó¦n¡B¤À¼íª÷«Ü§Ö®³¨ì¡B6¨t±ÂÅv¦X§@¡BÃÄÃÒ¡B¥XÃĤÀ¼íª÷¡A§Ö3¦~ºC5¦~¡m§Ú¤£À´²qªº¡n¤~¯à§¹¦¨¡AªYÄ£ªÑ»ù¹FÄA®p¡C¤@©w¤£¯à«æ«æ¤]¨S¦³¥Î¡AºCºC¨Ó¡C¤j®a·í°Ñ¦Ò¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/11/10 ¤W¤È 08:46:59²Ä 2669 ½g¦^À³
|
R¤j§Ö¶}ª÷¤f¥[«ù·sÃıÂÅv³t«×¤Îª÷ÃB!!!! Åý¤j®a¦n¹L¥V¡A°Ý¤½¥q³£»¡¦³®ø®§·|¤½§i ª©¤Wªº¦P§Ó¡G¾Ä°_§a~¥u°P¦¨¥\¤£³\¥¢±Ñ~~ ============================================== VeruªºEUA¸g¹L¿E¯P°Q½×«á¡A¥H8¤ñ5ªº§ë²¼结ªG¡A¥¢±Ñ!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/10 ¤W¤È 07:12:29²Ä 2668 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/8 ¤W¤È 08:17:11²Ä 2398 ½g¦^À³ Veru stockÃzº¦®É¡A«¥´£¥Xĵ¥Ü:¤£ª¾¹D¸ê®Æ¯u°°©Ê¡A«¥Âର«O¦u¬Ý«ÝEUA! 10¤ë6¤éFDAÃĪ«¿Ô¸ß©eû·|°Q½×ªº«ÂI±N¥]¬A¦b¦w¼¢¾¯¦º¤`²v°ªªº±¡ªp¤UªºªvÀø®ÄªG¤j¤p¡A¦w¥þ¼Æ¾Ú®wªº¦³¤j¤p¡A¥H¤Î½T©wÀÀijªº¤H¸s¡C [¦w¼¢¾¯¦º¤`²v°ª]¬OªÅ¤èªº§ðÀ»µJÂI¡A¤µ¤Ñ¬Ý°_¨Ó¯u¤£¹³ªÅ¥Þ¨Ó·! ----------------------------------------------------------------------------------------------- VeruªºEUA¸g¹L¿E¯P°Q½×«á¡A¥H8¤ñ5ªº§ë²¼结ªG¡A¥¢±Ñ!!! |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/11/6 ¤U¤È 12:24:55²Ä 2667 ½g¦^À³
|
ªñ´Á±qª©«e¸ê°Tµo²{¬ü°ê¤AñQ¦w×ô³B¤è«D³B¤è´N¹F67»õ¬ü¤¸¡A¤S¬ù¥e¥þ²y¤T¤À¤§¤@¡A¥þ²y°ª¹F¤G¦Ê»õ¬ü¤¸¤~¬O¡A¤ñ«e±¤j®a°Q½×µû¦ôÁÙ°ª¤@¿¡C´£¨Ñ¤j®a°Ñ¦Ò¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/11/4 ¤U¤È 01:57:23²Ä 2666 ½g¦^À³
|
³o¤@Áû°µ±o¦¨¥\´N¬O830³B¤èÃÄ¡F¥i¥H¥þ²y¤@¦¸±ÂÅv¡C¬O¶Ü¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/4 ¤W¤È 10:45:35²Ä 2665 ½g¦^À³
|
2022.10.30ªYÄ£¤îµh·sÃĸÑÂê40¦~¨x¬r©Ê°ÝÃD °ê»Ú¤j¼t±ÂÅv¦b±æ ¦¶³Í¥Á±µ¨ü¤¤¥¡ªÀ°OªÌ±M³X®Éªí¥Ü... ¦¶³Í¥Áªí¥Ü¡A¦bµL¨x¬r©Ê¤îµhÃÄSNP-810ÁÚ¤J·sªº¨½µ{¸O«á¡A[¤]±N¶i¦æ¤îµh¥[³Â¾K¾¯ªº½Æ¤è¤fªAÃÄ«~¬ãµo¡A¥Î¥H¦]À³¤¤«¯f¯kµh¡A¸Ñ¨M¥Ø«eÃþ¾~¤ù¤îµhÃĪ«¶Ü°Øµ¥¦¨Å}°ÝÃD]¡F¦P®É±N¥[³t¯×ªÕ¨x·sÃÄSNP-610¶}µo¡Aº¥ý±NÂX¼W1¿ªº¬ãµo¤Hû¡C ---------------------------------------------------------------------------------------------- 1.¤µ¤é¤½§iªºÂù°¼½¥Ãö¸`¸m´«¯f¤H³N«á¯kµh±±¨î¤§Á{§É¸ÕÅç¬O¥H¤W[ ]¤º®eªº©µÄò! 2.¦¹¦¸SNP-810»P¤£¦¨Å}¤î¼@µhÃĦX¨Ö§ë»P¤§¤AñQÓi×ô¾¯¶q¬°650²@§J¡A¸Ó¾¯¶q¤w¶W¹L¬ü°êFDA³W©w¤AñQÓi×ô½Æ¤è¾¯¶q¤£±o¶W¹L325²@§J¤§³W©w--->¹L°}¤l¬Ý¬ÝFDAÁ{§É¸ÕÅçºô¦³µLµn¿ý??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/4 ¤W¤È 10:28:57²Ä 2664 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/25 ¤U¤È 10:28:31²Ä 574 ½g¦^À³ »O¥_ºa¥ÁÁ`Âå°|¤HÅé¸ÕÅç©eû·|(¤@)²Ä 131 ¦¸·|ij¬ö¿ý ¤½§iª© ¶}·|®É¶¡¡G109 ¦~ 11 ¤ë 2 ¤é¤U¤È 2 ®É¥¿ pµe¥D«ù¤H¡G³¯¥¿Â× pµe¦WºÙ¡G·s±j®Ä¤£¦¨Å}¤îµh²Õ¦XÃÄ Sebacoyl Dinalbuphine Ester ¤Î [µL¨x¬r¤AñQÓi×ô]¥Î©óÂù °¼½¥Ãö¸`¸m´«³N«á¤§¤¤«×¦ÜÄY«¯kµhªvÀø ------------------------------------------------------------------------------------ °_ÀYªº¾Ç³N¬ã¨s¥ÎÁ{§É¸ÕÅç |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/11/4 ¤W¤È 08:43:29²Ä 2663 ½g¦^À³
|
¥»¤½¥qµL¨x¬r©Ê¤AñQÓi×ô¤îµh·sÃÄSNP-810 (¦w®õ®³¯k)Àò±oTFDA®Öã¶i¦æ©óÂù°¼½¥Ãö¸`¸m´«¯f¤H³N«á¯kµh±±¨î¤§Á{§É¸ÕÅç ³o±ß¤½§G¬O·Q?? ³æ¤@or½Æ¤è |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/11/2 ¤U¤È 02:51:37²Ä 2662 ½g¦^À³
|
ªGµL¬r¡A³o¬O²Ä¤@®anªº©Ò¥H¤ä·|¥L¡F¦P®É¤]µ¹²Ä¤G®a¦]¬°«Ü«n¡C¯u©êºp¡I |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/11/2 ¤U¤È 02:21:00²Ä 2661 ½g¦^À³
|
ªG¤£¦p¹w´Á¤¤¤î¦X§@«á¡AªYÄ£¦Aקï¦A©eì¨Ó¨º®a¸ÕÅçµ² |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/11/2 ¤U¤È 02:05:11²Ä 2660 ½g¦^À³
|
ªñ´Á¸ê°T¤£¤Ó²M·¡¡Aµ¹¥¦¥Î¤OŪ¡F²Ä¤@®anµL¬r¸ÕÅçµ² |
|
|
·|û¡G©ú¤é´¸10152496 µoªí®É¶¡:2022/10/31 ¤U¤È 10:13:28²Ä 2659 ½g¦^À³
|
·PÁ¦U¦ìª©¤j¥ý¶iªº¤À¨É ¤p©f±µÄ²¿³ÂdªÑ¦~¸êºâ²L... ¦ý³o3-5¦~¤]ºâÁÙ¤£¿ù¡A±`±`¬Ý¦U¦ì¤j¤jªº¸ê°T¤À¨É¡AºCºC§ë¤J...ºCºCµ¥ (¦L¶H¸û²`ªº§¯¿O!¬P¬P!¤pÂûÂû!¿}Ä_Ä_!¯uªº¬O«Ü¦³·P...¨þ¨þ) ·íµM¤]¦³¦Yüªº(X´¼230¶R¤J170§Ôµh³Î·R«á¨Ó¤WÂd«eöt¨ì1XXX...) Á`ı±o¶R¿³ÂdªÑ´N¬On@ªº¦í®É¶¡©ì¿i~~~µ¥¤]¤£¥¢×¨¾i©Ê°Ú! ³Ì«áÁÙ¬Oþ¥y«nªº (µ¹§Ú±ÂÅv~¨ä¾l§K½Í~) |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/10/31 ¤U¤È 08:28:02²Ä 2658 ½g¦^À³
|
dk¤j ±z«e´X¤é¤w¥ý¦æ°h³õ ªÑ»ù¤U¶^·íµM·|¦³À£¤O ²Ä£¸®a¡u¦X¬ù¨ì´Á¡A¥¼¹F¥Ø¼Ð¡v¤½¥q¦³¤½§i ²Ä¤G®a¤p¹«¸ÕÅç¹F¦¨¥Ø¼Ð¡A¤]¤½§i§â¸ÕÅç¼Æ¾Úµ¹¤©¡C ¦A¨Ó´N¬O²Ä¤@®a¬O§_±µ¨ü²Ä¤G®aªº¸ÕÅç¼Æ¾Ú¡H ¦pªG±µ¨ü¡A¦ô¦³¨âºØ¤è¦¡¡G 1¬O§¹¥þ±µ¨ü¸ÕÅç¼Æ¾Ú 2¬O±µ¨ü¥H²Ä¤G®a¤p¹«ªº¸ÕÅç¤è¦¡«°µ ¦pªG¤£±µ¨ü¡A¥i¯à¦A½ÍÂù¤è¦X·Nªº¸ÕÅç¤è¦¡«°µ¡C Á`¤§¡A¦X§@¦X¬ù¤G®a³£¦b½Í¡I ¤£µM«ç·|¦³º®a¦³¡u±Ñ¨B´_¬¡¡vªº¾÷·|¡I |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/31 ¤U¤È 07:56:56²Ä 2657 ½g¦^À³
|
¤p§Ì¦³ÂI·d¶Ã¤F ·s»D¤¤«ü¥X==>µL©`´Á¶¡¨ä¤¤¤@®a¦X§@¼t°Ó(j or g)½T»{¸ÕÅçµ²ªG¤£¦p¹w´Á¡A¥HP¦X§@¤¤¤î¡C ³o¦³«°T¶Ü??ÁÙ¬O¤£ºâ??( ©Ò¥H¬O¤½¥q»{¬°¦³°ÝÃD¥B¦³«H¤ß©Ò¥H¦A´£¨Ñµ¹³o¤@®a½T»{(j or g)??¦X§@¤£¬O¤¤¤î¤F? §Ú°O±o¦n¹³¬O¬üor¼Ú ³o¤G®añªº¦X¬ù¤£¤Ó¤@¼Ë¡C¤@Ó¦n¹³¬Oñ¬ùª÷¡A¥t¤@Ó¤ñ¸û¹³©e°U¸ÕÅç? ======================================================== ¦¶³Í¥Áªí¥Ü¡AµL¨x¬r©Ê¤îµhÃÄSNP-810¡]¦w®õ®³¯k¡^©ó2020¦~¡B2021¦~¤À§O»P2®a°ê»Ú¯ÅÃļtñq¦X§@¨óij¡AµL©`´Á¶¡¨ä¤¤¤@®a¦X§@¼t°Ó½T»{¸ÕÅçµ²ªG¤£¦p¹w´Á¡A¥HP¦X§@¤¤¤î¡C ¤£¹L¡AªYÄ£¹Î¶¤¨S¦³©ñ±ó¡A§ä¥X°ÝÃD¡Bקï¬ã¨spµe¤¤ªº¤@¶µ±ø¥ó«á¡A¦b¦P¤@®a¸ÕÅ礽¥q«±Ò¸ÕÅç¡A9¤ë22¤éÀò±o¥¿¦¡¸ÕÅç³ø§i¡AÃÒ¹êSNP-810¬°µL¨x¬r©Ê¡C¤é«e¤w´£¨Ñ°Êª«¸ÕÅçµ²ªGµ¹»P¤½¥qñq¦³Àv¦X¬ùªº°ê»Ú¤îµhÃļt°Ó¡C ªYÄ£¬ãµoªº¤îµhÃÄ«·s½T»{ÃҹꬰµL¨x¬r©Ê¡A¤]Åýº®a°ê»Ú¤j¼t¦X§@®×¦³¾÷·|¡u±Ñ³¡´_¬¡¡v¡C |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/10/31 ¤U¤È 05:45:55²Ä 2656 ½g¦^À³
|
³Ìªñ¦³Ãö810ªº¸ÕÅ礽§i ¼W¥[¼Ï¶s¸ÕÅç ¶W¹L¼Ð·Ç¾¯¶q °ª¹F4-8§J ²Ä¤G®aÃĮĸÕÅç¤w³q¹L¡A±À´úµL§ó§ï¾¯¶q«°µ°ÝÃD¡C ²Ä¤@®aY±µ¨ü²Ä¤G®aªº¼Æ¾Ú«h½Í¦X§@¦X¬ù°ÝÃD¡I ¦pªG¤£±µ¨ü¡H«h¦³«°µ¸ÕÅ窺¥i¯à¡C |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/10/31 ¤U¤È 02:24:53²Ä 2655 ½g¦^À³
|
³o½g·s»D¨ä¹ê¨S¦³·sªº¤º®e¡AÓ¤H±ÀÂ_¬O±ÂÅv½Í§Pªº¤@Ó¸ê°T¤â¬q¡C ·s»D¤¤´£¨ì¡y§ä¥X°ÝÃD¡Bקï¬ã¨spµe¤¤ªº¤@¶µ±ø¥ó¡z¡AY¦³×§ï½á§Î¾¯ªº¤ñ¨Ò¡A¬Y¨ÇÁ{§É¼Æ¾Ú¥i¯à»Ýn°µ«¡A¥H¨ú±o·sªº¥NÁª«¼Æ¾Ú¡C ±q¤½¥qªñ´Á¦h¶µÁ{§Éªº±Ò°Ê¡AÓ¤Hı±o¬O¦³³o¼Ëªº½Õ¾ã¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/31 ¤U¤È 01:15:49²Ä 2654 ½g¦^À³
|
¨S¬Ý¨ì¤½¥q«°T¼á²M¡Aªí¥Ü¬Q¤é·s»D³ø¾É¬O¦³©Ò¥»?! |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/31 ¤W¤È 11:49:04²Ä 2653 ½g¦^À³
|
¬Ojj¬ãµo¸Ñ¬r¾¯¤£¬Ogsk´¶®³¯k¡F¤£ºÞ¤j¼t¦p¦ó½Lºâ¡AªYÄ£ÁÈ©w¤F¡I¦¶¸³»¡ªYÄ£¶ZÀò§Qªñ¤F¡A·|¦b°ê»Úµo¥úµo¼ö¡C¥¼¨Ó14Ӥ륲·|¦³¤j½T©¯¡I |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/31 ¤W¤È 11:19:48²Ä 2652 ½g¦^À³
|
º®a´N´¶®³¯kgskÃļt¡A¥¦ÁÙ·Q¬ãµo¸Ñ¬r¾¯Åý¤¤¬rªÌ¨Ï¥Î¡AÄ~Äò¤jÁÈ´¶®³¯kªº¿ú¡F¬Ý¤F¨º«h¦¶¸³µoªíªº·s»D¡÷¼ÖÆ[¡I¥¼¨Ó14Ó¤ë·|¦³¨âÓº²Â_¤é¥i´Á«Ý¡C |
|
|
·|û¡G¤ý¥ý¥Í10149972 µoªí®É¶¡:2022/10/31 ¤W¤È 09:05:39²Ä 2651 ½g¦^À³
|
R¤j¡G¬Oªº¡A³oÓºô§}¬O¦¶¸³±µ¨ü¤¤¥¡ªÀ±Ä³Xªº®ø®§ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/31 ¤W¤È 08:20:18²Ä 2650 ½g¦^À³
|
¨ºÓºô§}³s¤£¤W! §Ú²q¬O¬Q¤é³o«h·s»D:ªYÄ£¤îµh·sÃĸÑÂê40¦~¨x¬r©Ê°ÝÃD °ê»Ú¤j¼t±ÂÅv¦b±æ udn.com/news/story/7241/6726037 ªYÄ£¬ãµoªº¤îµhÃÄ«·s½T»{ÃҹꬰµL¨x¬r©Ê¡A¤]Åý[º®a]°ê»Ú¤j¼t¦X§@®×¦³¾÷·|¡u±Ñ³¡´_¬¡¡v-->[º®a]¬O«ü¨º¤@®a??? ------------------------------------------------------------------------------------------- ·|û¡G¤ý¥ý¥Í10149972 µoªí®É¶¡:2022/10/30 ¤U¤È 10:39:04²Ä 2649 ½g¦^À³ news.mitake.com.tw/html/1/20221030/95F7626A-2558-ED11-BFB7-ECEBB895092F.html |
|
|
·|û¡G¤ý¥ý¥Í10149972 µoªí®É¶¡:2022/10/30 ¤U¤È 10:39:04²Ä 2649 ½g¦^À³
|
news.mitake.com.tw/html/1/20221030/95F7626A-2558-ED11-BFB7-ECEBB895092F.html |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/30 ¤W¤È 10:55:32²Ä 2648 ½g¦^À³
|
2022.8.31µØªF5¤j¦W®Õ®ý¦¿¤j¾Ç³Ì·s¬ã¨s¡GCMZ@ER-NEs纳¦Ì§Þ术¦³±æ°f转°sºë©Ê¨x¯f www.toutiao.com/article/7138028614150423055/ ®ý¦¿¤j学医学°|¤_2022¦~8¤ë4号¦b¡mBiomaterials¡n¡]IF=15.304¡^杂§Ó¤W发ªí¤F该团队ªº³Ì·s¦¨ªG¡C¦b这项¬ã¨s¤¤¡A¬ã¨sªÌ³q过¨Ï¥Î§Ü®ñ¤Æ剂维¥Í¯ÀEÌ۫ؤF内质ÊI¹v¦V¤p¤À¤l对¤Q¤GÖJ°òfÁD酰Ói(p-DBSN)×饰ªº纳¦Ì¨Å剂¡]CMZ@ER-NEs¡^¡A¥H装载©M递°e细M¦â¯ÀP450®a±Ú2亚®a±ÚE¦¨员1¡]CYP2E1¡^§í¨î剂´â¥Ò巯«}Ðü(CMZ)¨ì¨x细Mªº内质ÊI¡A¥Î¤_¦ì点¯SÉݩʧí¨î¡C结ªG显¥Ü¡AÆÓ论静脉ª`®g还¬O¤fªA¡ACMZ@ER-NEs对ºC©Ê°sºë¼ÉÅS³£ªí现¥X显µÛªº¨x«O护§@¥Î¡A¦}¥B没¦³脱¹vªº药ª«¬r©Ê¡C ---------------------------------------------------------------------------------------------- CMZ@ER-NEs:¬°¤FÁקKÃĪ«¶i¤J¨ä¥L¾¹©x©Î¨È²ÓMµ²ºc¤Þ°_ªº°Æ§@¥Î¡]¨Ò¦p¡ACMZ ¶i¤J¤j¸£·|¤Þ°_ÂíÀR©M¶Ê¯v§@¥Î¡^¡A»Ýn¾A·íªº¿é°e¨t²Î±N CMZ ¥[¸ü¨Ã¿é°e¨ì¨xŦ¡A¯S§O¬O¶i¤J HCs ªº ER¡A¥Î©ó¦ìÂI¯S²§©Ê§í¨î ®ý¦¿ªºCMZ@ER-NEs(¼w°êCMZ¥~±¾¤É¯Å¦w¥þª©¥») PK ªYÄ£SNP-610/630 ¡A½Ö±N³Ó¥X??? |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/29 ¤U¤È 06:28:33²Ä 2647 ½g¦^À³
|
¤½¥q8¨tµL¨xµÇ¬r¤îµh¾¯Y¤W¥«¡An¤j¤O«Å¶Ç¡I°£ì¦³¤AñQ¾b×ô100»õ¬ü¤¸¥~¡A¶ËµÇ¤îµh¾¯¬ÛÃöÃĦ³780»õ¬ü¤¸»Ý¨D¡A¤]nµ¹¤©«Å¶Ç¥´À»¨Ã·m§ð¡I6¨t°£¤F¬ü¦n¥¼¨Ó¥~¡Aµ²¦X8¨t¥i¥H¨«ÀùÃĬã¨s¡AY¦¨¥\´N¤£±o¤F¤F¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/29 ¤U¤È 06:17:24²Ä 2646 ½g¦^À³
|
¼Ú·ùÁ{§É¸ÕÅçµù¥U www.clinicaltrialsregister.eu/ctr-search/trial/2012-005730-11/DE Effect of Clomethiazole (Distraneurin®) on CYP2E1 Activity, transaminases, Liver fat content, and liver stiffness during Alcohol Detoxification ¡V a pilot Study ¼w°êCMZ(CYP2E1§í»s¾¯)Á{§É¸ÕÅçÅãµÛ§ïµ½¤FALD°sºë©Ê¨xª¢¡A¦ý¬O[¥Ñ©óCMZ¨ã¦³¦¨Å}©Ê¡A¦]¦¹¤£¯àªø´ÁªA¥Î¡C] SNP-6(CYP2E1§í»s¾¯)ª«ªº§@¥Î¾÷¨î¬Û¦P!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/29 ¤U¤È 01:23:28²Ä 2645 ½g¦^À³
|
SNP-6(CYP2E1§í»s¾¯)±´°QªvÀø°sºë©Ê¯×ªÕª¢Àø®Ä! ----------------------------------------------------------------------------------------------- 2022.3¤ë30¤é °sºë©Ê¨x¯f±Ô¨Æ¦^ÅU¡G±qÅÖºû¤Æ¨ìÀù¯g dmr.amegroups.com/article/view/8093/html ...ªñ 40 ¦~¨Ó¡A§Ú̹êÅç«Ç¤@ª½¦b¬ã¨s²ÓM¦â¯À P4502E1 (CYP2E1) ¦b ALD ©M°sºë¤¶¾ÉªºPÀù§@¥Î¤¤ªº§@¥Î¡C ... ¦¹¥~¡ACYP2E1 ¦b ALE ¤¤ªº§@¥Î¦b CYP2E1 ºV°£¤p¹«¤¤±o¨ì¤F¥O¤H¦L¶H²`¨èªºÃÒ©ú¡A¤£¶ÈÅã¥Ü¥XºC©Ê¶¼°s«á®ñ¤ÆÀ³¿E¼Ð»xª«ªºÅãµÛ°§C¡A¦Ó¥BÁÙÅã¥Ü¥X¨xŦ²Õ´¾ÇªºÅãµÛ§ïµ½ ( 166 )¡C¥t¤@¤è±¡A¹L«×ªí¹F CYP2E1 ªº°Êª«ªí²{¥X ALD ªºÄY«µ{«×¼W¥[ ( 167 , 168 )¡CCMZ¡]¤@ºØ¯S²§©Ê CYP2E1 §í»s¾¯¡^¹ï CYP2E1 ªº§í¨î¤]§ïµ½¤F°Êª«¹êÅ礤ªº ALD¡]169¡^¡C ,,,³o¥O¤H«HªA¦a±j½Õ¤F CYP2E1 ¦bPÀù§@¥Î¤¤ªº§@¥Î¡C ³Ìªñ¤@¶µ¹ïªñ 100 ¦W ALD ±wªÌ¶i¦æ¨x¬¡À˪º¬ã¨sªí©ú¡ACYP2E1 ©M ƐdA ¤§¶¡¥H¤Î CYP2E1 ©M¨xÅÖºû¤Æµ{«×¤§¶¡¦s¦b°ª«×ÅãµÛªº¬ÛÃö©Ê¡]174¡^¡C [³o¨Ç¼Æ¾Úº¦¸ªí©ú CYP2E1 ¤]¥i¯à¬O ALE ±wªÌ¨xÅÖºû¤Æ¶i®iªºì¦]¡C] [³o¨Ç¼Æ¾Úº¦¸ªí©ú CYP2E1 ¤]¥i¯à¬O ALE ±wªÌ¨xÅÖºû¤Æ¶i®iªºì¦]¡C] [³o¨Ç¼Æ¾Úº¦¸ªí©ú CYP2E1 ¤]¥i¯à¬O ALE ±wªÌ¨xÅÖºû¤Æ¶i®iªºì¦]¡C] ³Ì«á¡A³Ìªñªº¤@¶µÀH¾÷Á{§É¸ÕÅç¥O¤H«HªA¦aÃÒ©ú¡ACMZ ¦b 10 ¤Ñ¤º¹ï CYP2E1 ªº§í»s§@¥Î³q¹L £\ °Êû¨x¯×ªÕ©M°§C¦å²MÂà®ò酶¬¡©ÊÅãµÛ§ïµ½¤F ALD ( 175 )¡C CYP2E1 ¦b ALD ©M°sºë¤¶¾ÉªºÀù¯g¤¤ªº§@¥Î¥iÁ`µ²¦p¤U¡G(II) CYP2EÁÙ°Ñ»P¦hºØPÀùª«ªº¿E¬¡©MRAªº°¸Ñ¡A³o¤]¦³§U©óÀù¯gªºµo®i¡C [¥Ñ©ó CMZ ¨ã¦³¦¨Å}©Ê¡A¦]¦¹¤£¯àªø´ÁªA¥Î¡A¦]¦¹¬O®ÉÔ´M§äµL¬rªº CYP2E1 §í»s¾¯¤F¡C] [¥Ñ©ó CMZ ¨ã¦³¦¨Å}©Ê¡A¦]¦¹¤£¯àªø´ÁªA¥Î¡A¦]¦¹¬O®ÉÔ´M§äµL¬rªº CYP2E1 §í»s¾¯¤F¡C] [¥Ñ©ó CMZ ¨ã¦³¦¨Å}©Ê¡A¦]¦¹¤£¯àªø´ÁªA¥Î¡A¦]¦¹¬O®ÉÔ´M§äµL¬rªº CYP2E1 §í»s¾¯¤F¡C] |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/28 ¤U¤È 04:41:50²Ä 2644 ½g¦^À³
|
2021.2.2 www.hindawi.com/journals/cjgh/2021/8854432/ ¤@ºØ·sªº CYP2E1 §í»s¾¯ 12-Imidazolyl-1-dodecanol(I-ol)¥Nªí¤F¨x²ÓMÀùªº¼ç¦bªvÀø¤èªk ... CYP2E1 §@¬°ÃĪ«¹vÂIªº«n©Ê¥i¯à¬O®Ö¤ß¡A¤×¨ä¬O¦b¨xµw¤Æ¨xŦ¤¤¡A¦]¬°¥¦ªº酶¬¡©Ê©M ROS §Î¦¨¦ü¥G¬O¨xÀùµo¥ÍªºÃöÁäÅX°Ê¦]¯À¡C¦]¦¹¡AI-ol ¥i¼ç¦b¦a¥Î©óéw©|¥¼´c©ÊÂà¤Æªº¨x²ÓM¡A±q¦Ó¨¾¤î±q¯×ªÕ©Ê¨xª¢©Î¨xµw¤Æ¦V HCC ªºÂàÅÜ¡A¥H¤Îªý¤î¸~½F²ÓMªº¶i®i¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/28 ¤U¤È 04:17:58²Ä 2643 ½g¦^À³
|
111/10/19¤½§i...SNP-630¦³®Ä¥NÁª«ªí²{¥X§ÜÅÖºû¤Æªº¼ç¤O¡A¥]¬AÅãµÛ°§CÅÖºû¤Æ¬ÛÃöªº¥Íª«¼Ð°O(§YCCL4©MCCL5)¡C¦¹¥~¡AFibroScan´ú¶q¥çÅã¥Ü¨ä§ïµ½¨xÅÖºû¤Æªº¥\®Ä¡C ¤W±ªºÅãµÛ°§C¨xŦÅÖºû¤Æ¥\®Ä»P2021.7.30·ç¨å¦P¦æªº¬ã¨s½×z¤@P. ¹Ï5:¯×ªÕÅÜ©Ê©M¨xÅÖºû¤Æ¤§¶¡ªºÁpô CYP2E1 ¦b°sºë©Ê©M«D°sºë©Ê¨x·l¶Ë¤¤ªº§@¥Î¡CROS¡B¤ÏÀ³©Ê¤¤¶¡Åé©M¯×½è¶W¸üªº§@¥Î -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤U¤È 01:09:17²Ä 2026 ½g¦^À³ SNP-6(CYP2E1§í»s¾¯)¥«³õº¨£·sÃĦP®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 1. 2021.7.30 www.ncbi.nlm.nih.gov/pmc/articles/PMC8348366/ ----------------------------------------------------------------------------------------- |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/27 ¤U¤È 07:11:10²Ä 2642 ½g¦^À³
|
±ÂÅv¦ü¥G¬O¤½¥q¡BªÑªF´Á¬ßªºµo®i¼Ò¦¡¡F±qÃĵئ۫ؼt50»õ¤¸¡A2026¦~À禬400»õ¤¸¥Ø¼Ð¡AY7¦¨²b§Q300»õ¤¸¡A¨CªÑÀò§Q100¤¸¡AªÑ»ù2000¤¸¡Cn»¡ªº¬OªYÄ£¬O«D±`¦³»ùȪº¤½¥q¡A´N¬O±ÂÅv½Í¤£§´¤]¦³§ó¦nªºµo®i³~®|¡A¨Ã«D¤Ñ¶ò¤§¨Æ¡C¬Û«H³oºØ§¹¬ü¯«ÃĤ@©w·|³Q±ÂÅv®³¨«¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/26 ¤U¤È 10:23:58²Ä 2641 ½g¦^À³
|
»PªYģñ¦X§@¨âÃļt¡A»P¨ä¥¦¤½¥q±q¦X§@¨ì±ÂÅv¨¬¨¬3¦~¡A©ú¦~¬O²Ä3¦~¡A±ÂÅvñ¤UÀ³¬O©ú¦~µo¥Í¡C8¨t2ÁûÃĶW§C¦ô±ÂÅv»ù¤]¦³8»õ¬ü¤¸¡A¦X²z»ù1600¤¸¡Aȱoµ¥«Ý¡Id¤j§Æ±æ¯à§ä¾÷·|¦^¨Ó¡A¤j®a¯àÁȤj¿ú¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/26 ¤W¤È 10:26:47²Ä 2640 ½g¦^À³
|
¦U¦ì¥ý¶i¡A¤p§Ì¥ý°h³õ¤F ¨ü¤£¤F¤F ¥H«á¦³¾÷·|¦A¨£ ============================ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/25 ¤W¤È 11:05:07²Ä 2639 ½g¦^À³
|
¤µ¤ÑÅܯ}¦Ê²Ä¥S¡AªÅÅw³ß¤@³õ¡C¤Ö¤F¤p¦Êw¡CÁÙ¬On´L«§Þ³N±¡C ½L±n¦V¤U©Î¦A¥ð®§¤F ======================================================= |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/24 ¤U¤È 02:33:21²Ä 2638 ½g¦^À³
|
¤½¥qÁö810¦³¤À°Ï±ÂÅv¶i¦æ¤¤¡A¦UÃļt¤]¦³¦U¦Û¦Ò¶q¡A³Ì²×µ²ªGÁÙ¬On®É¶¡¤~¯à´¦¾å¡AªÑªF©ãªº¬O¦nÃÄ´N¬Oȱo§ë¸ê¡F6¨t³¡¤ÀÅ¥±M®a»¡3´Á®¼¿N¿úªºn¤@»õ¬ü¤¸¡A©Ò¥H¤½¥q¦b2´Á±ÂÅv¥X¥h¦Ò¶q¤]¹ï¡CÁ`»¡ªYÄ£¦³«D±`¦nªº¥¼¨Ó¡AÁÙ¬On®É¶¡ªº¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/24 ¤U¤È 02:03:42²Ä 2637 ½g¦^À³
|
ºô¯¸¦n¤[¨S¬Ý¤F¡A¦n¹³¦³§ó·s?? ¸Ü»¡¦^¨Ó¡A¤U¦C·s»D¦³«áÄò??ÁÙ¦b½Í¦X§@Äò¬ùor ·s¬ù??¹L¥h8Ó¤ë¤F!!! 109/12/21ñ¬ù¤§°ê»ÚÃļt¡A¨Ì¾Ú¦X§@¨óij¤º®e¡A¤w¤ä¥Iµ¹¥»¤½¥qñ¬ùª÷¡C¦]©e°U²Ä¤T¤èÅçÃÒ³æ¦ì°õ¦æ³¡¥÷¸ÕÅç¡A©|¥¼§¹¦¨¥Ø¼Ð¡A¥Ø«eÂù¤è¤´Ä~Äò¤À¨É¸ÕÅç¼Æ¾Ú¡A¨ÃÄ~Äò©e°U²Ä¤T¤èÅçÃÒ³æ¦ì¡A¶i¦æÅçÃÒ¸ÕÅ礤¡A¤]¥¼¥I¨½µ{¸Oª÷¡A¦¹¨Æ¹ï¤½¥q°]°È·~°È¨ÃµL«¤j¼vÅT¡C¸Ó¦X§@¨óij¨Ì¦X¬ù´ÁÀ³©ó111/02/23©¡´Á¡A«áÄò¦X§@Äò¬ù©Îñq·s¬ùµ¥¬ÛÃö¨Æ©y¡A¥ç¦b¶i¦æ¤¤¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/21 ¤U¤È 12:33:43²Ä 2636 ½g¦^À³
|
²Ä2®a¬ü°ê¶¤South Rampart Pharmaªº SRP-001¨S¦³¨x¬r©Ê¨S¦³µÇ¬r©Ê--Á{§É¸ÕÅç¦h¾¯¶q»¼¼W(MAD)¨ì4000mg(4g)??? ¹wpP1µ²ªG±N¦b 2023 ¦~²Ä¤G©u«×¤½§G¡C 1.2022.9.21ªº·s»D¤º®e www.clinicalleader.com/doc/a-new-pain-treatment-requires-accurate-and-reliable-data-0001 2. FDA clinicaltrials.gov/ct2/show/NCT05484414?term=South+Rampart+Pharma&draw=2&rank=1 --------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/20 ¤U¤È 08:32:31²Ä 2628 ½g¦^À³ ªYÄ£¦¶¸³¬Ý¹L¨Ó!!! (SNP-810Ävª§¹ï¤â-²Ä2®a¶i¤JP1¤F) SRP-001 ¬O¤@ºØ·s«¬¹ï¤A酰®ò°ò×ôÃþ¦üª«¡A¨ã¦³¿W¯Sªº§@¥Î¾÷¨î¡A¦]¬°¥¦¦b¹ï¤A酰®ò°ò×ô¤¤¨S¦³¨x¬r©Ê¡C¨´¤µ¬°¤î²£¥Íªº«DÁ{§É©MÁ{§É¼Æ¾Ú³£¤ä«ù SRP-001 °ª«×®t²§¤ÆªºÄvª§©w¦ì¡A¨ä¤¤¥]¬A¡G ¯à°÷´î»´¯kµh©Mµo¿N §Y¨Ï¬O°ª¾¯¶qªvÀø¤]¨S¦³¨x¬r©Ê µL°ª¾¯¶q¬ÛÃöµÇ¬r©Ê |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/10/21 ¤W¤È 11:27:20²Ä 2635 ½g¦^À³
|
ÁÙ¬O¥xÆWªº¤½§i¸ò¬ü°êªº¬O¦P¤@¸ÕÅç¡H |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/10/21 ¤W¤È 11:17:13²Ä 2634 ½g¦^À³
|
R¤j ¬ü°êªº¸ÕÅç¡A¤½¥q¨Ã¥¼¤½§i¡C ¨Ì±z©Òz¡A¸ÕÅ笰ÃİʤO¾Çªº¬ÛÃö¸ÕÅç¡AÄÝ©óP1¶¥¬q¡C ¤½¥q¦V¬ü¥Ó½Ðªº¡u¼Ï¶s¸ÕÅç¡v¦ü¥GÁÙ¨S¦³®Öã¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/21 ¤W¤È 09:35:00²Ä 2633 ½g¦^À³
|
(SNP-810Ävª§ªÌ)²Ä2®a¬ü°ê¶¤»¡n¦b2020.Q3¶i¤JP1¡Aµ²ªG©µº¢¨ì2022.1¤ë¶}©lP1¸ÕÅç--¦L¶H¬O¤S©µ¨ì8¤ë¥¿¦¡¶}©l ·sÃÄÁ{§É®Éµ{´X¥G¨S¦³¤@®a¦b¦p´Á¶}®i£x. |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/21 ¤W¤È 09:26:46²Ä 2632 ½g¦^À³
|
R¤j±M·~¡A©êºp¡Aªí¹F¤£²M¡C À³¸Ó¬O»¡³o2Ópipelineªº¶i«×¬O¤£¬O¤ÓºC¤F~~ÁöµM¦ÑJ»¡¬Y¤½¥q¥Î¤H¤Ö¥i¥H§@¨ì¥Lº¡·Nªº¤ô·Ç ¶R¤J³£§Ö3¦~¤F¡A¤Ó§é¿i¤H 3¦~ ¦w¦¨³£½æ¥X¥h¤F ³o¤G¤Ñ¬Ý¨ì·s»D³£¥H¬°¬O±ÂÅv¤F¡An°±µP «¢ ³Ì¦n¬O¤À¶}¨Ó±ÂÅv©Î¤À°Ï¡A³o¼Ë·Ï¤õ©ñ¤£§¹ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/21 ¤W¤È 09:25:08²Ä 2631 ½g¦^À³
|
2022.10.20¤½§i: ¥»¸ÕÅçÄݩ󥻤½¥qSNP-810¼Ï¯Ã©ÊÁ{§ÉÅçÃÒ¸ÕÅ礧¤@¡A¸ÕÅç³]p¬O¦h¾¯¶q¡B³æª¼¡B³æ¤¤¤ß¤Î¤fªAµ¹»P´¶®³¯k©ÎµL¨x¬r©Ê¤îµh·sÃÄSNP-810¤§Á{§É¦w¥þÅçÃÒ¸ÕÅç¡A§ë»P¾¯¶q4-8§J¡A¸Ó¸ÕÅ羯¶q¤w¶W¹L²{¦æ¤AñQÓi×ô(Acetaminophen)ÃÄ«~»¡©ú®Ñ®Öã¨Ï¥Î¨C¤é³Ì¤j¾¯¶q¡A¹wp§¹¦¨36¦ì¨ü¸ÕªÌ¡A¨ú±oÁ{§É¦w¥þµ²ªG«á¡A¦A¦V½ÃºÖ³¡¹Ãĸp¿Ô¸ß·sÃÄ®Öã¤W¥«¡C ------------------------------------------------------------------------------------- ¼Ï¯Ã©ÊÁ{§ÉÅçÃÒ¸ÕÅç---§¹¦¨36¦ì¨ü¸ÕªÌ¡A¨ú±oÁ{§É¦w¥þµ²ªG«á--¦A¦V½ÃºÖ³¡¹Ãĸp¿Ô¸ß·sÃÄ®Öã¤W¥«¡C ¦ü¥G¬O«ü³oӼϯéʸÕÅ秹¦¨«á¥i§ï¥HµL¨x¬rAPAP·sÃĤW¥«??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/21 ¤W¤È 08:51:05²Ä 2630 ½g¦^À³
|
P1¦¬36¤H¥¿±`°Ú¡C 2022.10.3·sµn¿ý¦b¬ü°êFDAÁ{§É¸ÕÅçºô¯¸: clinicaltrials.gov/ct2/show/NCT05563961?term=SafeTynadol&draw=2&rank=2 A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and Various Formulations of SafeTynadol® in Healthy Volunteers «á±°l§LÁÙ¤£¨¬¼{! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/21 ¤W¤È 08:24:17²Ä 2629 ½g¦^À³
|
¦U¦ì¥ý¶i¡G «ç¬Ý¥Ø«eªº·s»D³sµo¡C«á¦³°l§L 36¤H¡Aºâ¦³¦b¶]¶i«×?? =========== ¥D¦® µL¨x¬r©Ê¤AñQÓi×ô¤îµh·sÃÄSNP-810(¦w®õ®³¯k)Àò±o TFDA®Öã¶i¦æ¶W¹L²{¦æ¤AñQÓi×ôÃÄ«~»¡©ú®Ñ³Ì¤j«Øij¾¯¶q¤§Á{ §ÉÅçÃÒ¸ÕÅç |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/20 ¤U¤È 08:32:31²Ä 2628 ½g¦^À³
|
ªYÄ£¦¶¸³¬Ý¹L¨Ó!!! (SNP-810Ävª§¹ï¤â-²Ä2®a¶i¤JP1¤F) SRP-001 ¬O¤@ºØ·s«¬¹ï¤A酰®ò°ò×ôÃþ¦üª«¡A¨ã¦³¿W¯Sªº§@¥Î¾÷¨î¡A¦]¬°¥¦¦b¹ï¤A酰®ò°ò×ô¤¤¨S¦³¨x¬r©Ê¡C¨´¤µ¬°¤î²£¥Íªº«DÁ{§É©MÁ{§É¼Æ¾Ú³£¤ä«ù SRP-001 °ª«×®t²§¤ÆªºÄvª§©w¦ì¡A¨ä¤¤¥]¬A¡G ¯à°÷´î»´¯kµh©Mµo¿N §Y¨Ï¬O°ª¾¯¶qªvÀø¤]¨S¦³¨x¬r©Ê µL°ª¾¯¶q¬ÛÃöµÇ¬r©Ê ¨S¦³Àݥμç¤O¡A¦]¬°¥¦¬O¤@ºØ«Dªü¤ùÃþÃĪ« --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/14 ¤W¤È 06:06:59²Ä 1588 ½g¦^À³ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/13 ¤U¤È 09:07:29²Ä 1586 ½g¦^À³ SNP-810Ävª§¹ï¤â-1¡C Kalyra KP-1199(¹ï¤A酰®ò°ò×ôÃþ¦üª«)¦bP1´£«e²×¤î ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/16 ¤U¤È 04:13:56²Ä 790 ½g¦^À³ SNP-810Ävª§¹ï¤â¦A+1¡A¬ü°ê¶¤¤w¦³3®a(¦³2®a®³¨ì¬ü°ê°ê¥ß½Ã¥Í¬ã¨s°|¡]NIH¡^ÃÙ§U)!!! ----------------------------------------------------------------------------------------------- ¬ü°ê¶¤§R¥h²Ä1®aKalyra KP-1199«á¡A²Ä2®a»¡n¦b2020.Q3¶i¤JP1¡Aµ²ªG©µº¢¨ì2022.1¤ë¶}©lP1¸ÕÅç¡A²Ä3®a«hÁÙ¦bÁ{§É«e.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/20 ¤U¤È 07:42:55²Ä 2627 ½g¦^À³
|
¦n©_TYNADOTE®(SNP-820)±q¤¤¤î(¼È°±)¦Ó«±ÒÁ{§É¸ÕÅ窺½t¥Ñ? ²ö«D·Qµ¹J&Jªº¸Ñ¬r¾¯ FomepizoleÀ£¤O? Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose clinicaltrials.gov/ct2/show/NCT05517668?term=Fomepizole&draw=2&rank=2 --------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/9/14 ¤W¤È 09:46:29²Ä 350 ½g¦^À³ ªYÄ£SNP-820(¹ï¤AñQÓi×ô¸Ñ¬r¾¯)¨Ã«D°ò©ó¥«³õ§Q¼í¦Ò¶q(¥Õ¸Ü´N¬OÁȤ£¤F¿ú)¡A¦Ó¬O±q¤½¦@½Ã¥Íªº¨¤«×«ä¦Ò¡A§Æ±æ¥H¬ãµo·sÃijyºÖ¯f±w¡A¥HºÉ¨ì¤½¥q¤§ªÀ·|³d¥ô¡C ³o®a¶}µo¹ï¤AñQÓi×ô¸Ñ¬r¾¯ªº·ç¨åPledpharma(¦b¬ü°ê¤W¥«)¡A¥«È2.78»õ¬ü¤¸(¶g¤¦¬5.16¬ü¤¸/2015¦~°ªÂI49¬ü¤¸) ¶g¤ªYÄ£¥«È37.2»õ¥x¹ô(¬ù1.3»õ¬ü¤¸) |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/10/20 ¤U¤È 05:39:17²Ä 2626 ½g¦^À³
|
To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdos clinicaltrials.gov/ct2/show/NCT05557448?term=Sinew+Pharma&draw=2&rank=2 µû¦ô¥HTYNADOTE®¨Ö¥ÎN-¤AñQ¥b¯Ö®ò»ÄªvÀø´¶®³¯k¥ÎÃĹL¶q¤¤¬r±wªÌªºÀø®Ä©M¦w¥þ©Ê¤§±´¯Á©Ê¸ÕÅç www1.cde.org.tw/ct_taiwan/search_case2.php?caseno_ind%5B1%5D=2192 SNP-820 Á{§É¸ÕÅçºâ¥¿¦¡¶}©l¶]¤F¡CÁöµMÁ{§É©Ò»Ýªº®É¶¡¤£ªø¡A¦ý¦¬®×±ø¥ó¬O¯u¹êªA¥Î APAP ¹L¶qªº¯f¤H¡A ¦b¥xÆWn¦¬º¡24¤H¤£ª¾¹Dnªá¦h¤Ö®É¶¡¡C Ó¤H±À´ú SNP-810/820 ¤@¨Ö½Í±ÂÅvªº¥i¯à©Ê«Ü°ª¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/20 ¤U¤È 02:38:14²Ä 2625 ½g¦^À³
|
°ò¥»±/®ø®§±°¾¥¿¦V¬Ý«Ý§a¡A¦ý§Þ³N±´N¬O«Ü®t ¬Ý¬Ý¬O¤£¬O¨«¦X¤@(¥þ³Ó)ªº¸ô¡A·dÓleo±ÂÅvª÷Åo ©Î ¬O¾ÇÄ_¹sªºµÇÃÄ¡An¤@ª½¦Y¡C =================================== ³ø¾É¡G¦bÁ{§É¸ÕÅ礤¡A±µ¨üªvÀøªº±wªÌ¦b²Ä12¶g®ÉªºALT»P°ò½uȬۤñ¦³ÅãµÛ°§C¡A¨S¦³Æ[¹î¨ìÄY«ªº¤£¨}¨Æ¥ó¡C¦¹¥~¡ASNP-630¦³®Ä¥NÁª«ªí²{¥X§ÜÅÖºû¤Æªº¼ç¤O¡A¥]¬AÅãµÛ°§CÅÖºû¤Æ¬ÛÃöªº¥Íª«¼Ð°O(§YCCL4©MCCL5)¡C¦¹¥~¡AFibroScan´ú¶q¥çÅã¥Ü¨ä§ïµ½¨xÅÖºû¤Æªº¥\®Ä¡C |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/10/20 ¤U¤È 01:17:39²Ä 2624 ½g¦^À³
|
¨S¦³¡uÄY«¡v¤£¨}¤ÏÀ³ ¤£¥Nªí¨S¦³¤£¨}¤ÏÀ³ |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/20 ¤U¤È 12:10:56²Ä 2623 ½g¦^À³
|
¦¹¦¸¦h¤F¨S¦³¤£¨}¤ÏÀ³¨Æ¥ó¡m³o¬O³\¦h¨ä¥L¨xÃĸؤ£¹LªºÄæ¡AÂର¨ä¥LÃij~¥u¦n¡n¡F¯à¦bÃľǷ|µoªí¡A¹üÅãÀu¶V©Ê»P¥þ²yÃn¥ú¡AÁô¬ù§i¶D§Ų́ä»ùȤ£¬O¥u¬O7¡B8¶ôªÑ»ù¤ÏÀ³¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/20 ¤W¤È 09:52:07²Ä 2622 ½g¦^À³
|
¬Ý¤@¤UªÑ»ù´Nª¾¹D¤F~~ ¤£¬O«¤j§Q¦h «¢ ¦pªG½Ã¹L140«e°ª´Nº}«G¤F |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/10/20 ¤W¤È 09:08:02²Ä 2621 ½g¦^À³
|
¬Ý³o¤½§iªº¤º®e ¦ü¥G«üªº¬O610 ÄÝ»D¤F ¤£¹L¦³°Ñ¥[¦~·|³ø§i Á`ºâ¬O¤p§Q¦h |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/20 ¤W¤È 08:20:07²Ä 2620 ½g¦^À³
|
³o¨½¦n§N²M~~§Oª©»¡³o¬O¸Ñª¼¦¨¥\¡AÅý§ÚÀ~¤F¤@¸õ ²r¤@¬Ý§Ú¥H¬°¬O±ÂÅv¤F ¦ý¦Ü¤Ö¤]ºâ¬O¦n®ø®§¤F |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2022/10/19 ¤U¤È 05:04:37²Ä 2619 ½g¦^À³
|
1.¨Æ¹êµo¥Í¤é:111/10/19 2.¤½¥q¦WºÙ:ªYÄ£¥ÍÂåªÑ¥÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q 4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î 5.µo¥Í½t¥Ñ: ¥»¤½¥qªvÀø¡u«D°sºë©Ê¯×ªÕ¨xª¢¡v·sÃÄSNP-630¤Î¦³®Ä¥NÁª«¤§°Êª«¸ÕÅç¤Î¤G´Á¤HÅéÁ{§É ¸ÕÅç¨ãÅãµÛªº§Üµoª¢¤Î§ÜÅÖºû¤ÆÀø®ÄÀò2022¦~©ó¬ü°êªi¤h¹yÁ|¦æªº¡u¬ü°êÃľǮa¦~·|¡v (AAPS 2022 PHARMSCI 360)±µ¨ü¨Ã©óªñ95°êªñ5000¾l¤H¤j·|¤¤¥¿¦¡µoªí¡C 6.¦]À³±¹¬I:¤£¾A¥Î 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ: ¤@¡BSNP-630ªvÀøªº¤p¹«ªº¨xµoª¢¡B¨x¯×ªÕÅÜ©Ê©MÅÖºû¤Æ±o¨ìÅãµÛ§ïµ½¡A¨äALT¤ô¥¡B ÅÖºû¤Æ¬ÛÃö¥Íª«¼Ð°O¡]§Yalpha-SMA¡BCol1a1¡BCol3a1©MTimp-1¡^§¡ÅãµÛ°§C¡C SNP-630©M¦³®Ä¥NÁª«³B²zªº¤p¹«ªº¨xŦ¤T»Ä¥Ìªoà§t¶q§¡ÅãµÛ°§C¡C¦bÁ{§É¸ÕÅ礤¡A ±µ¨üªvÀøªº±wªÌ¦b²Ä12¶g®ÉªºALT»P°ò½uȬۤñ¦³ÅãµÛ°§C¡A¨S¦³Æ[¹î¨ìÄY«ªº¤£¨} ¨Æ¥ó¡C¦¹¥~¡ASNP-630¦³®Ä¥NÁª«ªí²{¥X§ÜÅÖºû¤Æªº¼ç¤O¡A¥]¬AÅãµÛ°§CÅÖºû¤Æ¬ÛÃöªº ¥Íª«¼Ð°O(§YCCL4©MCCL5)¡C¦¹¥~¡AFibroScan´ú¶q¥çÅã¥Ü¨ä§ïµ½¨xÅÖºû¤Æªº¥\®Ä¡C ¤G¡BSNP-630ªº¦³®Ä¥NÁª«¤w§¹¦¨²Ä¤G´ÁÁ{§É¸ÕÅç°ª¡B§C¨â¾¯¶q²Õ¦@36¦W¨ü¸ÕªÌ¡A´Á¤¤ ¤ÀªRµ²ªGÅã¥Ü¦bÁ{§ÉÀø®Ä«ü¼Ð»P¥¼ªAÃÄ«e¤ñ¸û¡A§e²{·¥ÅãµÛªvÀø®ÄªG¡A¦¨¥\¹F¦¨¦b¯×ªÕ ¨xª¢ªvÀø¤Wªº¥Ø¼Ð¡CSNP-630¥ç¤wÀò¥xÆWFDA®Öã¶i¦æ¨Ã§¹¦¨Á{§É¤@´Á¸ÕÅç¡A¼Æ¾ÚÅã¥Ü SNP-630¦b¤HÅé¤W¨ã¦³°ª«×¦w¥þ©Ê¡A¥Ø«e¥¿¿n·¥³W¹ºÁ{§É¤G´Á¡CSNP-630¬°ªvÀø¯×ªÕ¨xª¢ ·s¦¨¤À·sÃÄ¡A°£¥»¨ÃIJz¬¡©Ê§ó±j¥~¡ASNP-630¥t¦³4Ó¥H¤W¬¡©Ê¥NÁª«¤w¦bÅ餺¸ÕÅç¤W ÃÒ¹ê¥iªvÀø¯×ªÕ¨xª¢¥B¨ã°ª«×¦w¥þ©Ê¡A¥iª½±µ§@¥Î©ó¨xŦ¡A°§C¨x¯×¡B¨xÅÖºû¤Æ¥Íª«¼Ð °O¡AªvÀø¯×ªÕ¨xª¢¡C ¤T¡B¥»¤½¥q³z¹L§ë½Z°ê»Úª¾¦W¬ÛÃö»â°ì·|ij¤Î¬ì¾Ç´Á¥Z¡A±j¤Æ·sÃıڸsªº¾Ç³N»ùÈ»P °ê»Úª¾¦W«×¡C ¥|¡B¥Ø«e¡u«D°sºë©Ê¯×ªÕ¨xª¢¡v©|µL¼Ð·ÇªvÀøÃĪ«¡A¼ç¦b°Ó¾÷Ãe¤j¡ANASH¥«³õ¥¨¤j¡A ¥i¦P®É®e¯Ç¦hÓ·sÃÄ¡C®Ú¾ÚGlobalData 2017¦~5¤ëªº³ø§i¹w´ú¡A¥]¬A¬ü°ê¡A¼Ú·ù¤¤j°ê ®a¡]ªk°ê¡A¼w°ê¡A¸q¤j§Q¡A¦è¯Z¤ú©M^°ê¡^©M¤é¥»ªºNASH¥«³õ¡A¦b¥¼¨Ó¤Q¦~ªº½Æ¦X¦~¼W ªø²v¹F45¢H¡C¥t®Ú¾Ú¼w·N§Ó»È¦æ¤ÎEvaluate Pharmaªº¹w´ú¡A¥þ²yNASHÃĪ«ªº¥«³õ³W¼Ò ¦b2025¦~¤W¬Ý350»õ~400»õ¬ü¤¸¡C¥Ø«e¥»¤½¥q¥¿¿n·¥´M¨D»P°ê¥~¤j¼t¦@¦P¦X§@©Î±ÂÅvµ¥ ¨Æ©y¡C ¤¡B·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¨Ã¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A §ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/15 ¤U¤È 05:27:54²Ä 2618 ½g¦^À³
|
¤U¬P´Á¤@¤S¬O¥[½X¤é |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/15 ¤U¤È 01:27:36²Ä 2617 ½g¦^À³
|
ªYÄ£¨xÃÄYn¤T´ÁÁ{§É¤]n¨x¤t¶Ü¡HÁÙ¬O¥i¥H¥Î¨ä¥L¸û¤£«I¤J©ÊÀË´ú¡H |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/15 ¤U¤È 12:18:06²Ä 2616 ½g¦^À³
|
«O·ç²±¸³»¡²{¦b¤jÃļtÁÈ«D±`¦h²{ª÷¡A³º¤ñ¥«ÈÁÙ°ª¡I¥L»{¬°®³³o¨Ç¿ú¨Ó¨ÖÁʤp¼t¦³¿ú³~¡I§Ú¸ÑŪ¤jÃļt¿ú¦h¹ïªYÄ£¬O¥¿¦V¡B¥Ø«eÀô¹Ò¤]«Ü¦n¡AªYÄ£µL¨xµÇ¬r§¹¬ü¯«ÃÄ¡B¨xÃIJĤ@¦W¡AY¯àÀò§Ö³q¡B¬ð¯}ªº¡A10¿¥¼¨Ó¤£¬O¹Ú¡I |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/10/15 ¤W¤È 06:08:32²Ä 2615 ½g¦^À³
|
CRO¦æ·~¤¶²Ð read01.com/zh-tw/gRO8Axz.html#.Y0nbvnZByUl ¥þ²yTOP10 CRO¤¤¶È¦³ÃÄ©ú±d¼w©M Charles Riverªº¥D·~ÄÝ©óÁ{§É«eÃĪ« ¥Dn°¼«©ó¦w¥þ©Êµû»ù °²³]6634¬O¦W¨¬²y·s¨q¡A¨ü¥þ²y¤Q¤j»¨ªù²y¶¤¤¤¨â®a«C·ý¡A¥B¤w³q¹L«e¤Q¤j¸g¬ö¤½¥q¤Î²y±´´ú¸Õ³q¹L¡A ñ¬ùª÷ªÖ©w¤£¨¥¥i³ë¡A´N«Ý®É¶¡´¦¾å¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/13 ¤U¤È 01:57:23²Ä 2614 ½g¦^À³
|
½²¤j¡A¤j®æ§½¡C ¤p§Ì¥u³Ñ¤U30%¥ª¥kÀò§Q¡A¤¤¶¡¦³¥X¤@¨Ç¡A³Ìªñ¤S¸É¦^§ó¦h¡C¤£¬O¯«µLªk¥X³Ì°ªÂI ¬Ý¬Ý³o110ªº©³¦³¨S¦³¼µ ¦ý¤½¥q¬£¦pªG¤£§V¤O½Í§P¡A¤j½L³o¼Ë®z¡A¤]¼µ¤£¦í~ÃD¥~¸Ü¡A©ñªÅªo³£ÁÈ¿ú¤F ³o2Ó¤ëÓ¤Hı±o¬O³Ì¦nªº®É¾÷¡A¤£n©M¦X¤@¤@¼Ë¦Y¤F¬u³Ó¡A¥¼¤W¥«ÅܤW¥«¡C¾Ç°ê¤§¤j³»¡A¤T¤Ñ¨ì300¦h¦n¡C ============================================================== ¨ì¦~©³¦n®ø®§ÁÙ¬O¦³¡A©ú¦~¤@©w·|§ó¦n¡I6¨t¤]n®É¶¡¬ã¨s¶i¦æ¡A§»Æ[¬Ý¤½¥q»ùȧë¸ê¡A©ú¦~³ø¹S²v·|¤ñ¤µ¦~°ª¡I©Z¥Õ»¡¨ì²{¦b¬°¤î¤µ¦~³ø¹S²v¤]¬ù4¦¨«Ü¤£¿ù¤F¡CÄ~Äò§a¡I |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/13 ¤U¤È 12:58:04²Ä 2613 ½g¦^À³
|
¨ì¦~©³¦n®ø®§ÁÙ¬O¦³¡A©ú¦~¤@©w·|§ó¦n¡I6¨t¤]n®É¶¡¬ã¨s¶i¦æ¡A§»Æ[¬Ý¤½¥q»ùȧë¸ê¡A©ú¦~³ø¹S²v·|¤ñ¤µ¦~°ª¡I©Z¥Õ»¡¨ì²{¦b¬°¤î¤µ¦~³ø¹S²v¤]¬ù4¦¨«Ü¤£¿ù¤F¡CÄ~Äò§a¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/11 ¤U¤È 09:21:17²Ä 2612 ½g¦^À³
|
²Ä1¤äTHR£]¿E°Ê¾¯¬ÝResmetirom. SNP-610´Á¤¤¤ÀªR...ªì¨B¼Æ¾ÚÀu©óResmetirom. -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/7/7 ¤W¤È 11:26:27²Ä 2199 ½g¦^À³ MGL-3745¼g¿ù§ï¥¿¦¨MGL-3196(Resmetirom)¡C 2022.7.5 ¤û¬z¤j¾Ç¨x¯f¾Ç«È®y±Ð±Â´µ¸¦ªâ«¢¨½´ËÂå¾Ç³Õ¤h: Resmetirom¡§¦³¥i¯à¦¨¬°²Ä¤@Ó³Q§åã¥Î©ó NASH ±wªÌªºÃĪ«¡¨ ------------------------------------------------------------------------------------------------- µ²½×: ³Õ¤h¨S»¡ªº¨Æ¡AResmetirom¬O§_¯u¯à¦¨¬°²Ä¤@Ó³Q§åã¥Î©ó NASH ±wªÌªºÃĪ«¡AÃöÁä¦b¦~©³ªºÅ]¤ýÃö¥d¨x¬ïµ²ªG¦p¦ó?(¤T´Á±on¨x¬ïLiver Biopsy) ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/7/3 ¤W¤È 06:27:54²Ä 2169 ½g¦^À³ ¬°¤°»ò¥s¹Ú´K¥H¨Dªºµª®×??? ..... SNP-610´Á¤¤¤ÀªR...ªì¨B¼Æ¾ÚÀu©ó:Ocaliva , MGL3196(Resmetirom¡^, Selonsertib |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/11 ¤U¤È 08:12:29²Ä 2611 ½g¦^À³
|
r¤jÂI¥X«ÂI¡A¦V¦Ì°êªºAkeroªÑ»ùÁÚ¶i¡AÁöµM»¡ªº«Ü¤ßµê(¹ï¤ñ¤µ¤Ñªº»ù¿ú) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/11 ¤U¤È 06:39:39²Ä 2610 ½g¦^À³
|
§Ú¤§«e1¤Ñ1ÁûPPIªvÀøG¼ìºÅ¡A´X¥G¨S·Pı¨ì°Æ§@¥Î¡A¦Y¤F6Ó¤ë¤w·Q°½Ãi¤£¦Y! NASHºC©Ê¯f¡A±wªÌÄ@·Nªø´Á§Ô¨ü·kÄo/äú¤ß¤ÏG/¸¡Âmµ¥°Æ§@¥Î??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/11 ¤U¤È 05:47:01²Ä 2609 ½g¦^À³
|
THR£]¿E°Ê¾¯ASC41 [52¶g] VS. Akero FGF21ªvÀø¶g´Á[24¶g] VS. SNP-610/630À³¸Ó¬O·|±q[12¶g]©Ôªø[24¶g]? Áö¬OºC©Ê¯f¡A¦ý52¶g¤Ó¤[¨o! -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/11/26 ¤W¤È 09:10:39²Ä 1486 ½g¦^À³ 2019/06/27 ¤u°Ó§ù¿·»T ªYÄ£¥ÍÂå¡]6634¡^27¤é«Å¥¬¡AºX¤U«½S¡u·s¤Æ¾Ç¦¨¥÷¡vªvÀø«D°sºë©Ê¯×ªÕ¨xª¢(NASH)²Ä¤G¥N·sÃÄSNP-630¡AÄ~¨ú±o«n«Dµo©ú±M§Q«á¡A¦AÀò±o¬ü°ê±M§Q¡A¦¹±M§Q¦³®Ä´Á©|¦³17¦~¡A³Ì¦h¥i©µªø¦Ü2041¦~¡A¹ï©ó¥¼¨Ó±ÂÅv¦³¨M©w©Ê¼vÅT¡C ...¥Ø«e¤w§¹¦¨¤»¶µ¤HÅéÁ{§É¸ÕÅç¡C¶i¦æ¤¤ªºSNP-6¨t¦C¶}©ñ¦¡Á{§É¤G´Á¬ã¨s¤wÀò±oÅãµÛ¤HÅéÀø®ÄÃÒ¾Ú¡C¾Ú´Á¤¤¤ÀªRµ²ªG¡A NASH¸ÕÅç²Õ¡A¸g [12¶g] ªvÀø«á¡A¨x¥\¯àÀø®Ä«ü¼Ð¤è±¡G¾¢Ói»Ä¤þ଻ÄÂà®ò°ò»Ã¯À(ALT)¡B¾¢Ói»Äf¾L»ÄÂà®ò°ò»Ã¯À(AST)¡B¨Å»Ä²æ²B¡]¨»¨C¡^¡]LDH¡^ÅãµÛ°§C¨ÃÀu©ó«eªu¤j¼tªºÁ{§É¤G´Á¬ã¨sµ²ªG¡F ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/8/20 ¤U¤È 01:49:07²Ä 299 ½g¦^À³ ª`·N¹Ïªí®É¶¡¶b:SNP-610¬OªvÀø [12¶g ] AST¡BALTÅãµÛ¤U° / Ocaliva ¬O18Ó¤ë¡C ©Ò¥H.... |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/11 ¤U¤È 04:25:42²Ä 2608 ½g¦^À³
|
n¥[ªo ºq§«Å§GTHR£]¿E°Ê¾¯ASC41ªvÀø¨x¬ï¬¡ÀËÃҹꪺ«D°sºë©Ê¯×ªÕ©Ê¨xª¢52©PII´ÁÁ{§É¸ÕÅ秹¦¨º¨Ò±wªÌµ¹ÃÄ ASC41¬OÁ{§É¶i«×¤¤°ê²Ä¤@¡B¥þ²y²Ä¤Tªº¥Î©ó«D°sºë©Ê¯×ªÕ©Ê¨xª¢(NASH)ªº¥Òª¬¸¢¿E¯À¨üÅé£] (THR£])¿E°Ê¾¯Ô¿ïÃĪ«¡CASC41 II´ÁÁ{§É¸ÕÅç¬O¥Ñ¤¤°ê¥Íª«§Þ³N¤½¥qµo°_ªº¥Ø«e¶i®i³Ì§ÖªºÀøµ{¬°52©P¤J²Õ¨x¬ï¬¡À˹êNASH±wªÌªºII´ÁÁ{§É¸ÕÅç |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/11 ¤W¤È 11:24:09²Ä 2607 ½g¦^À³
|
³o¨â®a¦³«e¨Ò¥i´`¡A»P§O®a¤½¥q¨xÃij¡¤À±q¦X§@¨óij¨ìñ±ÂÅv¬Û¶Z3¦~¡A810¥Ø«e§Ö2¦~¤F¤]¬O¥¿±`¡C6¨tµL½×ªá¸¨½Ö®a¹ïªÑªF³£¬O¤j§Q¦h¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/10 ¤W¤È 11:30:43²Ä 2606 ½g¦^À³
|
¨S¨Æ´N¤@ª½¤ÏÂЬݫe¤å¡A¤j¥b¬Or¤j±M¤å¡Fì¨Ó¼b¥Í¤]¬O¹ï¨xÃĦ³¿³½ì¡A¨ºªYÄ£¨xÃÄ6¨t±ÂÅv¤]©M³o¨â®a¦³Ãö«Y¡IºÝ¬Ý¥X»ù¦p¦ó¨M©wµ¹½Ö¡A¬JµMÇÃĤ@¨Ö±ÂÅv¡AÅܲ§©Ê´N¬O¤À°Ï»P¥þ²y¨âºØ¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/10 ¤W¤È 10:46:05²Ä 2605 ½g¦^À³
|
¬Ýr¤j«e¤ågskËß10»õ¬ü¤¸»P¤@®a¨xÃĬãµo¤½¥q¦X§@¡i2021¡B11¡j¡A¥i¨£g¹ï¨xÃĬO¦³¿³½ìªº¡FÂX¤j¦X§@¥i¯à´N¬O¨xÃÄ6¨t¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/9 ¤U¤È 12:21:14²Ä 2604 ½g¦^À³
|
ªYÄ£¥u»EµJ[¨x¯f]·sÃĬãµo¡A¸£Àù»P¨ä¥L¾AÀ³¯g±o¬ÝLicense-inÃļtªº·NÄ@! Àù¯g¥ÎÃĪ«¦hµLªk³q¹L¦å¸£«Ì½ª¡A¦]¦¹¡A¥i¥Î©óªv療¸£¸~½Fªº¤Æ療ÃĪ«¨ü¨ì·¥¤jªº§½¡C ------------------------------------------------------------------------------------------------ scitechvista.nat.gov.tw/Article/C000003/detail?ID=5026001f-55bb-4855-acc8-7e93b40624b8 ¹Í¹Í¹Í¡I²Óµß¤Å¶i¡I³o¸Ì¬O¤j¸£ªºµ´¹ï¨¾¿m¡X¡X¦å¸£«Ì»Ù ¤HÅé§ó¾Ö¦³¡u¤T¤j«Ì»Ù¡v¡A©{¦p°í©T«°Àð¡A¯à©è¾×¥~¬É²§ª«ªº§ð¤J¡C¤T¤j«Ì»Ù¥]¬AL½L«Ì»Ù¡B¸z¹D«Ì»Ù»P¡u¦å¸£«Ì»Ù¡v¡]©ÎºÙ¦å¸£»Ù¾À¡Ablood¡Vbrain barrier¡ABBB¡^¡A¨ä¤¤¡A¦å¸£«Ì»Ù³Ì¬°½ÆÂø¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/9 ¤U¤È 12:09:21²Ä 2603 ½g¦^À³
|
±w¤@ª½¦Y´¶®³¯k¦n¤F¤j¥b¡Ar¤j³o¸ê°T¦³ÃСI3196¬O¨xÃÄ«e½ú¡A¥u¦³¤@Ó¾÷Âà¡A6¨t¦³2Ó¾÷Âà®ÄªG§óÀu¡IªYÄ£Y¯à¬ãµoÀùÃĪ«¡A¦pªê²KÁl¡I |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/9 ¤W¤È 11:44:32²Ä 2602 ½g¦^À³
|
¤AñQ¦w×ô¨ã®øª¢±þµß¥\¯à¡A«e¤å¦³½Í¨ì¤@¦ì¡@Àù |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/9 ¤W¤È 10:57:54²Ä 2601 ½g¦^À³
|
SNP-810±ÂÅv»ùÈ???(¤îµhÃÄ+Àù¯g¥«³õ) 1.¤U¦C¸ÕÅç¥HSNP-810¥i´£°ª¾¯¶q¡A¸ÕÅçµ²ªG??? 2.SNP-610/630»PSNP-810ªvÀø¸£Àù¡A¨ã¦³¥[¼®ÄÀ³? www.turkishneurosurgery.org.tr/pdf/pdf_JTN_2427.pdf (¬Ý¹Ïªí´N¤@²M¤G·¡) ¬ã¨sµ²ªGªí©ú¡A¼³¼ö®§µh¹ï½¦½è¥À²ÓM½F²ÓM¨ã¦³§Ü¸~½F§@¥Î¡A³oºØ¬¡©Ê¬O¥Ñ¤£¦Pªº«H¸¹³q¸ô»¤¾É¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/27 ¤W¤È 10:07:08²Ä 1066 ½g¦^À³ SNP-610/630»PSNP-810ªvÀø¸£Àù??? --------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/27 ¤W¤È 09:53:44²Ä 1065 ½g¦^À³ DGAT1¬O¤@个«D±`¦³§Æ±æªv疗恶©Ê胶质¥À细M½F(¤@ºØ³Ì±`¨£¤]¬O³Ì¨ã«Iŧ©Êªº¸£Àù)ªº·sªº药ª«¹v点¡C ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/14 ¤W¤È 09:08:28²Ä 1026 ½g¦^À³ 2020.10.26¼³¼ö®§µh¹ï½¦½è¥À²ÓM½F²ÓM¼W´Þªº¼vÅT www.turkishneurosurgery.org.tr/pdf/pdf_JTN_2427.pdf µ²½×¡G§Ú̪º¬ã¨sµ²ªGªí©ú¼³¼ö®§µh¹ï½¦½è¥À²ÓM½F²ÓM¨ã¦³§Ü¸~½F§@¥Î¡A¨Ã¥B³oºØ¬¡©Ê¬O ¥Ñ¤£¦Pªº«H¸¹³q¸ô»¤¾É¡C...§Ú̵o²{¼³¼ö®§µh´î¤Öªº²ÓM¼W´Þ¨ú¨M©ó [¾¯¶q]©M[«ùÄò®É¶¡].... ¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1¶ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/27 ¤W¤È 09:53:44²Ä 1065 ½g¦^À³ DGAT1¬O¤@个«D±`¦³§Æ±æªv疗恶©Ê胶质¥À细M½F(¤@ºØ³Ì±`¨£¤]¬O³Ì¨ã«Iŧ©Êªº¸£Àù)ªº·sªº药ª«¹v点¡C 2020.8.4 www.x-mol.com/news/457072 ªñ¤é¡A¬ü国«X¥è«X¦{¥ß¤j学肿½F¤¤¤ß³¢¼w¨}±Ð±Âªº¬ã¨s团队¡A¥Hµ{²»³Õ¤h©M¯Õ®p³Õ¤h为¦}¦C²Ä¤@§@ªÌ¦bCell Metabolism杂§Ó¤W发ªí题为¡§Targeting DGAT1 ameliorates glioblastoma by increasing fat catabolism and oxidative stress¡¨ªº¬ã¨s论¤å¡A该¬ã¨sº¦¸´¦¥Ü调节¯×ªÕ»Ä储¦s酶¡X¡X¤G酰°ò¥Ìªo-酰°ò转²¾酶¡]DGAT1¡^¡X¡X¬O¤HÊ^恶©Ê胶质¥À细M½F关键ªº¯×质¥¿Å调节¦]¤l¡A¦}´¦¥ÜDGAT1¬O¤@个«D±`¦³§Æ±æªv疗恶©Ê胶质¥À细M½Fªº·sªº药ª«¹v点¡C 该¬ã¨sº¦¸´¦¥Ü¤F¥Ìªo¤Tà©MDGAT1¦b胶质¥À细M½F¯f¤H组织标¥»¤¤°ªªí达¡A¥BDGAT1ªºªí达¶qÉO¯f¤Hªº¾ãÊ^¦s¬¡时间§e负¬Û关¡]图1¡^ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/8 ¤U¤È 04:39:49²Ä 2600 ½g¦^À³
|
§^¤£¥Î¾á¤ß®Ö¼u ¬Ý¬Ýªo»ù opec+«X°ê¤~¬O³Ì¤j¨ü¯qªÌ §Ú¬O½ä¦Ì°ê²]°Õ~~©ñªÅ¥ÛªoÁ«¦º¤F ¯u´±¥´ ¤£¥uªÑ»ù 쪫®Æ¤]gg ªo»ùÁÙupup ¤Ï¥¿§Ú¨S©Ð ¨S¿ú «·sÂk0¨Ó»¡ ¤@°_«·s¥Xµo==>§Æ±æ¤pÄ£Åý§Úfire ´«¥y¸Ü¸Ü ¯u¥´¤F ¤îµhÃĤ]n½æ¨ì¤£n¤£n ¤Ï¥¿¬P´Á¤@¨Ó¬Ý¬Ý¥Í§Þ¹ï¤j½L ½Ö²]Àú ============================================================================= ¤pÄ£¤£¬O¤¤¤Ñ¤jÀY¤]¦n ¤£µM·|«ºt®±²±³Q¤Õ©ú¦Y¤Fªºµ²§½ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/8 ¤U¤È 01:21:09²Ä 2599 ½g¦^À³
|
³Ì²×ÁÙ¬O¥X²{§Ú³Ì¾á¼~ªº®Ö¼u«Â¯Ù!!! ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/22 ¤W¤È 10:55:27²Ä 1725 ½g¦^À³ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/17 ¤U¤È 12:34:46²Ä 1710 ½g¦^À³ §Ú¥H¬°¬O¥Ñ«Xù´µ¶}¤õ¤ÞÃz¡Aµ²ªG¯Q§JÄõª¯¥M¤H¶Õ¡AºÆª¯¥ý«r¤H! ------------------------------------------------------------------------------------------------ ´Á±æ¥_·¥ºµ´¶¤B¦b¥Ï¤FºÆª¯2Óºµ´x«á±¼ÀY´N¨«¡A¤£µM...«u |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/8 ¤U¤È 01:11:06²Ä 2598 ½g¦^À³
|
2022.10.7 À³¹ï®Ö¾Ô«Â¯Ù¡H¬ü°ê«æ±ÄÁÊ¡u92»õ¿ç®g¯fÃĪ«¡v ¬ü«X¤À¶Ç¤j¶q±ÄÁÊ¿ç®g¯fÃĪ«¡B¸K¤ù ------------------------------------------------------------------------------------ ¯u®ÖÃz ºG ºG ºG ¤Ñ¦ö¸Uª«¥ÍÆF! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/8 ¤U¤È 12:57:50²Ä 2597 ½g¦^À³
|
µÇ¬r©Ê! ¨ì 2030 ¦~¡A¥þ²y«Dªü¤ùÃþÃĪ«¯kµhªvÀø¥«³õ³W¼Ò±N¹F¨ì 779.1 »õ¬ü¤¸ www.grandviewresearch.com/press-release/global-non-opioid-pain-treatment-market 2022 ¦~ 9 ¤ë¡A¬ü°ê FDA «Øij¦bÃh¥¥ 20 ¶g®ÉÁקK¨Ï¥Î«Dªü¤ùÃþÂíµh¾¯ªvÀø¡A¦]¬°¥¼¥X¥ÍÀ¦¨à¥X²{µÇŦ°ÝÃDªº¥i¯à©Ê«Ü°ª¡C¬F©²ªº¦¹ÃþÁ|±¹¥i¯à·|¨î«DÍrÅé§Üª¢ÃĪº³B¤è¡A±q¦Ó¨î«Dªü¤ùÃþÃĪ«¯kµhªvÀø¥«³õªº¼Wªø¡C ¬F©²ªº¦¹ÃþÁ|±¹¥i¯à·|¨î«DÍrÅé§Üª¢ÃĪº³B¤è ¬F©²ªº¦¹ÃþÁ|±¹¥i¯à·|¨î«DÍrÅé§Üª¢ÃĪº³B¤è |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/8 ¤U¤È 12:49:14²Ä 2596 ½g¦^À³
|
µÇ¬r©Ê! 2020.10.15 FDAµo¥¬ÃĪ«¦w¥þĵ°T www.fda.gov/media/142967/download ¬ü°êFDAµo¥¬Äµ°T¡A§³®W20¶g¥ª¥k©Î§³®W«á´Á¨Ï¥Î«DÃþ©T¾J§Üµoª¢ÃÄ¡]NSAIDs¡^®£¾ÉPL¨à¨u¨£¦ýÄY«ªºµÇŦ°ÝÃD¡A¶i¦Ó¤Þµo¦Ï¤ô¹L¤Ö©M§³®W¨Öµo¯g¡AÀ³ÁקKªA¥Î¡C «DÍrÅé§Üª¢Ãijq±`¥Î©ó½w¸Ñ¯kµh©M°h¿N¡C¥¦Ì¥]¬Aªü¥q¤ÇªL¡B¥¬¬¥ªâ¡B萘´¶¥Í¡BÂù´âªâ»Ä©M¶ë¨Ó©õ¥¬µ¥ÃĪ«¡C -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/1 ¤U¤È 08:52:35²Ä 2370 ½g¦^À³ SNP-810µLµÇ¬r©Ê³oÓÀuÂI¡A¹ï©ó·m§ðNSAIDs¡]«DÃþ©T¾J®øª¢¤îµhÃÄ¡^ªº¥«³õ¥÷ÃB¤j¦³§U¤O! ¤îµhÃį}ÃaµÇŦ«OÅ@¾÷¨î!!! www.commonhealth.com.tw/article/74087 ½Ð·V¥Î¤îµhÃÄ¡IµÇŦ¬ì¦WÂå¨Iµh§i¥Õ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/8 ¤W¤È 10:31:22²Ä 2595 ½g¦^À³
|
¬Q¤Ñ¬üªÑ±Y2.11%(630ÂI)¡A8+9¯««i¦Aöt+9.57%(¬ð¯}9/13°ª)¡AFGF21ÃĪ«¸Þ²§¦a1¤Ñ! ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/14 ¤W¤È 06:16:17²Ä 2463 ½g¦^À³ ¬üªÑ±Y¶^3.94% VS. NASH·§©ÀªÑÃzº¦:Akero (+136.76%) / 89bio Inc(+40%) «Ü¤£´M±`ªº1¤Ñ. |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/8 ¤W¤È 08:11:04²Ä 2594 ½g¦^À³
|
³£¦³³\¥i¤F ÁÙ¤£»¶Ü? ¨ì©³¦bµ¥¤°»ò ¥xªÑ¬P´Á¤@¤Sn³Q¬üªÑ¸õ¤ô¼v¦V ¤pģģ·|¤£·|¶^¯}120©O?? ============================================= ¦³¤@¨Æ¤@ª½¤£¸Ñ¡G¸³¨Æªøªí¥Ü¡A¸Ó¤½¥q¶}µoªºµL¨x¬r©Ê¤AñQÓi×ô¤îµh·sÃÄSNP-810¡AÀò¬ü°êOTC monograph³\¥i¡A¤w¨ú±oNational Drug Code¡]°ê®aÃÄ«~ÅçÃÒ¸¹¡^¤Î¬ü°ê¥«³õ¾P°â¸ê®æ¡C ¤jÃļt±ÂÅvª÷°ª¡A¾P°â¶q¤j¤S¯à°¨¤W¥Îì¨ÓÃÄÃÒÄ~Äò¾P°â¡Aµ¥·sÃÒ¤U¨Ó¦A´«ÃÒ¡A¤À¼íª÷¤]°¨¤W¦³¡A³o¬O¤½¥q±ÂÅvº¿ï²{¦b¦X§@¤j¼tì¦]¡F¬Û«H©¼¦¹¦X§@¨Ã¥BÂX¤j¦X§@¤~¬OºÍ´¼¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/7 ¤U¤È 11:57:26²Ä 2593 ½g¦^À³
|
¤jÃļt±ÂÅvª÷°ª¡A¾P°â¶q¤j¤S¯à°¨¤W¥Îì¨ÓÃÄÃÒÄ~Äò¾P°â¡Aµ¥·sÃÒ¤U¨Ó¦A´«ÃÒ¡A¤À¼íª÷¤]°¨¤W¦³¡A³o¬O¤½¥q±ÂÅvº¿ï²{¦b¦X§@¤j¼tì¦]¡F¬Û«H©¼¦¹¦X§@¨Ã¥BÂX¤j¦X§@¤~¬OºÍ´¼¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/7 ¤U¤È 09:50:13²Ä 2592 ½g¦^À³
|
ªGµM¬O¤j®æ§½¡A³£µ¥¤F¤G¦~¤F¡AÁÙ®t¤TÓ¤ë´N¦~©³¡A¾Ç°ê³»¥h¦~º²Â_¤@¤U¤T¤Ñ ª½¹F300 ¥¢¥hªº¦b·sÃÄ®³¦^¨Ó |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/7 ¤U¤È 07:39:37²Ä 2591 ½g¦^À³
|
¹ï¤½¥qµL¨xµÇ¬r§¹¬ü¯«ÃÄn¦³«H¤ß¡I±ÂÅv®×·mµÛn¤£¥²¾Þ¤ß¡A¤½¥q¥²µM·|¥H¤½¥q¦³§Q±¡ªp½Í§P¡A¦n¨Æ¦b¦~©³«e·|¥X²{¡AÁ`¬O³oºØ·Pı¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/7 ¤U¤È 03:03:33²Ä 2590 ½g¦^À³
|
«¢«¢ ªGµM¬O¼ÐÃD¸Ø¤jÂI´N¦³¤HÃö¤ß §^¥i¨S»¡¤°»ò¤½¥q¤°»òÃıÂÅv¨S¹L®@?????¤]¨S¹ï»ùÃö¨t ¤]¨S¤ºÀ` ±ÂÅv¨S¹L==>§Ö°k§a ¥i¥Nªí©È¨S¹L¨S±ÂÅv´N§Ö½æ ¨S«H¤ß¤]´N½æ ¦³«H¤ß´N¥[½X ¾A¥Î¦b¨C¤@Ó²£·~¨C¤@Ó¤½¥q ÁÂÁ´£¿ô ²q¤@²q¤£¥Çªk§a ¬Ý¤F¤j¶^ ¤ß±¡¤£¦n ©`¦Ì¤á¤Ö¤F¼Æ¤Qw ³oªO¤Ó§N²M¤£¹³¥_·¥ ¤£¦nª±§r ¥un§OªºªO¤j ¤£n¶Ãcue ´N¨S¨Æ |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/10/7 ¤U¤È 02:40:37²Ä 2589 ½g¦^À³
|
dK¤j ±ÂÅv¨S¹L¡H ¤½¥q¨S¦³¤½§i §O³yÁÁ¡H ¦pªG¬O±z©ñ°²°T®§¡H ¥i¯à·|¦Y¤W©x¥q¡H |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/7 ¤U¤È 02:26:23²Ä 2588 ½g¦^À³
|
±ÂÅv¨S¹L==>§Ö°k§a Ä@½äªA¿é ¤p¶R¤@ÂI ³oÓ¶q 100±i´N©Ô¤F¤@¥b ======================= ªY ¤µ¤Ñµo¥Í¤F¤°»ò🤔 |
|
|
·|û¡G©ú¤é´¸10152496 µoªí®É¶¡:2022/10/7 ¤U¤È 01:56:00²Ä 2587 ½g¦^À³
|
²ö©ú+®£·W+¦@¦ñ=¤j¶^¡H ¤µ¤Ñ´N¾ß´X±i°_¨Ó¦s©ñ ·Qn§Úªº²¼¶Ü¡H µ¹§Ú±ÂÅv¨ä¾l§K½Í¡C |
|
|
·|û¡Gªiªi10151449 µoªí®É¶¡:2022/10/7 ¤U¤È 01:16:02²Ä 2586 ½g¦^À³
|
ªY ¤µ¤Ñµo¥Í¤F¤°»ò🤔 |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/6 ¤W¤È 09:20:32²Ä 2585 ½g¦^À³
|
·sÃij洫³o¤ä ¤W¬Ý800? «¢«¢ ³o´N¬O¦Ì°ê¸ê¥»¥«³õªº§Q®` ¤£¦p§ÚÌ´XÓ©`¦ÌªÑ§ë²¼Åý·sÃĤU¥«(¾Ç¥x·L)¥h¦Ì°ê§a ================================================= Akero¦b2017¦~³Ð¥ß¡Aû¤u37¤H¡A 9/13Ãzº¦¦¬29.05¡A¬Q¤é¦¬38.31(³Ð·s°ª)¡A¥«È17.78»õ¬ü¤¸¡C akerotx.com/pipeline/ pipeline´N1¤äÁ{§É¤G´ÁNASHÃĪ«Efruxifermin ¡A§OµL¥Lª«! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/6 ¤W¤È 08:12:48²Ä 2584 ½g¦^À³
|
NASH¥«³õ§lª÷¾y¤OµLªk¾×! Akero Therapeutics «Å¥¬§¹¦¨ÂX¤j´¶³qªÑ¤½¶}µo°â2.3»õ¬ü¤¸(9/15´£¥æ9/19§¹°â) ir.akerotx.com/news-releases/news-release-details/akero-therapeutics-announces-closing-upsized-public-offering-0/ 2022¦~9¤ë15¤é¦V¬ü°êÃÒ¨é¥æ©ö©eû·|´£¥æ¤F»Pµo°â±ø´Ú¬ÛÃö©M´yzªº³Ì²×©ÛªÑ»¡©ú®Ñ¸É¥R©MÀHªþ©ÛªÑ»¡©ú®Ñ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/6 ¤W¤È 08:01:26²Ä 2583 ½g¦^À³
|
2022.8.1 ¡m¬húí¤M¡n¤l¥Z³Ì·s发¥¬¡G¥þ²y¨C3个¦¨¤H´N¦³1¤H¿©±w¯×ªÕ¨x www.163.com/dy/article/HDNED9TI05349C3G.html ...¥þ²yS围内¡A«D°sºë©Ê¯×ªÕ©Ê¨x¯fªº±w¯f²v³£§e现¥X³v渐¼W°ªªº趋势 --------------------------------------------------------------------------- ¯×ªÕ¨x¤£¬O¯f-->¦ý¯fÅܬ°¯×ªÕ¨xª¢´N¥i¯àn±zªº©R(¨xŦ³QºÙ¬°¡u¨IÀqªº¾¹©x¡v¡ANASHªì´Á¨S¬Æ¯gª¬¡A±wªÌÃø¥Hµoı¨x¥X°ÝÃD)-->¦A¯fÅܦ¨¨xÅÖºû¤Æ(F1~F3)»P¨xµw¤Æ(F4)´N¬On±zªº©R! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/6 ¤W¤È 07:03:15²Ä 2582 ½g¦^À³
|
Akero¦b2017¦~³Ð¥ß¡Aû¤u37¤H¡A 9/13Ãzº¦¦¬29.05¡A¬Q¤é¦¬38.31(³Ð·s°ª)¡A¥«È17.78»õ¬ü¤¸¡C akerotx.com/pipeline/ pipeline´N1¤äÁ{§É¤G´ÁNASHÃĪ«Efruxifermin ¡A§OµL¥Lª«! ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/13 ¤U¤È 10:09:04²Ä 2458 ½g¦^À³ ¥Ø«e¬üªÑ¤j¶^ VS. NASH·§©ÀªÑÃzº¦:Akero (+160%) / 89bio Inc(+46%) ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/30 ¤U¤È 10:17:26²Ä 2573 ½g¦^À³ .Akero¦Aº¦13%+³Ð¤µ¦~°ª¡A£¯£¯£¯¡A¶Â¥Õ¦§g¥X³õ¤f¥Õ:§O¤Hªº¥¢±Ñ´N¬O§Úªº§Ö¼Ö? |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/3 ¤U¤È 04:33:42²Ä 2581 ½g¦^À³
|
ªYÄ£°¯×ªÕ¨xª¢ÃÄÃĮĺâ²Ä¤@¦W¡A±Æ«e±4Áû¤¤¡A¤@Áû¥¢±Ñ¤@ÁûÂà¦V³Ñ2Áû¡A³o2ÁûY¦¨¥\¤]¤£¼vÅTªYÄ£µo´§¡AY¥¢±Ñ¨ºªYÄ£Åܦ¨¤Ñ¤§Åº¤l¡F¥Ø«e¨xª¢ÃijæÁû¶ÈÁ{§É«e´Nn7»õ¬ü¤¸±ÂÅv¡A«¥ªYÄ£¼Æ¾Ú¦n¨ã°sºë«D°s©Ê¨xª¢¬Ò¯à¾A¥Î¡B¥¥°ü¤]¦æ¡A2Áû¤@¨Ö±ÂÅv15»õ¬ü¤¸¥H¤W¡AY®³¬ð¯}¸ê®æ¦A¥[5»õ¬ü¤¸¡CªYÄ£«eµ{¦üÀA¡I¥[ªo¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/3 ¤W¤È 09:14:59²Ä 2580 ½g¦^À³
|
1.¥x·LÅéTLC599 ¤G´Á: clinicaltrials.gov/ct2/show/NCT03005873?term=TLC599&draw=2&rank=3 Experimental: TLC599 LD group:12 mg DSP with 100 µmol PL (1.0 mL) Experimental: TLC599 HD group:18 mg DSP with 150 µmol PL (1.5 mL) Placebo Comparator: 1.5 mL normal saline 2.¥x·LÅéTLC599 ¤T´Á: Experimental: TLC599:TLC599 (1mL) IA injection Active Comparator: Dexamethasone sodium phosphate 4mg (1mL) IA injection Placebo Comparator: Normal saline (1mL) IA injection -------------------------------------------------------------------------------------------- TLC599¤D¥x·LÅé¿W®a[ªø®Ä½wÄÀ]°t¤è¤§¦a¶ë¦ÌªQÁC»Ä¶uÃĪ«(Dexamethasone sodium phosphate) ÃĪ«¥Øªº¦bÅçÃÒ6Ӥ몺[ªø®Ä½wÄÀ]®ÄªG¡A«ç»ò¤£¦b¤G´ÁÁ{§É´N¥ÎDexamethasone sodium phosphate°µ¹ï·Ó? |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/10/2 ¤U¤È 04:18:45²Ä 2579 ½g¦^À³
|
¥x·LÅé TLC599 Ãö¸`ª¢¤î¯kµhÃÄÁ{§É¤T´Á¥½¹FÅãµÛ®ÄªG! 6.7E ¬üª÷±ÂÅvª÷¦¨®£¦¨ªw¼v¡C Endo says osteoarthritis pain candidate failed in late-stage study seekingalpha.com/news/3886056-endo-says-osteoarthritis-pain-candidate-failed-in-late-stage-study |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/2 ¤U¤È 02:00:45²Ä 2578 ½g¦^À³
|
®ø¤Æ¹D¬ï¬}¥¬¬¥ªâ¡A¨â¨t¦³6¦Ê»õ¬ü¤¸¥i¥H·m§ð¡CY¤@¦Ê»õ¬ü¤¸¥«¦û¤@¦¨¤À¼íª÷¨CªÑ400¤¸Ã¬§Q¡C±ÂÅv¶V«á·|¶V°ª¤£¥²«æ¡C¹q¸£®t¯u©êºp¡I |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/2 ¤U¤È 01:38:58²Ä 2577 ½g¦^À³
|
ªYÄ£8¨tµLµÇ¬r©Ê¤w®Ê¤É¬°§¹¬ü¯«ÃÄ¡IÀ£Ë¦³µÇ¬rG¼ìºÅ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/2 ¤W¤È 10:57:12²Ä 2576 ½g¦^À³
|
´º³Í³£±ÂÅv¤F¡AªYÄ£¬Onµ¥¦h¤[ ´º³Í³o¨Ç·s»D¤§«eª£¹L¤F ³o¤]¯à¼Q40% ¤ºÀ`¤Ó²r¤F ¤£n³Q¶W¨®¤F!! ======================== §Oºô³£¦bª`·N·sÃĤF ¤£ª¾¬O¦n¬OÃa ¬Ý¬Ý¨º¨Ç¤£·Çªº¦Ñ¿é |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/10/1 ¤U¤È 04:17:48²Ä 2575 ½g¦^À³
|
¤jÃļt°µ¥Í·Nºâ®tªº¡IªYÄ£4ÁûÃÄ¥þ®³¡AÅnÂX¤îµh剤¡B¨xª¢¥«³õ¦h¤j¡I20»õ¬ü¤¸¤@¦¸¥þ®³¦h°®¯Ü¡I³o¼Ë§Q¼í¤~¥i©È¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/10/1 ¤W¤È 03:15:12²Ä 2574 ½g¦^À³
|
¬Ý¨ì¤FR¤j¤À¨Éªº®ø®§¡AºÎ¤£þÓ¤F¡I·s药¤½¥q¨ì©³¦bµ¥¤°¤\¡A¥x湾ªº药这没¦³¤H关ª`吗¡H§Æ±æ¯à¥´¯}²°¤@ªº兽¥þª÷ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/30 ¤U¤È 10:17:26²Ä 2573 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/13 ¤U¤È 07:49:31²Ä 2456 ½g¦^À³ Akero¤µ¤Ñ¶}½L«e+12.52 öt¯}102.04%!!! --------------------------------------------------------------------------------------- Akero¦Aº¦13%+³Ð¤µ¦~°ª¡A£¯£¯£¯¡A¶Â¥Õ¦§g¥X³õ¤f¥Õ:§O¤Hªº¥¢±Ñ´N¬O§Úªº§Ö¼Ö? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/30 ¤U¤È 10:06:46²Ä 2572 ½g¦^À³
|
F4¯u¤£ªP¬°¸T°Ï! 2022.9.30 IntercptªÑ»ù±Y¶^ 20% ì¦]:F4ªºREVERSE study¥¼¹F¼Ð! -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/7/10 ¤U¤È 02:51:24²Ä 2219 ½g¦^À³ Intercept·Q¤jº¡³e¨úÃÒ¡A´N¬OnÁpÃĪvÀø! °ê¥~±À¦ôOcaliva¦bF2~F3®³ÃÒ¾÷²v60%(«¥¥[1¤À=¤C¤À¾a¥´«÷) F4ªºREVERSE study¦bQ3·|¥X¨Ó(¦]¨x¬r©Ê¡AF4®³ÃÒ¾÷²v§C=3¤À¤Ñª`©w=¤Hºâ¤£¦p¤Ñºâ) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/30 ¤U¤È 08:14:22²Ä 2571 ½g¦^À³
|
2022.9.16Áú°êNASH±ÂÅv®× www.businesskorea.co.kr/news/articleView.html?idxno=100421 Dong-A ST ¤w±N DA-1241¡]¤@ºØªvÀø 2 «¬¿}§¿¯f©M«D°sºë©Ê¯×ªÕ©Ê¨xª¢ªºÃĪ«¡^©M DA-1726¡]¤@ºØªvÀøªÎD©M«D°sºë©Ê¯×ªÕ©Ê¨xª¢ªºÃĪ«¡^±ÂÅvµ¹¦ì©óªi¤h¹yªº¯Ç´µ¹F§J¤W¥«¤½¥q NeuroBo¡C ¥¦±NÀò±o 2200 ¸U¬ü¤¸ªºº¥I©M»ùÈ°ª¹F 3.16 »õ¬ü¤¸ªºµo®i¨½µ{¸O¡C¥¦ÁÙ¦³ÅvÀò±o°Ó·~¤Æ«áªº¯S³\Åv¨Ï¥Î¶O¡A¦ý¥¼©ÜÅS¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/30 ¤U¤È 05:50:10²Ä 2570 ½g¦^À³
|
2022.9.30 ´º³Í·sÃÄJKB-122±ÂÅvIMUN¡AÁ`±ÂÅv¨½µ{ª÷¹O1.2»õ¬ü¤¸(¥[2019¦~0.26=1.46»õ¬ü¤¸) JKB-122¾AÀ³¯g¶}µo±Ä¦hy¨Ã¶i¡A¥]¬A«D°sºë©Ê¯×ªÕ¨x¯f(NAFLD)¡BC«¬¨xª¢¯f¬r(HCV)¤Þ°_¤§ºC©Ê¨xª¢¡B¦ÛÅé§K¬Ì¨xª¢(AIH)µ¥ ¥[ 2019¦~¤w±N±N¨È¬wÅv§Q¥H2,600¸U¬üª÷©M¤W¥««áªº¾P°â¤À¼í±ÂÅv¤©¤¤°ê¥»¤gCROÀsÀY¥ø·~®õ®æÂåÃÄ(300347.SH)¤l¤½¥qùÚÁl¥Íª«¡C ------------------------------------------ ªYÄ£±on¥[§Ö¸}¨B¤F!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/30 ¤U¤È 05:40:44²Ä 2569 ½g¦^À³
|
¤£¨ì1¶g¤S¨Ó1Ó±ÂÅv®×! 2022.9.30 ¿Õ©M¿Õ¼w¥H 7.03 »õ¬ü¤¸ªº»ù®æ±q Ventus ¤â¤¤¦¬ÁÊ NASH ÃĪ«(Á{§É«e) pharmaphorum.com/news/novo-nordisk-grabs-nash-drug-from-ventus-in-703m-deal/ ¹w¥I¤F 7000 ¸U¬ü¤¸ ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/25 ¤W¤È 08:46:14²Ä 2539 ½g¦^À³ ³Ìªñ°ê¥~NASHÃĪ«¶}©l¼ö¾x¤F! ¶W3亿¬ü¤¸¤Þ进(¤j¤¤µØ°Ïn»ù3.07»õ¬ü¤¸¡A¦¹ÃÄÁ`±ÂÅv¥[¤W¼Ú¬üµ¥¦a>10»õ¬ü¤¸µLÄa©À)¡I |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/9/30 ¤U¤È 04:33:37²Ä 2568 ½g¦^À³
|
dk¤j½ÍÀu¨ÖªYÄ£21»õ¬ü¤¸¡A²z©Ê¨Ó½Íªá³o¿ú¬OÈ¡I¦]¬°4ÁûÃÄ¥ú±ÂÅvª÷´Nn21»õ¬ü¤¸¡A¬Ù4¿¤À¼íª÷¤ä¥X¡A¦Ü¤Ö¦³4¿§Q¼í¡A¹ê½è§Q¼í¤£¤î4¿¡FY¦³¦¹¾÷½t¤]¬O²{¦bªÑ»ù10¿¡C¯Â°Q½×¡C |
|
|
·|û¡GPeter Lin10152815 µoªí®É¶¡:2022/9/30 ¤U¤È 12:25:57²Ä 2567 ½g¦^À³
|
Nelson¡A¥_·¥¬P¥[¤@¥[¦³6®ÚÅo¡C§A¦³¨S¦³¶]ªº¤Î®É¡H ¤U¦¸n¦hÅ¥¤£¦P·N¨£³á¡C ªüªù¡C ------------- Nelson¡A§Ú¤]¦³¥_·¥¬P¡A¤£¹L¥u¬Oª±ª±¡AÁȸѪ¼¦æ±¡¡C ¦Ñ°®w¦s888ÅÜ333¡A¦b178½æ¥X¦^¥»(¤£³g)¡A³Ñ¤U333½ä¸Ñª¼¸ò¥¼¨Ó(¤j³g)¡A¬O¦Ñ°¤½¶}¶K¤åªº¡C§Ú¨º¸Ì¶Ã»¡¡H ------------- DK¤j¡ARoger¤j¡A ¦b¡yªYÃÄ¡z°Q½×¨ä¥LªÑ²¼¡A§Ú§¹¥þ¨S¦³°ÝÃD¡IÓ¤H¤]«D±`³ßÅwÅ¥¨ì¥H¤£¦Pªº¨¤«×¤Î°T®§¨Ó¤ÀªR¦Û¤vªº§ë¸ê¼Ðªº¬O§_¦³§Ú¨S¬Ý¨ìªº¼ç¦b·ÀI¡H¡I ¦ý¬O§ÚµLªk»{¦P Peter Lin ©ó 9 ¤ë 7 ¤é¡A¹ï¡y¥_·¥¬P¡z¥H¤Uªºµû½×¡I¦]¬°¦³®Ú¾Ú¶Ü¡H¶º¥i¥H¶Ã¦Y¡A¸Ü¤£¯à¶ÃÁ¿¡I .. ¤§«eªº¤@Óµû½×¡A¤]¦³¥¢°¾»á¡G ¡y¦A¨Ó»¡¤@¤U¥_·¥¬P¡A¬Ý·|¤£·|º¦¡H ¦Ñ°¤£³g¥ý½æ60%²{ªÑ¥ý¦^¥»¡A³Ñ¤Uªº¤j³g40%«ùªÑ½ä¡C ¥i¼¦ªº´²¤á¡C¡z ¡yªYÃÄ¡z¸ò¡y¥_·¥¬P¡z¡A§Ú³£¦³«ùªÑ¡I ¡K ¦P®É¡A§Ú¤]«Ü¬Ý¦n¡yªYÃÄ¡zªº¼ç¤O¡I ¡K §Æ±æ¥xÆW¡y¦n¡zªº¥Í§Þ¤½¥q¥i¥H¦@¦n¡I ¥[ªo⛽️ ¯¬ ¤¤¬î¨Î¸`§Ö¼Ö¡I §ë¸ê¶¶§Q¡I ------------- Roger¤j¡A§Ú¬O¥X¨Ó¦R¼Ñ¤@¤U»Ä§ÚÁ¿¥_·¥¬Pªº¤H¡A§O¦b·N¡C ¤µ¤Ñ¬Ý¨ì°ªºÝ¤@¸s¹F¤H¦b»Ä¦Ñ°¡AÁ¿ªº¤]¨S¿ù¡A»¡¸Ñª¼«e§CÂI¶R¡A¤£n°l°ªµ¥¸Ñª¼¡C ¦ý»¡°ªºÝ²{¦b»ù®æ§C¡A¤~¥i¥H¶R¨Óµ¥WHO¤T´Á¡A§Ú§Ö¯º¦º¡C ¦]¬°°ªºÝWHO¤T´Á®Ú¥»¸Ñ¤£¤Fª¼¡C 150¤H½T¶E¸Ñª¼¬O¥H¨¾·P¬V¤H¼Æ¬°¦ôp¶q¤ÎÈ¡A³oӼ˥»¤H¼ÆOK¡A¦]¬°¨¾·P¬Vªº¦ôp¶q(È)«Ü®e©ö±q¤p¼Ë¥»¼Æ¤¤Æ[¹î±o¨ì¡C ¦ýomicronªº«¯g¤ñ²v¡A¤j¬ù¥u¦³¤d¤À¤§2(¨S¥´¬Ì])~5 (¦³¥´¬Ì])¡A¦ôp¶q(È)«ÜÃø±q¤p¼Ë¥»¤¤Æ[¹î±o¨ì¡C 18000ªº¤T´Á¼Ë¥»¼Æ¡A¤À±±¨î²ÕVS¹ï·Ó²Õ¡A±±¨î²Õ¦A¤À´X¤ä¬Ì]¡A®Ú¥»§@¤£§¹ªº¡A¤×¨ä¨º¤TÓ°ê®a³£¦~»´¤H¡A¦~»´¤H¦³¥´¨S¥´¬Ì]ªº«¯g¤ñ²v¡A®Ú¥»´X¥G¤@¼Ë¡A¬On«ç»ò±o¥X¨¾«¯g«OÅ@¤O¤j©ó70%? °£«DWHO§@¹ú¡A§â«¯g¼Ð·Ç¶}«ÜÃP«Ü¼e¡C ¤£µM¥u¯à¾ô±µ¤F¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/30 ¤W¤È 08:19:59²Ä 2566 ½g¦^À³
|
¦^·Q2020¶}©l ¦b¤j³°ªº³£¬O¥´¬ì¿³°êÃÄÁÙ¦³¤@¨Ç·í¦a¥Í§Þªº¤½¥q ¤]¨S¤°»ò¿ï¾Ü¡A¦ý¦Ü¤Ö¨S¦³¹³TW ¥´¤£¨ìªº°ÝÃD¡C¤W¤H¦³¶}ÄÀ~~ ¨CÓ¤H³£»¡¬O¥´¦w¤ßªº¡A¬O¿}¤ô!! ¦ý¦Ü¤Ö¬OFDA¦P·Nªº¡A¤ñ°ªX(¦Û²n)¦n ¨S¬Fªv·Qªk¡A¦ý¬ì¾Ç´N¬O³o¼Ë¡C¤@§è¨ì¬Fªv¡A¦³¤H´NµLµø¬ì¾Ç¡C ¸Ü»¡¬üªÑ¤S¸õ¤ô¤F¡A¬Ý¬ÝGSK·|¤£·|¥Î¤@¼Ëªº¿ú¨Ó¶R·sÃÄ(¤Û·Q¤¤)¥Î21»õ¬ü¤¸¶RAffinivax ====================================================== ÁÙ¯à¨ú¯º¤j³°¬Ì]¶Ü? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/30 ¤W¤È 07:46:55²Ä 2565 ½g¦^À³
|
ÁÙ¯à¨ú¯º¤j³°¬Ì]¶Ü? 2022.9.29 ¤j³°º´ÚmRNA·s«a¬Ì]¦b¦L¥§获ã¨Ï¥Î ¦L«×¥§¦è亚国®a¹«~药«~监ºÞ§½«Å¥¬¡A±Â¤©§Ú国·s«¬«a状¯f¬rmRNA¬Ì]紧«æ¨Ï¥Î±Â权 ¦L¥§¹«~药«~监·þºÞ²z§½负责¤HPenny K Lukito证实¡A该¬Ì]¤w经获±o¦b¦L¥§ªº紧«æ¨Ï¥Î±Â权©M²M¯u认证¡A将¥Î¤_°ò础§K¬Ì©M¥[üL针¡G¡§这¬O¤@Ïú°ò¤_mRNA§Þ术ªº¬Ì]¡A¥i¥H¦b 2¡X8 摄¤ó«×¤U储¦s¡A¥i¥H¦b±`规§N链条¥ó¤U储运¡A临¥Î«eÆӻݸÑ冻¡C (Àx¦sÀô¹Ò±ø¥ó¬ÆÀu©ó½÷·ç-¦b¤@¨Ç§N链«Ø设¦}¤£发达ªº国®a¡AARCoV¬Ì]¬Û对¤_辉·ç¥H¤Î²ö¼w纳ªºmRNA¬Ì]¦³©ú显ªº竞争ɬ势) -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/8 ¤U¤È 12:24:18²Ä 1191 ½g¦^À³ ¬°¦ó¥xÆW3®a·s«a¬Ì]¥þÀ£¦b«组³J¥Õ¬Ì]¡A¤£°µmRNA¬Ì]? »¡¬ï´N¬O§Þ³N¤£¨ì¦ì¡C ·í°ê¤H¼J¯º¤j³°°êÃÄ»P¬ì¿³ªº·À¬¡¬Ì]®É¡A®í¤£ª¾¤j³°²Ä1¤ämRNA¬Ì]¤w¦b¾¥¦èô¶i¤J3´ÁÁ{§É! (Àx¦sÀô¹Ò±ø¥ó¬ÆÀu©ó½÷·ç) ...对¤ñ辉·ç¬Ì]¡A¨U´ËARCoV¬Ì]ªº®tÉݦb¤_¥i¦b2-8摄¤ó«×环¹Ò¤U«O¦s¡C¦b医学´Á¥Z¡mCell¡n¤W¤½¥¬ªº动ª«试验¤¤¡A为¤F评¦ôARCoVªº热稳©w©Ê¡A军¨Æ医学¬ì学°|¯³¦¨®p±Ð±Â团队将¬Ì]³Ì长¦b±`温¤¤储¦s7¤Ñ¡AµM¦Z将¥¦ª`®g¨ì¤p¹«Ê^内¤´µM¦³®Ä¡C这¨Ï±oARCoV¥i¥H¤j¤j°§C§N链运输ªº¬D战¡A¦b¤@¨Ç§N链«Ø设¦}¤£发达ªº国®a¡AARCoV¬Ì]¬Û对¤_辉·ç¥H¤Î²ö¼w纳ªºmRNA¬Ì]¦³©ú显ªº竞争ɬ势¡A¦³±æ¥´¯}欧¬ü¦bmRNA¬Ì]领°ìªº垄断¦a¦ì¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/29 ¤U¤È 01:53:55²Ä 2564 ½g¦^À³
|
¿D¬w带动¬ü国FDA¡A¨R¤F¡I谢谢R¤j¤À¨É |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/29 ¤U¤È 12:56:11²Ä 2563 ½g¦^À³
|
¿D¬wTGAªº±M®a¿Ô¸ß©eû·|¦b11¤ë±N¨M©w§ïÅÜ¥Á²³Àò±o´¶®³¯kªº¤è¦¡! ¦b¤@¥÷¿W¥ß±M®a³ø§iºÙ«C¤Ö¦~ÀݥΡ§¥O¤H¾á¼~ªº¼W¥[¡¨«á¡A¼³¼ö®§µh¦b¿D¤j§Q¨Èªº¾P°â¥i¯à·|¨ü¨ì¨î¡C ¹ï¸Ó¦~ÄÖ²ÕÃĪ«¹L¶qªº¾á¼~«P¨Ï°ê®aÃÄ«~ºÊºÞ¾÷ºc¦Ò¼{¨î¡A¥]¬A¨C¤HÁʶR¤@¥]©Î¨â¥]ªº¨î¡A¥H¤Î¸T¤î¦b¨S¦³³B¤èªº±¡ªp¤U¦V 18 ·³¥H¤U¾P°â¡C ¬° TGA ¼¶¼g³ø§iªº±M®a¤p²Õ´N¼³¼ö®§µhªº¾P°â´£¥X¤F¥|¶µ«Øij¡A¼³¼ö®§µh¬O¤@ºØ¥H Panadol ©M Tylenol µ¥±`¨£«~µP¾P°âªº¥Dn¤îµhÃÄ¡C ³o¨Ç±¹¬I¥]¬A´î¤Ö¶W¥«©M«K§Q©±¦b¨S¦³³B¤èªº±¡ªp¤U¥X°âªº¥]¸Ë¡A¥H¤Î¦b¨S¦³Ãľ¯®v«Øijªº±¡ªp¤U¦bÃÄ©±¥X°âªº¥]¸Ë¡F¨Ã±N¥æ©ö¨î¬°¤@¥]©Î¨â¥]¡A¥H´î¤Ö®a®x®w¦s¡C ¥¦ÌÁÙ¥]¬A¨î 18 ·³¤Î¥H¤Wªº¤H¦b¨S¦³³B¤èªº±¡ªp¤UÁʶR¡A¨Ã¥u¶}§ï¨}ÄÀ©ñªº¼³¼ö®§µh³B¤è¡C ¸Ó¤p²Õ´£¥X¤F¥t¥~¤T¶µ«Øij¡G§ïµ½¹ï¼³¼ö®§µh¼ç¦b¦M®`ªº·¾³q¡Aºû«ù©MÂX¤j¦Û§Ú¶Ë®`«áªº«áÄòÅ@²z©M¤ä«ù¡A¥H¤Î´£°ª¹ï§ó¦w¥þªºÃĪ«Àx¦s©M´î¤ÖÀx¦sªº»{ÃÑ¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/29 ¤W¤È 11:52:34²Ä 2562 ½g¦^À³
|
°ª层¤]nª¾¹D这®ø®§¤~¦³§Q¤_´£°ª谈ªºÉ²®æ¦pªG¤£ª¾¹D¡Amarketing ´N¤Ó®t劲¡I¤F |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/29 ¤W¤È 08:46:01²Ä 2561 ½g¦^À³
|
¿D¬wªº³ø§iè¦b8¤ë§¹¦¨¡A·í¦³§Q»P¥[³tªYÄ£»PGSKªº±ÂÅv½Í§P! (TGA·|¤£·|¹ï¿D¬w¯«ÃÄ´¶®³¯k¥X«¤â???) ¿W¥ß±M®aÃö©ó¹ï¤A酰®ò°ò×ô¬G·N¦Û§Ú¤¤¬r·ÀIªº³ø§i www.tga.gov.au/sites/default/files/2022-09/paracetamol_report_final.pdf ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/14 ¤U¤È 01:38:49²Ä 1983 ½g¦^À³ TGA±N¹ï¯«ÃÄ´¶®³¯k¥X«¤â?! 2022.5.12 ¿D¤j§Q¨ÈªºÃÄ«~ºÊºÞ¾÷ºc(TGA)¥¿¦b¦Ò¼{¨î¨Ï¥Î¥@¬É¤W³Ì±`¥Îªº¤îµhÃÄ¡C ...³ø§i±N¦b 7 ¤ë«e§¹¦¨³ø§i ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/27 ¤U¤È 10:04:52²Ä 1252 ½g¦^À³ ±N¨C¤é¾¯¶q¥Ñ4g°¦¨3§J¡A¹ïÃļtªº¾P°â¶q¼vÅT´N¬O¥´¤F75§é! ¥t¥~¡A¿D¬w/¯Ã¦èÄõªººÊºÞ¾÷ºc¦³·N¹ï¥]¸Ë®e¶q¨î¡A¹ïÃļtªº¾P°â¶q¼vÅT¤]¬Û·í¤j¡C©Ò¥HSNP-810ªº[¥i¼W¥[¾¯¶q]¡A¤]ªí¥ÜÃļtªº¾P°â¶q¥i¥HÅܤj! --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/19 ¤U¤È 01:13:39²Ä 1215 ½g¦^À³ ...¤µ¦~5¤ëTylenol¦b¿D¬w¤W¬[¶}½æ¡A³Ì«Ü¤j¦]¯À´N¬OGSKªº´¶®³¯k¨ÑÀ³µu¯Ê |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/28 ¤U¤È 04:10:46²Ä 2560 ½g¦^À³
|
r¤j¤ÓÁ¾µê¤F~À°§Ṳ́pªÑ¥Á¹ê²{°]°È¦Û¥Ñ¤£n³Q¶ÀÂΤ¯/°ê³»¤§¬y§|«b~ÁÂÁÂr¤jÅý§ÚÁͦNÁ×¥û¡C·íµM¬ÕÁ«¦Û¥I¡C¦pªG¬ü°êÃÄ°Ó±ÂÅv¡A¤]Åܦ¨¬üª÷¨ü´fªÑ¤F |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/28 ¤U¤È 03:56:47²Ä 2559 ½g¦^À³
|
·PÁ±zÌ´X¦ì»°Àn¤l¤W¬[£¬¡A¤£¹L§Ú³ßÅw¦Û¥Ñ¦Û¦b! §ÚÁ|Â˶ø¥ì´µ¯S¤j(89¤£Â÷¤Q¬O¥Í§Þ¤H)¡C --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/18 ¤U¤È 01:18:00²Ä 2489 ½g¦^À³ µì¬O§òÀn¤l... |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/28 ¤U¤È 03:54:42²Ä 2558 ½g¦^À³
|
©Ó½²¤j¶Q¨¥¡A¨C¤Ñ³£¦b¬Ý¥L¦³¨S¦³°±µP¡A¸}³£³Â¥Ø¤F §Ú´Nn©È¤pªY¨«°ê³»/¦X¤@¼Ò¦¡¨R¨ì300¡A¤x¸g¥¢¥h¦n´X¦¸¾÷·|¡C¤@¥X§¹´N°l¤£¦^¨Ó@@ ========================================= ¤d¸U¤£n§ë°¡IªYÄ£¤~n¶}©l¡A§Ú¬O¥þ¤O©ãªYÄ£¥B³£¤£½æ¡CªYÄ£±N¨Ó¬OªÑ¤ý¾÷²v«Ü°ª¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/9/28 ¤U¤È 02:16:56²Ä 2557 ½g¦^À³
|
¤d¸U¤£n§ë°¡IªYÄ£¤~n¶}©l¡A§Ú¬O¥þ¤O©ãªYÄ£¥B³£¤£½æ¡CªYÄ£±N¨Ó¬OªÑ¤ý¾÷²v«Ü°ª¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/28 ¤U¤È 01:44:08²Ä 2556 ½g¦^À³
|
¬On¾Ç¤Oª÷ªº¼Ò¦¡¶Ü?¦pªGR¤jÄ@·N¡A§Ú¥i¥H°^Äm¼Æ¤Q±iªº²¼¡A¤£µM§Ú¤µ¤Ñ³£·Q§ë°¿é¤@¥b¤F¡C ¥»¨Ó·Q»¡¤j½L¤£¦n¡A¥D¤Oª£¥Í§Þ¡A¬Ý¨Ó¨Sª¿¤F¡C =================== r¤j¤]n·í¤¯¤£Åý¤£n«È®ð¡A¤~¯àÅý¦Û¤vµo´§¤½¥q§ó¦n¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/9/28 ¤U¤È 01:18:24²Ä 2555 ½g¦^À³
|
r¤j¦b±M·~¤W¬O¬Û·í³»¦y¡A¦b´²¤á¤¤¤]¬O¶W¤j¤á¡A¦b¥»ª©¬O»âÀY¦Ï¡FÓ¤H¤]§Æ±æ¤j®a±ÀÁ|¥L¶iªYÄ£·í¸³¨Æ©ÎºÊ¨ÆÃþ¾°È¹ï¤½¥q¦³¹ê½è¥\¯à¡A¦Ó¤£¬O¤@¯ë¹S¶ÄµL°^Äm¸³¨Æ¡C§ÚÓ¤HÃѤ~½T¨S¦³Á|¤~¯à¤O¡A¬Ý½Ö·|Á|¤~±ÀÂË¥L¶iªYÄ£°^Äm¡Ar¤j¤]n·í¤¯¤£Åý¤£n«È®ð¡A¤~¯àÅý¦Û¤vµo´§¤½¥q§ó¦n¡C |
|
|
·|û¡GPeter Lin10152815 µoªí®É¶¡:2022/9/28 ¤W¤È 11:50:02²Ä 2554 ½g¦^À³
|
¤j®an¬Ã±¤Roger¤j¡A¾ãÓ·sÃĪѧë¸ê¤H¡A§Ú¥uªARoger¤j¤@Ó¡C |
|
|
·|û¡GPeter Lin10152815 µoªí®É¶¡:2022/9/28 ¤W¤È 11:41:53²Ä 2553 ½g¦^À³
|
¥_·¥¬P¦Ñ°ªºAPP¤£¾å±o«ç»ò¿ì¡H ¦ÑÀYÆ¿¦Ñ·ÝÆ¿¦Ñ°³o¤T°¦¦Ñ¥P£°¡A¯º¦º¡C ¤@Ӹ˹G¡A§^Æ¿§^Æ¿§^ªº¡C ¤@Ӹ˯«¡A¯TÆ¿¯TÆ¿¯Tªº¡C ¤@Ӹ˰¡A§jÆ¿§jÆ¿§jªº¡C «¢«¢«¢¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/28 ¤W¤È 09:20:49²Ä 2552 ½g¦^À³
|
¤~¥á60±i½L¤¤´N¥i¥H¥´¨ì110¥H¤U¡A¿³¶Q¤j«ã¯«µL»~ ============================================== ¸Ü»¡¬Q¤Ñ¤S³Q°ê³»ªB¤Í»Ä»¡¡AÁÙ¦n¨SÅ¥§Úªº«Ø·N´£¹L¨Ó·sÃÄ(¨ä¹ê§Ú¥u¬O»¡ªYÄ£ªº¥Ø¼Ð¡A¨S¥s¥L´«¡A¥u¬O»¡°ê³»ªº«H¥Î¯}²£)¡A¥u¦]¬°¬Q¤Ñ¥Í§Þºñªoªo¡A°ê³»¬O¬õªº¡CªB¤ÍÁÙ¥[½X~~§ë¸ê¦³·ÀI¡A¦Ût¬ÕÁ«§r |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/27 ¤W¤È 10:00:02²Ä 2551 ½g¦^À³
|
ªx¤¤¤Ñ¨½´N¼Æ¦X¤@¡B·sÄ£¦^Àɳ̤j ¤µ¤Ñ¤S¤Ö¤F¦n¦hQQ¡A±b±¤W¤S¤Ö¤F30%¡A¾¤©ú«eªº¶Ân¦h¤[©O |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/26 ¤U¤È 11:04:27²Ä 2550 ½g¦^À³
|
·Ç ¦Ü¤Ö200±iµu½u¨R§¹¥X¥ú ©ú¤Ñ·|Åý¥L̦Z®¬¶Ü |
|
|
·|û¡GPeter Lin10152815 µoªí®É¶¡:2022/9/26 ¤U¤È 04:05:17²Ä 2549 ½g¦^À³
|
¨Ó¨Ó¥h¥hªºµu½u«È¡AÀH·N¤F¡C ............. ¤µ¤ÑÃz¤j¶q¯}©³120¡A¥Í§Þn¦^ÀɤF |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/26 ¤U¤È 01:06:26²Ä 2548 ½g¦^À³
|
¤µ¤ÑÃz¤j¶q¯}©³120¡A¥Í§Þn¦^ÀɤF ¾Ç¾Ç©P¥É¦©¨Ó¼É¶Â®Æ¡A´N¬O¾Ç°ê³»§Q¥Î·s»D¥X³f¡Aº²Â_¤@¤U§a!! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/26 ¤W¤È 10:31:53²Ä 2547 ½g¦^À³
|
³Ìªñ¦pªG¨S®ø®§¡A³Ì¦n´N¬O¥H½L¥N¶^¤F ============ ¦X¦¨¯uªºÃø«×«Ü°ª¡C¤×¨ä¬O©ñ¶q¥Í²£ ¤§«e³£¦X¤£¥X¨Ó¡A§ä¥N¤u¼t¤~¥i¥H¡A¦ý¶Qªºn©R(³o®É«á´N·Q¨ì¦w¦¨§C»ù½æµ¹«O¾U¡A¾÷¨®) ================================== «¤¤¤§«ªºSNP-630ªº¦X¦¨»PÀu¤Æ¦³µL¬ð¯}?(µ´¹ï»PSNP-630ªºÁ{§É¶iµ{»P±ÂÅv¦³Ãö«Y¡ASNP-610¨S¦³¦X¦¨ÃøÃD¡C) |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/26 ¤W¤È 09:37:01²Ä 2546 ½g¦^À³
|
³o®a¤½¥q¥ú¾a¤º½u´NÁȽ¤F ¥Î150w»@ª÷´«´Xe¡A¤Ó¦Eºâ¤F¡C ³oÓ¤H¥i¯à¬O©È³QÃö§a>< ================= ¦³¤H«~!¥ýÃã¥ôµ¥9/10¤½§i«á¦A½æ¡A¤£ªg¤º½u¶ûºÃ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/25 ¤U¤È 09:41:03²Ä 2545 ½g¦^À³
|
¥Ø«e¤j®a³ÌÃö¤ß©³¤U(¤T)±ÂÅv »P (¤»)¤WÂd¡C «¥¬O·Q¤F¸Ñ«¤¤¤§«ªºSNP-630ªº¦X¦¨»PÀu¤Æ¦³µL¬ð¯}?(µ´¹ï»PSNP-630ªºÁ{§É¶iµ{»P±ÂÅv¦³Ãö«Y¡ASNP-610¨S¦³¦X¦¨ÃøÃD¡C) ----------------------------------------------------------------------------------------------- ¤µ¦~¦~³ø¤º®e 111 ¦~«×Àç¹Bpµe ¡i¤@¡j111 ¦~«×¥Dn¸gÀç¤è°w (¤@) «ùÄò¯×ªÕ¨xª¢»PµL¨x¬r©ÊÔ¿ï·sÃĤ§¦U¶µ¶}µopµe (¤G) °õ¦æ SNP-8 ¨t¦C²£«~Á{§É¸ÕÅç (¤T) »P°ê»Ú¤j«¬Ãļt¬¢½Í§Þ³N±ÂÅv¤§¦X§@pµe ²{¤w»P¤G¶¡°ê»ÚÃļt¹F¦¨¦X§@¨óij¡A¨Ã³°Äò»P¨ä¥L°ê»ÚÃļt¬¢½Í¤¤¡A°£«ùÄò°õ¦æ¦X¬ù¤§ÅçÃÒ¸ÕÅç¥~¡A´Á³\¥H»P°ê»Ú¤j¼t ±µy¤§¬ãµo¹ê¤O¡AÂX®i¶i¤@¨BÂX¤j¦X§@¤§«´¾÷¡C (¥|) ì®ÆÃĤ§¦X¦¨»PÀu¤Æ «ùÄò©e°U¥~³¡¬ã¨s³æ¦ì´N¥Ø¼Ð¤Æ¦Xª«°õ¦æ»sµ{§ï¨}¤§Àu¤Æ¬ã¨s¡B¥H¤Î¬ÛÃöµ²ºcl¥Íª«¤§¦X¦¨¡A´Á±æ¤j´T§ïµ½ÃÄ«~¦X¦¨¤§ ²£²v¡A¦³®Ä°§C¥¼¨Ó¶q²£¤§¦¨¥»¡C (¤) ©Ý®i±M§Q§G§½¥H«Øºc§¹¾ã´¼¼z°]²£¤§«OÅ@ºô ¥»¤½¥q¦b±M§Q¤è±¡AÄ~Äò©e°U±M·~´¼°]ºÞ²zÅU°Ý¤½¥q¡A±Ä¥~³ò¡B¤¤³ò¤Î¤º³ò¤À¶¥¬q¥Ó½Ðµ¦²¤¡A¹ï©ó¨C¥ó±M§QºÉ¥i¯àª§¨ú§¹ ¾ã«OÅ@Åv§Q½d³ò¡A¤w¹F¨ì³Ì¨Î¤Æ±M§Q§G§½¤§µ¦²¤«OÅ@¤§¦¨®Ä¡C (¤») ¥Ó½Ð¤WÂd¥H´£¤É°ê»ÚÄvª§¤O |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/25 ¤U¤È 06:20:10²Ä 2544 ½g¦^À³
|
«¥¦b2021.5.7´£¥X§Æ±æ¦³¤H¦bªÑªF·|°Ý°Ý¡AÀ³¸Ó¬O¨S¤H¸ß°Ý! ¥i¤£§Æ±æµo¥Í¸ò¯E¹©OBI-888¦P¼Ëªº¨Æ@ -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/7/2 ¤W¤È 11:24:48²Ä 2160 ½g¦^À³ ¬Ý¬Ý¯E¹©¡ASNP-630¦¨¥»¬OÁô¼~?! ----------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/5/7 ¤U¤È 05:44:04²Ä 1099 ½g¦^À³ Q2:ª¾¹DSNP-630«ÜÃø¦X¦¨¡A»s³y¦¨¥»¨s³º¦h°ª? ----------------------------------------------------------------------------------------------- 2022¦~7¤ë2¤é ¶g¤» ¤W¤È4:10 ¯E¹©¡]4174¡^1¤é¤½§i¡AºX¤U§ÜÅé·sÃÄOBI-888Áö¨ãÁ{§É¶}µo»ùÈ¡A¦ý¥Í²£¦¨¥»°¾°ª¡A¥«³õ®Ä¯q°¾§C¡A¨M©w´£¦©ó²Ä¤G©u«á²×¤î¦¬®× |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/25 ¤U¤È 06:13:11²Ä 2543 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/7/12 ¤W¤È 09:52:26²Ä 2236 ½g¦^À³ ¦³¤Ö¼Æ¤p¤À¤lÃĦX¦¨¨BÆJ¦h¥B²£²v·¥§C¡A¦¨¥»°ª©ó¤j¤À¤lÃÄ!(SNP-630«ÜÃø¦X¦¨!!!)... -------------------------------------------------------------------------------------- 1.©e°U¬ã¨s °]¹Îªk¤H¤¤µØ´º±dÃľǰòª÷·|110/5/1~111/4/30 SNP-630ÃÄ«~¤Æ¦Xª«(¦X¦¨Àu¥ý)©e°U§Þ³NªA°È 2.©e°U¬ã¨s »OÆW¤j¾Ç 110/7/1~111/6/30 SNP-630¦X¦¨ÃÄ«~¬ã¨spµe®Ñ SNP-630«ÜÃø¦X¦¨¬OÁô¼~¡A§Æ±æ¦³¬ð¯}! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/25 ¤U¤È 06:01:40²Ä 2542 ½g¦^À³
|
SNP-810 [¤p¹«]¹êÅ禨¥\ÅçÃÒµL¨x¬r©ÊÀø®Ä¡A²¾Âà¨ì¤HÅé¸ÕÅç¡A¥¢±Ñ¾÷²v¦h¤j? «¶K www.facebook.com/watch/?v=593295861957143 JP(19¤À):...²{¦b§ÚÌ¥i¥H[¦Y¤@²~]®@ ³£¤£·|¦³¨x¬r©Ê³á ¨ì³oºØ¦a¨B¤F ·íµM ³oÁÙ»Ýn¤@¬q®É¶¡¤~·|¤W¥« -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/20 ¤U¤È 08:44:53²Ä 2006 ½g¦^À³ ¬Ý¨Ó[¦Y¤@²~=100g]¤]¤£·|¤¤¬r¬O¯u¦a!¨Ì¨C¤é«Øij¶q4g*20¿=80g ¦~³ø74¶:¥»¤½¥q©Ò¶}µo¤§µL¨x¬r¤îµh·sÃÄ¡AªA¥Î¥i¹F¦w¥þ¾¯¶qªº [20¿] ¤´¤£·|¤¤¬r¡A¥¼¨Ó¬Æ¦Ü¦³¥i¯à¥i¥H§¹¥þ¨ú¥N²{¦³ªº¤AñQÓi×ô¤îµhÃÄ¡A¬G¥Ø«e¥«³õ¤Wªº¦U¤jÃļt¥i¯à¬O¥»¤½¥q¼ç¦b¦X§@¹Ù¦ñ§í©Î¬OÄvª§ªÌ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/25 ¤W¤È 09:44:01²Ä 2541 ½g¦^À³
|
dk¤j,§Ú¤£t³d¥ôªº²q´ú¬OXXXÃã¥ô«á½æ¥X!(¦³¤H«~!¥ýÃã¥ôµ¥9/10¤½§i«á¦A½æ¡A¤£ªg¤º½u¶ûºÃ) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/25 ¤W¤È 09:19:37²Ä 2540 ½g¦^À³
|
SNP-610Àu©óElafibranor (PPAR£\/£_¿E动剂) Genfit»PIpsen (¶R¤U´¼Àº¯ØŦÀùÃĪ«)¦b2021¦~ñ4.8»õ¬ü¤¸±ÂÅvElafibranorªvÀøìµo©ÊÁx¥Ä©ÊÁxºÞª¢(PBC)¸ÕÅç VS. ¥¿¤j¤Ñ´¸ªá3.07»õ¬ü¤¸ªº[PPAR]¿E动剂Lanifibranor ¡A¥i¿E¬¡PPARªº¥þ³¡3Ïú亚«¬£\¡B£^¡B£_¡C -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/25 ¤U¤È 11:31:56²Ä 2019 ½g¦^À³ SNP-610Àu©óElafibranor (PPAR£\/£_¿E动剂-Genfit) Genfit¤½¥q¦b2020¦~终¤îElafibranor NASH项¥Ø news.bioon.com/article/6759334.html Genfit»PIpsen¦b2021¦~ñ4.8»õ¬ü¤¸±ÂÅvElafibranorªvÀøìµo©ÊÁx¥Ä©ÊÁxºÞª¢(PBC)¸ÕÅç ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151µoªí®É¶¡¡G2020/7/3¤W¤È08:05:38²Ä35½g¦^Î` - The decreases in several clinical parameters from baseline to the end of treatment were greater in SNP-610-12-week treatment than Ocaliva, Cenicriviroc, Elafibranor, MGL3196 or Selonsertib treatment in literature, especially in ALT. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/25 ¤W¤È 08:46:14²Ä 2539 ½g¦^À³
|
³Ìªñ°ê¥~NASHÃĪ«¶}©l¼ö¾x¤F! ¶W3亿¬ü¤¸¤Þ进(¤j¤¤µØ°Ïn»ù3.07»õ¬ü¤¸¡A¦¹ÃÄÁ`±ÂÅv¥[¤W¼Ú¬üµ¥¦a>10»õ¬ü¤¸µLÄa©À)¡I¥¿¤j¤Ñ´¸±¸ª÷ [PPAR]¿E动剂¡A进§ð400亿ºC©Ê¨x¯f¥«场 zhuanlan.zhihu.com/p/567362449 (ªYÄ£)¥Ñ©ó CYP2E1 ¥Dn¦b¥Dnµo¥Í¥NÁªº¨x²ÓM¤¤ªí¹F¡A¹v¦V§í¨î CYP2E1 ¥i¯à¹ê²{ì¦ì¨x²ÓM¤¤ªºPPAR £\¿E¬¡!!! (ªYÄ£)¥Ñ©ó CYP2E1 ¥Dn¦b¥Dnµo¥Í¥NÁªº¨x²ÓM¤¤ªí¹F¡A¹v¦V§í¨î CYP2E1 ¥i¯à¹ê²{ì¦ì¨x²ÓM¤¤ªºPPAR £\¿E¬¡!!! (ªYÄ£)¥Ñ©ó CYP2E1 ¥Dn¦b¥Dnµo¥Í¥NÁªº¨x²ÓM¤¤ªí¹F¡A¹v¦V§í¨î CYP2E1 ¥i¯à¹ê²{ì¦ì¨x²ÓM¤¤ªºPPAR £\¿E¬¡!!! ----------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/28 ¤U¤È 06:14:44²Ä 2032 ½g¦^À³ ¹v¦V§í¨î CYP2E1 ¥i¯à¹ê²{ì¦ì¨x²ÓM¤¤ªº PPAR £\¿E¬¡!!! 1.2021¦~ñ4.8»õ¬ü¤¸±ÂÅvElafibranorªvÀøìµo©ÊÁx¥Ä©ÊÁxºÞª¢(PBC)¸ÕÅç 2.¥Ø«e¡AUDCA©MOCA¬O¶È¦³ªº¨âºØÀò±oFDA§åã¥Î©óªvÀøÁx¥Ä²J¿n¯gªºÃĪ«¡A¥¦Ì³£¬Oªk¥§¾JX¨üÅé¡]FXR¡^ªº°tÅé¡C ----------------------------------------------------------------------------------- 2017.8.30 Nature½×¤å:PPAR£\¬¡¤Æ¥i¨¾¤îÁx¥Ä²J¿n©Ê¨x·l¶Ë www.nature.com/articles/s41598-017-10524-6 1993 ¦~ªº¤@¶µ¬ã¨sµo²{¡APPAR£\ ¿E°Ê¾¯¹ïÁx¥Ä²J¿n±wªÌ¦³¯q PPAR£\ ¿E¬¡¥i¯à³q¹L½Õ¸`£] -FAO °ò¦]¡]¥]¬A Cpt1b¡BCpt2 ©M Mcad¡^¨Ó§ïµ½Áx¥Ä²J¿n©Ê¨x·l¶Ë¡C¨xŦ¤¤ PPAR£\ ¬¡¤Æªº¦³¯q§@¥Î³Ì²×·|¾ÉPª¢¯g²ÓM¦]¤lªº´î¤Ö¡A³o¥i¥H¥~±À¨ì¨ä¥LÁx¥Ä²J¿n±¡ªp¡]¨Ò¦pÃĪ«©Î Bsep §í¨î»¤¾Éªº¡^¡C³o¨Çµo²{¤ä«ù³o¼ËªºÆ[ÂI¡A§Y PPAR£\ ¿E°Ê¾¯¥i³q¹L¤W½Õ£] -FAO ¥Î§@Áx¥Ä²J¿n©Ê¨x·l¶ËªºªvÀø´À¥N«~¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/28 ¤U¤È 05:22:04²Ä 2031 ½g¦^À³ ªYÄ£¥²nÅçÃÒ³o½g½×¤å´£¥Xªº¾÷¨î:SNP610(CYP2E1§í¨î-->¤º·½©Ê¥NÁª«ÅãµÛ¼W¥[-->¿E¬¡ PPAR£\-FGF21)¡C 2022.5¤ë www.sciencedirect.com/science/article/pii/S2211383522000545 ¥Ñ©ó CYP2E1 ¥Dn¦b¥Dnµo¥Í¥NÁªº¨x²ÓM¤¤ªí¹F¡A¹v¦V§í¨î CYP2E1 ¥i¯à¹ê²{ì¦ì¨x²ÓM¤¤ªº PPAR £\¿E¬¡¡A³o¥i¥HÁ× §KÁ{§É¤¤°¸º¸µo¥Íªº«D²Õ´¯S²§©Ê PPAR £\¿E¬¡ªº°Æ§@¥Î--->SNP-610Àø®Ä¦w¥þÀu©óElafibranor (PPAR£\/£_¿E动剂) --->SNP-610Àø®Ä¦w¥þÀu©óElafibranor (PPAR£\/£_¿E动剂) 2021¦~ñ4.8»õ¬ü¤¸±ÂÅvElafibranorªvÀøìµo©ÊÁx¥Ä©ÊÁxºÞª¢(PBC)¸ÕÅç |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/25 ¤W¤È 08:36:26²Ä 2538 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/7/8 ¤U¤È 04:17:18²Ä 2213 ½g¦^À³ ¤ð±e¹L¤À¾á¼~NASHÄvª§ªÌ¡A±z¦³°l®Ú¨s¬kªººë¯«¡A§âC¨xÃĪ«(ªv¡)¥«³õ¬Ý¤@¤U´N©ú¥Õ! ---------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/7/2 ¤U¤È 01:35:37²Ä 2163 ½g¦^À³ ·í²Ä¤@ÓNASHÃĪ«¤W¥«¡ANASH»â°ì´N·|¯u¥¿ªº¤õÃz°_¨Ó¡C°ê»Ú¤j¼t¨ì®É鹬°F¬Û争¡A¥Î¥L̪º¶¯«p°]¤O¦¬Áʤp¤½¥q(º®¯Î¤§§Q)¡C¥¼¨ÓNASH»â°ì¯à¥´±o¦h¤õ¼ö? ¥i¥H°Ñ¦Ò´X½gC¨xÃĪ«ªº¬G¨Æ: 1.www.gbimonthly.com/v11_2015/v11cover_2015_00.html 2.news.gbimonthly.com/tw/celebrity/show.php?num=18130 ²¦³ºNASH¬OÓ¥¨¤jªº¥¼¶}µoºC¯f¥«³õ!!! (JP:¦]¬°³oÓÃĪº¥«³õ¤Ó¤j¡A©Ò¥H§Ú¤£¥h·m²Ä1 ¤£·m²Ä2 ¤£·m²Ä3 §Ú·mÓ²Ä4³£¥i¥H«Ü¤j¤@¶ô.... )---³o¬q»¡ªkµ¥¦PC¨xÃĪ«¥«³õ²{ªp! www.facebook.com/watch?v=298211662214622 ------------------------------------------------------------------------------------------------- JP¨¥·N¤£«æ¤£«æ~ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/25 ¤W¤È 08:31:54²Ä 2537 ½g¦^À³
|
ÁÂÁÂr¤j´£¿ô ================= ´ç¦³½t¤H§a¡A¥±`¤ß¡C¸U¤@¤Sº¦¤W¨Ó¡A´N¡K¡K¡L ¸Ü»¡¥Ø«e³£¦bµ¥·sÃÄn°±µÊªº®ø®§~~ copyð°òªº¨«¶Õ¥ý¡AªÑ¥«¤£Ã ¥Í§Þ¥XÀY¤Ñ==>¿\¥É¤£µo¥ú(ÁÙ¬O¤£Ä@·Nµ¹¹ï©¤ or ¤£¤J¹ï¤è²´) =============================== ¤¤°ê¥Íª«»sÃÄ¥H 3.07 »õ¬ü¤¸(¤j¤¤µØ°ÏÅv§Q)±q Inventiva¶R¤JNASH ÃĪ« 2022 ¦~ 9 ¤ë 22 ¤é ¤¤°ê¥Íª«»sÃĦ³¤½¥qªº¤l¤½¥q¥¿¤j¤Ñ¼yÃÄ·~¶°¹Î¦³¤½¥q¥H°ª¹F 3.07 »õ¬ü¤¸ªº»ù®æ±q Inventiva SA ¦¬ÁʤF lanifibranor ªº¤j¤¤µØ°ÏÅv§Q¡C¸Ó¥æ©ö¥]¬A¦b¤¤°ê¤j³°¡B»´ä¡B¿Dªù©M¥xÆW¦a°Ï¶}µo©M°Ó·~¤Æ¸ÓÃĪ«ªºÅv§Q¡A¥Î©óªvÀø«D°sºë©Ê¯×ªÕ©Ê¨xª¢¡] NASH ¡^©M¨ä¥L¥NÁ¯e¯f¡C |
|
|
·|û¡GWalden10140608 µoªí®É¶¡:2022/9/24 ¤U¤È 11:20:04²Ä 2536 ½g¦^À³
|
NASH ¥«³õ«Ü¤j¨S¿ù ½Ð°ÝR¤j ¡AªYÄ£ ªº NASH ¨t¦C²£«~¦ó®É¤~·|¶iÁ{§É¤T´Á? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/24 ¤U¤È 03:34:36²Ä 2535 ½g¦^À³
|
¤¤°êNASH¥«³õ¦³¦h¤j? Õu测ºâ¡A¨ì2025¦~¡A¤¤国¨C¦~ªºNASH [·s发¯f¨Ò]©Î将达¨ì200ÉE¤H¡A¬O«D¤p细MªÍÀù[·s发¯f¨Ò]ªº[两¿]¡C¦Ó¥Ø«e¡A¥þ²y©|ÆÓ针对¦¹Ïú¯e¯fªº药ª«获§å¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/24 ¤W¤È 10:22:07²Ä 2534 ½g¦^À³
|
¤¤°ê¥Íª«»sÃÄ¥H 3.07 »õ¬ü¤¸(¤j¤¤µØ°ÏÅv§Q)±q Inventiva¶R¤JNASH ÃĪ« 2022 ¦~ 9 ¤ë 22 ¤é ¤¤°ê¥Íª«»sÃĦ³¤½¥qªº¤l¤½¥q¥¿¤j¤Ñ¼yÃÄ·~¶°¹Î¦³¤½¥q¥H°ª¹F 3.07 »õ¬ü¤¸ªº»ù®æ±q Inventiva SA ¦¬ÁʤF lanifibranor ªº¤j¤¤µØ°ÏÅv§Q¡C¸Ó¥æ©ö¥]¬A¦b¤¤°ê¤j³°¡B»´ä¡B¿Dªù©M¥xÆW¦a°Ï¶}µo©M°Ó·~¤Æ¸ÓÃĪ«ªºÅv§Q¡A¥Î©óªvÀø«D°sºë©Ê¯×ªÕ©Ê¨xª¢¡] NASH ¡^©M¨ä¥L¥NÁ¯e¯f¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/24 ¤W¤È 09:11:48²Ä 2533 ½g¦^À³
|
·|û¡Gdk10140377 »¡Ó¤£³ôªº¨Æ¡A¦b©MªB¤Í°Q½×XX¡AÁ¿¨ì³Ì«áªB¤Í¸£²Û¦¨«ã¡A¤Ï¥¿XXªºªÑ»ù¤ñXX°ª¡C«ç¼Ë!!!!!! ------------------------------------------------------------------------------------------------- dk¤j,¥h©Ô±zªB¤Í¤@§â! ª`·N¤d±i¥H¤Wªº°ÊºA«Ü¤£´M±`¡A¨¥ºÉ©ó¦¹! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/24 ¤W¤È 08:51:03²Ä 2532 ½g¦^À³
|
¯à¶W¶VÃĵسo®a¥«È¡u¼Ð¬ñ«ü¼Ð¡v¡A¤£¥~¥G¬OÃĪ«¾AÀ³¯g¥«³õ¤j¤p! ªYÄ£»P¤ß®®³o¤G®a¦P¬O¤pªÑ¥»¨»´¦p¿P¡A¤@¥¹ÃĪ«¦¨¥\¡A¤£¨ã¦³¬Æ¦Ü¶W¶V¡u¼Ð¬ñ«ü¼Ð¡v¥«Èªº¼É§Q¬ü¾Ç? --------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/8/17 ¤W¤È 07:42:01²Ä 2319 ½g¦^À³ Peter Lin¤j,±z·|³ßÅw°¨û¤µ¤Ñªº³o¥y¡G[³oÓ««×¯×ªÕ¨x¦pªG¦¨¥\ªº¸Ü¡A©Ò¦³«e±ªº¥[°_¨Óªº»ùȳ£¤£¤Î³oÓ¡I²{¦bÁÙ¦¡I] ---------------------------------------------------------------------------------------------------- ªYÄ£¤pªÑ¥»¨»´¦p¿P¡A¤@¤é¯×ªÕ¨xª¢NASHÃĪ«¦¨¥\¡A³o¥y¡§¤jÄP¤@¤é¦P·°_,§ß·nª½¤W¤E¸U¨½¡C¡¨±N«Ü¶K¤Á¡C §ë¸ê¤@©w¦³·ÀI¡A§OÀ£¨®a(ÁÙ¤£¨ì®ÉÔ)! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/24 ¤W¤È 08:34:04²Ä 2531 ½g¦^À³
|
¦p§Ú»¡ªº¥H¥«È¬Ý«Ý«hÁö¤£¤¤¥ç¤£»·¨o¡C(¶W¶VÃĵØÃĪº¥«È + ªÍ¶¡¥ÖÀù¥«³õ2025¦~¥«³õ¬ù¬°6»õ¬ü¤¸) ±µ¤U¨Óªº«ÀYÀ¸¡AÆ[¬Ý¥_·¥¬PADI-PEG20»P¦X¤@ON101ªº°ªÃB±ÂÅvª÷·|¤£·|Åý·sÃĪѪmÄËÃzªí! ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/10 ¤W¤È 08:24:13²Ä 2416 ½g¦^À³ »¡¸Ñª¼ÃD§÷ªºªÑ»ù°ª§C«ÜÃø«Ü¶Ë¸£µ¬¡AÓ¤Hªº»{ª¾®t²§¡A¨ä°ª§Cµ²ªG´N¬O¤j¤j¤£¦P¡A§Ú¶É¦V¥HÁ`¥«Èµû»ù¡A¼vÅT¦]¤l:ÃĪ«²{ªp(Á{§É´ÁP1~P3,Ävª§ªÌµ¥)¡A¥«³õ¤j¤p(ÃÄ»ù,±wªÌ¼Æµ¥)...¡A«hÁö¤£¤¤¥ç¤£»·¨o¡C ¥H¤UÓ¤H²L¨£¶È°µ°Ñ¦Ò: 1.¥H«e°ò¨È»P¯E¹©ªº¸Ñª¼¥«È?(3®a³£¬OÀù¯gÃĪ«) 2.²{¦bÃĵØÃĪº¥«È? «ä¦Ò¤H®a¯d¤U(¤j³g)ªº³¡¦ì¬Oµ¥¤°»ò¡A±ÂÅvª÷ÃD§÷»P¯Ç¤JMSCIªk¤H©Ô©ï??? ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/7 ¤U¤È 09:19:29²Ä 2393 ½g¦^À³ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/13 ¤U¤È 02:40:52²Ä 2071 ½g¦^À³ ¦b¦X¤@FB825¥H5.3»õ¬ü¤¸±ÂÅvLEO»sÃÄ¡A쥻»{¬°±µ¤U¨Ó·|¬O¥_·¥¬PADI-PEG20»P¦X¤@ON101½l³y¬ö¿ý... -------------------------------------------------------------------------------------------------- ¦p¦¹¸Ñª¼¦æ±¡ºG¿é´X¦~«eªº°ò¨È»P¯E¹©¡A²´¤UÁÙ¤£¨ì³»ÂI¤~¬O! ¦]¬°±µ¤U¨Óªº«ÀYÀ¸¡A³o2®aªº±ÂÅvª÷¥´¯}¥x·LÅ骺6.7»õ¬ü¤¸¡A§Ú¬O»{¬°¨S¦³Äa©À¡A°ªÃB±ÂÅvª÷À³¸Ó·|Åý·sÃĪѪmÄËÃzªí! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/23 ¤U¤È 02:27:46²Ä 2530 ½g¦^À³
|
¤@.¦¨¥\ªºÀù¯g°Êª«¹êÅç¡A²¾Âà¨ì¤HÅé¸ÕÅç¡A¦³99%¥¢±Ñ¤F! heho.com.tw/archives/18273 ª¾¦Wªº¬ü°êÀù¯g°ò¦]¬ã¨s±M®aBert Vogelstein´N´¿¶}ª±¯º»¡¡A¾Ô³ÓÀù¯g«D±`²³æ¡A¥un§â¯f¤H³£Åܦ¨¦Ñ¹«´N¦n¤F¡C³o¥y ¸Ü¬Oª±¯º¸Ü¡A¦ý«oÁ¿¥X¤F¹ê¸Ü¡A¦]¬°¦Ñ¹«¸ò¤HÃþ¯uªº¦³«Ü¤jªº®t²§¡C ¤G.SNP-810 [¤p¹«]¹êÅ禨¥\ÅçÃÒµL¨x¬r©ÊÀø®Ä¡A²¾Âà¨ì¤HÅé¸ÕÅç¡A¥¢±Ñ¾÷²v¦h¤j? (¤p¹«¬O¬ã¨sÁ{§É¤W¬ÛÃöªº«æ©ÊÃĪ«¨x¬r©Ê¾÷¨îªºº¿ï¹êÅç¼Ò«¬) 1. 2022¦~ www.mdpi.com/2673-4389/2/3/8/htm Mitchell©M¦P¨Æµo²{¡A¤p¹«¹ïAPAP¬r©Êªº±Ó·P©Ê»P¤HÃþ¬Û·í¡A¨Ã©w¸q¤F¤p¹«¼Ò«¬¤¤¬r©Êªº¦´Á¨BÆJ¡C«nªº¬O¡A¤p¹«ªº APAP¹L¶q¡A[·Ç½T¦a¦A²{][·Ç½T¦a¦A²{][·Ç½T¦a¦A²{]¤F¦b¯f¤H©M¤HÃþ¨x²ÓM¤¤Æ[¹î¨ìªº²ÓM¦º¤`©M¨x·l¶Ëªº¤j³¡¤À¾÷ ²z¡A°ß¤@ªº¨Ò¥~¬O»P¤p¹«¬Û¤ñ¡A¦b¤HÃþ¤¤Æ[¹î¨ìªº¯f²z¥Í²z¹Lµ{§ó¥[©µ¿ð¡C¦]¦¹¡A¦b¤p¹«¼Ò«¬¤¤Àò±oªº¾÷¨î¼Æ¾Ú©MªvÀø¤z ¹wµ¦²¤¥i¥H«Ü¦n¦aÂà¤Æ¬°¤HÃþªº¯f²z¥Í²z¾Ç.... 2.2012¦~ www.ncbi.nlm.nih.gov/pmc/articles/PMC3478469/ ¦´Á¼Æ¾Úªí©ú¤j¹«¹ï APAP ¬r©Ê¨ã¦³§Ü©Ê¡C¦]¦¹¡A¤p¹«¬O¾÷¸Ì¬ã¨sªºº¿ïª«ºØ¡C¦¹¥~¡A³Ìªñªº¬ã¨sªí©ú¡AAPAP ¦b¤HÃþ¤¤ ªº¬r©Ê¾÷¨î»P¤p¹«¬Û¦ü¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/9/23 ¤U¤È 02:22:56²Ä 2529 ½g¦^À³
|
¬Ý¨Ó¼ÖÆ[¡I¤£¶ËµÇ±M§Q¤]¥²¦³¹ê¤O¤~¯à¥Ó½Ð¨ì¡F¥¬¬¥ªâÃþ¤îµh¾¯¤]Ãø¾×µL¨x¬rµÇ¬r¦w®õ®³¯k¾y¤O¡I¥þ¥@¬É400»õ¬ü¤¸¤îµh¾¯¥«³õ¼e¼s¡A¤£ÁY¤AñQ¦w×ô100»õ¬ü¤¸¥«¦û¡C |
|
|
·|û¡Gghost10151970 µoªí®É¶¡:2022/9/23 ¤U¤È 01:54:18²Ä 2528 ½g¦^À³
|
@¦V«e¤j¡A¥Î¤£µÛ¾á¤ß😓¡AÆp¥Û¤@¸ô½ß¹L¨Óªº¡ã ¥«¦û¥þ¥@¬É¥ÎÃĤ@©w·|ÂÔ·V°µ¨ì¥@¬É²Ä¤@¡C |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/9/23 ¤U¤È 01:16:55²Ä 2527 ½g¦^À³
|
¤w¨Ì¾Úñ¬ùÃļtªº»Ý¨D §¹¦¨¤F²Ä¤T¤èÃĮĸÕÅç ¦ô¤w¶i¤J½Í±ÂÅvªº¶¥¬q ¦Ü©ó¥t¤@®a¡A¥i¥H¤£¥Î¦b·N¡C ¦]¬°¯u±ÂÅv¥X¥h¡AÃīܧִN¤W¥«¡C ©¡®É·|¤£½Ð¦Û¨Ó ¥Ø«e¤½¥q¬J¤w¶}©l¥Ó½Ð¡u¤£¶ËµÇ¡vªº±M§Q ´NºÉ§Ö¶i¦æ¡u¤£¶ËµÇ¡v¸ÕÅç ¦pªG¡A¤]ÅçÃÒ¤F¡u¤£¶ËµÇ¡v¡I ¥þ¥@¬É¨C¦~Ãe¤jªº¤îµhÃÄ¥«³õ ®Ú¥»§ä¤£¨ìÄvª§ªº¹ï¤â ½m¦n°ò¥»±¤~¬O¤ý¹D¡I |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/9/23 ¤U¤È 12:53:00²Ä 2526 ½g¦^À³
|
±q¦¶¸³¿w©w»¡¤£°µp3¦n¹³¬O±ÂÅv¦³¼ÖÆ[©w§½¡A¥i¥H³o¼Ë¸ÑŪ¶Ü¡H |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/9/22 ¤U¤È 03:40:57²Ä 2525 ½g¦^À³
|
¥H¤U¬°¦P¾Ç·| Jeff ªº¶K¤å¡A¶È¨Ñ°Ñ¦Ò¡C ---------- ¥H¤U³£¬O²q´ú¡A·íÅ¥¤@Óºô¸ô¶Ã§èªº¬G¨Æ¡C JJ¦bµo²{¦Û¤v¶}µoªº¤îµhÃįuªºÅܦ¨¾ý¯»¤§«á¡A¢©óFDAªº«Â¯Ù¡A¥u¦n¦A§äªYÄ£¦X§@¡C«Ü¦h¶Ý¦åªº«ß®v¤]¦bµ¥«Ý¤@Ó¯S§Oªº·N¥~¡A¨ì®ÉÃg»@©Ê½ßÀv¡A¥i¬Oºâ»õ¬üª÷ªº¡C ¦]¬°±qªYÄ£¦´Á¦~³ø¬Ý¨Ó¡A®ÄªG¤]´N¦hÓ¨â¤T¿¡A¦Y¦hÁÙ¬O·|¦º¤H¡Aªp¥B¤]µLªkÂX¼W¨Ï¥Î¡C©Ò¥H¦³³o¯µ±K¸ÕÅç¡C¥Hµ²½×¨Ó¬Ý¡A·í¤¤´N¬O¦³§ï°t¤è¡AÅýµL¨x¬r³Ì¤j¤Æ¡C³o¨Ç³£¬O¥h¦~ªº¨Æ¤F¡C©Ò¥H¥¼¨Ó¦Y810°t¤èªº¤îµhÃÄ¡A¥u·|³Q¼µ¦º¡B¼O¦º¡A¤£·|³Q¬r¦º¡C ·s»D»¡n«·s«ì´_¦X§@ªºÀ³¸Ó¬O«üGSK¡C¥H¤îµhÃĦѤG¦Ó¨¥¡A·íµM¤£¥i¯à¸ò²Ä¤@¦W¤@¼Ë¥u´«ªþ«¬¾¯¡A¥²¶·®³µÛSafetynadol¥hÂX¥R¥«¦û²v¡A©Ò¥H·|«·sphase1¤ñ¸û¡C ¥H·s»Dªº¸ê°T¦Ó¨¥¡AÀ³¸Óºâ¬O©w®×¤F§a¡I¦ý¦X¬ù¼f¾\´Á¯uªº«Ü¤[¡A¦ó®É¤~¯à±ÂÅv¡A¥u¦³ªYÄ£¸ò¥D¤Oª¾¹D¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/22 ¤U¤È 12:42:55²Ä 2524 ½g¦^À³
|
±µ¤U¨Ó´N¬O¬Ý±ÂÅv«ç½Í??¤À°Ïµ¹¤@Ó¥ýÁÙ¬O???¤S¦Ò¼{¤°»ò¤½²³§Q¯q¤§Ãþ? |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/9/22 ¤W¤È 10:59:58²Ä 2523 ½g¦^À³
|
¨Ì¦¶Á`©Ò¨¥ ²Ä¤T¤èÅçÃÒµ²ªG¬O1®a¦³Àv¦X¬ù ¥t1®a´Á¤w©¡¡A¥¿¦b¬¢½Í¦X§@®×¡C ²³æ¨Ó»¡¡A¤w©¡´Á³o®a¡A¬O§_·|±µ¨ü²Ä¤T¤èÅçÃÒµ²ªG¡H ©Î¬O¥t°µ¸ÕÅç¡H³o»Ý¥Ñ¤½¥q¥h½Í¡I Y¬O¡A1®a½Í¦n±ÂÅv¡A¥t1®a¥i¯à·|±µ¨ü§a¡I ¦]¬°¡A¥ý¤W¥«¥ýĹ¥«³õ¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/9/22 ¤W¤È 10:42:41²Ä 2522 ½g¦^À³
|
©Ò¥HÀø®ÄÅçÃÒ³ø§i¥uµ¹¤F²Ä¤G®aÃļt? ²Ä¤@®a´Á¹L¤F¡A¸ê®Æ·|µ¹¶Ü? ¦³ÂI°ÝÃD¬O«·s½Õ¾ãÅçÃÒ±ø¥ó«á¡A±o¨ì¬Q¤é¤½§iªº¥¿¦Vµ²ªG(·|¤£·|¬O¤§«eJ¤j´£¨ìªº³¡¤À©O?) ¤µ¤Ñ¥_·¥½Ä¤W¤Ñ¤£ª¾·|´X¤ä¡C¤]¨S±a°Ê·sÃÄ@@ ============================ SNP-810쥻»P¨â®a°ê»ÚÃļtñ¸p¦X§@¨óij¡A°w¹ï³o¶µ¬ãµo¤¤ÃĪ«¶i¦æÀø®ÄÅçÃÒ¡A¨ä¤¤¤@®aÃļt¦X§@ÅçÃÒªº´Á¤w¹L¡A¦ýªYÄ£¤´¦b¬¢½Í«·s«ì´_¦X§@¡F¥t¤@®aÃļt¥X¸ê¶i¦æÀø®ÄÅçÃÒ«á¡Aµo²{ÅçÃÒµ²ªG¤£¦p¹w´Á¡A¦ý¬O¸g¹LªYÄ£«·s½Õ¾ãÅçÃÒ±ø¥ó«á¡A±o¨ì¬Q¤é¤½§iªº¥¿¦Vµ²ªG¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/22 ¤W¤È 08:59:10²Ä 2521 ½g¦^À³
|
Ãø©Ç²Ä3¤è³ø§i¶O®É³o»ò¤[¤~¥X¨Ó! 2022.9.22·s»D:ªYÄ£ªí¥Ü¡A¥Ø«e»PªYÄ£¬¢½Í¦X§@ªº¤½¥q¬°¥þ²y¾P°â¤AñQÓi×ô¦¨¥÷¤îµhÃĪº¤j¼t¡AY¦¨¥\±NSNP-810±ÂÅvµ¹³o¨Ç°ê»ÚÃļt¡A¥un§ó§ï½á«¬¾¯¡A¤£¥Î§ó´«ÃÄÃÒ¡A«áÄò¦b¤£»Ý°µ¤HÅéÁ{§É¸ÕÅ窺«e´£¤U¡A´N¥iÅýSNP-810ª½±µ±À¤J¥«³õ¡C (OTC«D³B¤è³o¶ô¤w¤£°µP3¼Ï¯ÃÁ{§É¸ÕÅç¡A§ï¥HP4) --------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/21 ¤W¤È 08:04:40²Ä 2506 ½g¦^À³ ....²Ä3¤è³ø§i¶O®É³o»ò¤[¤~¥X¨Ó¡A¦³ÂI¥X¥G·Q¹³!(¬Ì±¡¼vÅT?) ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/22 ¤W¤È 05:32:12²Ä 2517 ½g¦^À³ ¸É¥¿²Ä2505½g¦^À³¦p¤U¡A¬Ý¨Ó¦pY±ÂÅv¦¨¥\(°ê»ÚÃļt¤£¥Î§ó´«ÃÄÃÒ)¡AOTC«D³B¤è³o¶ô¤w¤£°µP3¼Ï¯ÃÁ{§É¸ÕÅç¡A§ï¥HP4¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/22 ¤W¤È 08:53:20²Ä 2520 ½g¦^À³
|
¥t¤@®aÃļt¥X¸ê¶i¦æÀø®ÄÅçÃÒ«á¡Aµo²{ÅçÃÒµ²ªG¤£¦p¹w´Á(²Ä2®aÃļtGSK Panadol?)¡A³o¨Æ¨S¤½§i: ©³¤U¥[¶}ªºÁ{§É¸ÕÅç·|»P³o¦³ÃöÁp¶Ü? --------------------------------------------------------------------------------------------------- ·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/9/20 ¤U¤È 05:15:41²Ä 2501 ½g¦^À³ ³oÓÁ{§É¸ÕÅ礧«e´N´¿°µ¹L¤F¡A¥u¬O·í®É SNP-810 ÁÙ¨S¦³¨ú±o¾Ç¦WÃÄÃÒ¡A³o¦¸¥i¯à¬O¥Î¾Ç¦WÃĵn°Oªº¦¨¥÷¨Ó°µ¡C ªk»¡·|¦³´£¨ì·í®Éªº¼Æ¾Ú¡G After a single and multiple oral dose of Panadol® or SNP-810 had demonstrated that SNP-810 could significantly decrease the AAP toxic metabolite (p < 0.005), up to 53% ------------------------------------------------------------------------------------------- ·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/9/20 ¤U¤È 12:26:08²Ä 2499 ½g¦^À³ ¸ÕÅçpµe¦WºÙ ¤@¶µ¦h¾¯¶qÁ{§É¸ÕÅç¡Aµû¦ô¨âºØAcetaminophen ÃĪ«¡]SafeTynadol®·s¾¯«¬»PPanadol®¡^©ó¨ü¸ÕªÌÅ餺¾¯¶q¨î©Ê¨x¬r©Ê¦w¥þ©Ê¤ñ¸û¬ã¨s ¸ÕÅç¥Ó½ÐªÌ¡G ªYÄ£¥ÍÂåªÑ¥÷¦³¤½¥q ¸ÕÅç©e°U/ÃÙ§U³æ¦ì¦WºÙ¡G ¦P¸ÕÅç¥Ó½ÐªÌ ¸ÕÅçpµe®Ñ½s¸¹¡G Oral AAP-002 ®Öã°õ¦æ¤å¸¹¡G 1110720978 ®Öãµn¿ý¤é´Á¡G 2022-09-16 ¸ÕÅç¹wp°õ¦æ´Á¶¡¡G 2021-11-01 ¦Ü 2023-12-31 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/22 ¤W¤È 08:44:20²Ä 2519 ½g¦^À³
|
²Ä1®aÃļt(J&J0,Tylenol ?)¦X§@ÅçÃÒªº´Á¨ì´Á¡A³oÓ¦³¤½§i: ¨Æ¹êµo¥Í¤é:111/02/23 2.¤½¥q¦WºÙ:ªYÄ£¥ÍÂåªÑ¥÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q 4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î¡C 5.µo¥Í½t¥Ñ: ¤@¡B¥»¤½¥qSNP-810·sÃÄ©ó109/12/21¤Î110/05/31¤À§O»P¤G®a°ê»ÚÃļtñq ·sÃĬãµo¦X§@¨óij¡A¶i¦æÀø®Ä½T»{µ¥¬ÛÃö¸ÕÅç¡C110/05/31ñ¬ù¤§°ê»ÚÃļt¡A °£¤w¤ä¥Iñ¬ùª÷¡A¥Ø«e¸ÕÅ祿¨Ì¦X¬ù¤º®e¶¶§Q¶i¦æ¤¤¡C ¤G¡B109/12/21ñ¬ù¤§°ê»ÚÃļt¡A¨Ì¾Ú¦X§@¨óij¤º®e¡A¤w¤ä¥Iµ¹¥»¤½¥qñ¬ùª÷¡C ¦]©e°U²Ä¤T¤èÅçÃÒ³æ¦ì°õ¦æ³¡¥÷¸ÕÅç¡A©|¥¼§¹¦¨¥Ø¼Ð¡A¥Ø«eÂù¤è¤´Ä~Äò¤À¨É¸ÕÅç ¼Æ¾Ú¡A¨ÃÄ~Äò©e°U²Ä¤T¤èÅçÃÒ³æ¦ì¡A¶i¦æÅçÃÒ¸ÕÅ礤¡A¤]¥¼¥I¨½µ{¸Oª÷¡A¦¹¨Æ¹ï ¤½¥q°]°È·~°È¨ÃµL«¤j¼vÅT¡C¸Ó¦X§@¨óij¨Ì¦X¬ù´ÁÀ³©ó111/02/23©¡´Á¡A«áÄò ¦X§@Äò¬ù©Îñq·s¬ùµ¥¬ÛÃö¨Æ©y¡A¥ç¦b¶i¦æ¤¤¡C |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2022/9/22 ¤W¤È 08:24:17²Ä 2518 ½g¦^À³
|
ªYÄ£¸³¨Æªøº[Á`¸g²z¦¶³Í¥Áªí¥Ü¡ASNP-810쥻»P¨â®a°ê»ÚÃļtñ¸p¦X§@¨óij¡A°w¹ï³o¶µ¬ãµo¤¤ÃĪ«¶i¦æÀø®ÄÅçÃÒ¡A¨ä¤¤¤@®aÃļt¦X§@ÅçÃÒªº´Á¤w¹L¡A¦ýªYÄ£¤´¦b¬¢½Í«·s«ì´_¦X§@¡F¥t¤@®aÃļt¥X¸ê¶i¦æÀø®ÄÅçÃÒ«á¡Aµo²{ÅçÃÒµ²ªG¤£¦p¹w´Á¡A¦ý¬O¸g¹LªYÄ£«·s½Õ¾ãÅçÃÒ±ø¥ó«á¡A±o¨ì¬Q¤é¤½§iªº¥¿¦Vµ²ªG¡C ¬Ý¨ì³o¬q¸Ü¬ðµM²D¤F¤@¤U ¦ý³Ì«áµ²ªG¬O¥¿¦V¬ðµM·x¤F¦^¨Ó |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/22 ¤W¤È 05:32:12²Ä 2517 ½g¦^À³
|
¸É¥¿²Ä2505½g¦^À³¦p¤U¡A¬Ý¨Ó¦pY±ÂÅv¦¨¥\(°ê»ÚÃļt¤£¥Î§ó´«ÃÄÃÒ)¡AOTC«D³B¤è³o¶ô¤w¤£°µP3¼Ï¯ÃÁ{§É¸ÕÅç¡A§ï¥HP4¡C ¤µ¦~¦~³ø¤º®e: ²Ä¤@¶¥¬q¥ý¥H¡§§C¬r©Ê¤AñQÓi×ô¡¨¤W¥«:SNP-810¤w¨ú±oÃÄ«~ÅçÃÒ¸¹¤Î¬ü°ê¥«³õ¾P°â¸ê®æ¡C 2021.09.22 www.hea.com.tw/newsDetail.asp?id=17709 ...¦¶³Í¥Á¸ÑÄÀ¡A»PªYÄ£¬¢½Í¦X§@ªº¤½¥q³£¬O¥Ø«e¤´¾P°â¤AñQÓi×ô¦¨¥÷¤îµhÃĪº¤j¼t¡AY¦¨¥\±NSNP-810±ÂÅvµ¹°ê»ÚÃļt¡A ¹ï¥¦Ì¨Ó»¡¥un§ó§ï½á«¬¾¯¡A¤£¥Î§ó´«ÃÄÃÒ¡C ²Ä¤G¶¥¬q¦A¥H Phase IV¸ÕÅç¡A±À¼s¦Ü¡§µL¨x¬r©Ê¤AñQÓi×ô¡¨:Phase IV¶¥¬q¬OÃÄ«~¤W¥««áªº°lÂÜ¡A¥B»P¤w®Ö㪺¾AÀ³¯g¬ÛÃö¡AºÊ´ú¸ÓÃĪ«¬O§_¦³¥ý«e´XÓ¶¥¬q¨Sµo²{ªº°Æ§@¥Î©Î¬O¤£¨}¤ÏÀ³µ¥±¡ªp¡A¸ÕÅç³]p¸û¬°Â²³æ¡A¦ý¬O»Ýn¤j¶qªº¯f¤H¶i¦æªø®É¶¡ªºÆ[¹î¡C ---------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤W¤È 10:42:03²Ä 1936 ½g¦^À³ ¤G) µL¨x¬r©Ê¤îµh·sÃÄ(OTC)¡G SNP-810 µ¦²¤¹B¥Î...¤§Äw½X¡C¦Ò¶qÅçÃÒ SNP-810 ¬°µL¨x¬r©Ê®É¶¡¸ûªø¡A§ÚÌpµe¤À¶¥¬q¨Ó§¹¦¨¡A²Ä¤@¶¥¬q¥ý¥H¡§§C¬r©Ê¤AñQÓi×ô¡¨¤W¥«¡A²Ä¤G¶¥¬q¦A¥H Phase IV¸ÕÅç¡A±À¼s¦Ü¡§µL¨x¬r©Ê¤AñQÓi×ô¡¨¡C (¤T) µL¨x¬r©Ê¤îµh½Æ¤è·sÃÄ(³B¤èÃÄ)¡G ...¤½¥q«áÄò¤´¦³³W¹º¹ï©ó¬ü°ê¥«°â 600ºØ§t¦³¤AñQÓi×ô¤§·P«_Ãĵ¥½Æ¤è¡AY¥Ñ SNP-810 ¨Ó´À´«¡A¥ç¥i¨ü°U¶i¦æÃİʤÎÃĮĸÕÅçÅçÃÒÀø®Ä¡C |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2022/9/21 ¤U¤È 02:52:05²Ä 2516 ½g¦^À³
|
¥_·¥¬P¸Ñª¼¹LÃö¹ï¾ãӥͧ޲£·~ªºª^³ò¬O¥[¤Àªº 9/16ªº®Öãµn¤J 9/20ªº«¤j°T®§¤½§i ¬Û«HªYÄ£¹Î¶¤¬O¦³»{¯u¦b°µ¨Æ ±µµÛÅý¤½¥q¨Óµo§G¡¨¦³³Ì·s¶i®i±NÀH®É¤½§i¡¨ªº¦n®ø®§§a¡I |
|
|
·|û¡Gadigo10135839 µoªí®É¶¡:2022/9/21 ¤U¤È 02:30:40²Ä 2515 ½g¦^À³
|
¥_·¥¬P¶¶§Q¸Ñª¼ ¹ïªYÄ£¤]¬O¤@¤j¹ªÀy ¥[ªo¤F |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/21 ¤U¤È 01:41:01²Ä 2514 ½g¦^À³
|
¬Û¸û©óÃĵØ(3¦~«e)»P¤ß®®³Ìªñ¤½§i¼W¸ê«áªºªÑ»ù±¡ªp¡AªYÄ£¤½¥q¨}µ½¤Ó¦h¤F! |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/9/21 ¤U¤È 01:27:18²Ä 2513 ½g¦^À³
|
Ó¤H¤]ÃÙ¦P¥u½×°ò¥»± »ù®æ¥Ñ¥«³õ¥h¨M©w ¦b³Û´X¤¸¡A¦ü¥G·N¸q¤£¤j¡C |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2022/9/21 ¤U¤È 01:16:16²Ä 2512 ½g¦^À³
|
±ÂÅvª÷¤½§G¡A30¤¸¬O¹sÀY§a¡I ¦ý§Ú«Øij¤£n¦b³oÁr´ú»ù¦ì³æ¯Â°Q½×°ò¥»±§Y¥i »ù®æ³¡¤Àµ¹¤j¤HÌ¥h·Ð´o´N¦n |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/21 ¤U¤È 12:54:55²Ä 2511 ½g¦^À³
|
«¥¤£¾Õµu½u§Þ³N¶R½æ¡A¦ýªø½u²´¥ú¦Û»{¨S¨«²´¹L! §Ú¨S¸ê¨÷³]©w¡A¥u¯à°µ¦h¡A©Ò¥H¬ÝªÅ¨Ã¤£°µªÅ!(°ê¹©°ªºÝ) ¬d²z.»X®æ:°ªÃBªº³ø¹S¨Ã«D¨Ó¦Û©ó¶R½æ¡A¦Ó¬O¦s¦b©óµ¥«Ý¤§¤¤¡C --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/8 ¤U¤È 12:24:18²Ä 1191 ½g¦^À³ ¬°¦ó¥xÆW3®a·s«a¬Ì]¥þÀ£¦b«组³J¥Õ¬Ì]¡A¤£°µmRNA¬Ì]? »¡¬ï´N¬O§Þ³N¤£¨ì¦ì..... ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/16 ¤U¤È 05:21:57²Ä 1522 ½g¦^À³ 3¨¥2»y»¡¤£²M¡A²Ä6·Pn«¥¯à¸ú¦h»·°{¦h»·! ...¤½¥q¦WºÙ¡G°ê¹© µo¨¥¤é´Á¡G2021/11/25 µo¨¥®É¶¡¡G16:29:53 µo¨¥¤H¡G´¿¤ì¼W 1.¸³¨Æ·|³q¹L¤é´Á(¨Æ¹êµo¥Í¤é):110/11/25 ... |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/9/21 ¤U¤È 12:53:13²Ä 2510 ½g¦^À³
|
Y¤½¥¬±ÂÅvª÷¡A¦Ü¤Ö¤«¼Q30¤¸¡C |
|
|
|